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Malaria is one of the deadliest diseases in human history. Nearly half of the world’s population, 
is at the risk in 106 countries. Only in 2016, this disease killed about 445,000 people, 72% of them 
being children under age five. It also accounts for US $12 billion dollars of direct costs in Africa 
alone. Five different species of Plasmodium cause malaria but P. falciparum is the most 
detrimental one, causing 50% of all malaria cases and is considered as the deadliest parasite in 
humans. Artemisinin (ART), a 15 C sesquiterpenoid is currently the only precursor to the most 
effective anti-malarial drugs. The World Health Organization (WHO) recommends the use of ART-
derived drugs in combination with other anti-malarial drugs (collectively called as Artemisinin-
based Combination Therapies, ACT), to prevent the development of ART resistance by the 
parasite. The natural source of ART is Artemisia annua, an Asteraceae plant native to East Asia. 
ART is synthesized in 10-cell glandular trichomes and accumulates extra-cellularly in the sub 
cuticular space. ART is synthesized in A. annua in low quantities, about 0.01-3% DW and, due to 
its complex molecular structure, it cannot be synthesized chemically in an economically viable 
way. Even though the semi-synthesis of ART has been successful in bioreactors, ART extraction 
from A. annua is much more economically viable. Therefore, it is important to understand the A. 
annua genetic contribution to ART synthesis to improve the ART yield of the plants. We 
characterized a collection of 12 different genotypes of Artemisia annua at West Virginia 
University in terms of developmental traits, biochemical profile, and gene expression to better 
understand the phenotypical differences of the germplasm in the collection. Plants were 
analyzed for height, biomass, leaf shape and leaf size, adaxial and abaxial trichome densities for 
morphological characterization. Freeze dried leaf material was extracted with hexane and an 
internal standard and the extractions were analyzed with GC-MS. Flash frozen leaf material were 
used to extract total RNA and analyzed for the gene expression of 15 genes with qRT-PCR. Based 
on the results, it was revealed that there is high phenotypical and metabolic variation among the 
genotypes. Monoterpenes made up for a large component of the hexane-extracted metabolome. 
Camphor and endo-borneol contributed significantly to differentiate the genotypes. Out of the 
all the genes analyzed, gene expression of three genes (FPS, CPR, and DBR2) were significantly 
different among the genotypes. Based on data, genotype J has the highest accumulation of ART 
and DHAA with anatomical characteristics supporting towards high ART and DHAA yield. Next, I 
and G genotypes also showed anatomical features supporting towards high ART and DHAA 
accumulation. The genotypes can be used to further investigate ideal genetic variations and 
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Artemisinin (ART) is the sesquiterpenoid the precursor of the main component that the World 
Health Organization (WHO) recommends as treatment for Plasmodium falciparum malaria 
(WHO, 2006). Artemisinin is a secondary metabolite naturally synthesized in the annual herb 
Artemisia annua (Asteraceae). ART is produced only in A. annua in small quantities, 0.01-1.4% of 
dry weight and its supply does not meet the global demand, which results that ART-based 
treatments (ACTs) are costly and the prices fluctuate drastically. Even though the semi-synthesis 
of ART using yeast (Saccharomyces cerevisiae) as a heterologous system has been successfully 
achieved, the production costs have made it a pricier alternative (Pelpow, 2016). Therefore, A. 
annua remains the most economically viable source for the synthesis of ART.   
The major goal of this research is to characterize phenotypically and genetically the twelve 
genotypes of Artemisia annua germplasm collection at West Virginia University regarding their 
accumulation of artemisinin (ART), dihydroartemisinic acid (DHAA) and artemisinic acid (AA), and 
compare the morphological and genetic factors that determine the levels of those metabolites 
within the genotypes. Understanding the factors that drive high ART and DHAA yield is important 
to breed for superior A. annua genotypes that can be used to fulfill the demand for ART-based 
active pharmaceuticals on time and at a reasonable and constant price.  
The first chapter of this thesis is a brief introduction to the importance of A. annua in malaria 
treatments and factors related to ART biosynthesis pathway with the current available literature.  
The second chapter presents the morphological characterization of the twelve genotypes of A. 
annua in the germplasm collection at West Virginia University. Plant height, biomass of the aerial 
system, leaf area as well as adaxial and abaxial trichome densities were measured and compared 
among the genotypes.  
The third chapter shows the GC-MS analysis of non-polar secondary metabolites extracted with 
hexane. Fifty-two peaks were identified with National Institute of Standards and Technology 
(NIST) mass spectral library and of those 52 compounds, two of which (camphor and endo-
borneol) were confirmed with authentic standards after pre-statistical analysis. The online 
MetaboAnalyst (4.0) software was used to analyze the relative abundance of compounds. 
The fourth chapter deals with the gene expression analysis performed to understand the 
transcriptional differences of the ART biosynthesis pathway genes among the twelve genotypes 
in the study. RT-qPCR was used to compare the mRNA levels for each gene between genotypes 
relative to a housekeeping gene using the SYBR Green fluorescence system. 
The fifth chapter discusses how to apply the knowledge gained from this research and already 
available information in the scientific literature towards the breeding of genotypes with high ART 
and DHAA yield and how to overcome the inherent barriers associated with A. annua genome.  
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The sixth and the last chapter presents the summary and conclusions reached with the data 





The historical importance and current status of malaria in the world 
 
Malaria is one of the deadliest disease of human history. Nearly half of the world 
population, 3.2 billion is at the risk in 106 countries. Only in 2016, malaria killed about 445,000 
people in the world, 72% of them being children under age 5. It also accounts for US$ 12 billion 
dollars direct cost only in Africa (CDC, 2018). Earlier it was believed that humans and chimpanzees 
each inherited cerebral malaria parasite-like infections from their common ancestor and these 
parasites co-evolved with their hosts (Escalante and Ayala, 1994). But it is now believed that 
cerebral malaria parasite infection arose in humans after acquiring it from a gorilla likely within 
the past 10,000 years (Liu et al., 2010b; Sundararaman et al., 2016). Some researchers believed 
that half of all human who ever lived died from malaria (Whitfield et al., 2002). A less known fact 
is that the Center for Disease Control (CDC) was founded in 1946 mainly to control malaria in the 
U.S. Even though malaria has been eradicated from many countries, it still threatens the lives of 
about half a million lives annually.  
There are five different Plasmodium species that cause malaria in humans: P. falciparum, 
P. malariae, P. vivax, P. ovale and P. knowlesi. P. falciparum is the most common in African 
region, accounting for 99% of reported cases in 2016 whereas P. vivax is the most common on 
American, South East Asian and Eastern Mediterranean regions (WHO World Malaria Report, 
2017). Although the U.S. did not have any reported cases in recent years, there are areas in the 
country susceptible to the presence of the Anopheles mosquito vector, such as: Southern Florida 
and Hawaii, and not to mention unincorporated territories, such as Puerto Rico and Guam. 
Therefore, it is of US interest not only to prevent the introduction of the disease in the country, 
but also to mitigate the disease by providing foreign aid with the aim to eradicate the disease 
globally. 
Malaria is characterized by an acute febrile illness with an incubation period of seven 
days or longer (WHO International Travel and Health Report, 2018). Between the two most 
common parasites causing malaria, P. falciparum and P. vivax, the former causes the most 
dangerous version of the disease, called the malignant form, whereas P. vivax causes less severe 
symptoms, called the benign form (Vogel, 2013). Initial mild symptoms of falciparum malaria 
can be fever, chills, headache, muscular aching and weakness, vomiting, cough, diarrhea, and 
abdominal pain. If not treated, more severe symptoms can occur, such as acute renal failure, 
pulmonary edema, generalized convulsions, circulatory collapse, following by coma and death 
(WHO International Travel and Health Report, 2018). Even though the initial mild symptoms of 
the disease may not be easily recognizable as malaria, it must be treated early because 
falciparum malaria can be fatal if treatment is delayed beyond 24 hours after the onset of clinical 
symptoms. Therefore, it is important to assume the possibility of falciparum malaria in cases of 
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having an unexplained fever, seven days after the first possible exposure to three months or 
rarely later after the last possible exposure to the malaria (vector) (WHO International Travel 
and Health Report, 2018). Other forms of malaria are not generally considered as fatal, except 
for a few cases of severe P. vivax recently reported. Additionally, P. vivax and P. ovale can remain 
dormant in the liver and cause relapses months after the exposure (WHO, 2018). 
Although most temperate countries have eliminated the malaria threat (Figure 1), 
according to the WHO’s World Report of Malaria 2017 (WHO, 2018), 216 million cases of malaria 
have reported in the world last year, with 90% of the cases from Africa whereas 7% and 2% from 
Southeast Asia and Eastern Mediterranean regions, respectively. In 2016, an estimated 445,000 
deaths have been reported in which 91% are from African region followed by 6% from East Asian 
region (WHO World Malaria Report, 2017) Out of the 91 countries reporting indigenous malaria 
cases in 2016, 80% of the burden is carried by India and 14 of sub- Saharan African countries ( 
WHO World malaria report, 2017).  
Even though anyone can be infected with malaria, the young and the elderly, pregnant 
women and immunosuppressed individuals are considered to be at greatest risk when living and 
travelling in areas where the disease is prevalent. It is a well-known fact that, despite the 
negative effects of the sickle cell disease, this trait protects against malaria infection, even in 
asymptomatic (heterozygous) individuals (Serjeant, 2010) – it’s therefore thought that the trait 
first evolved as a protection against the disease in endemic regions of Africa. 
Quinine (an ingredient of tonic water) had been traditionally used as medicine against 
malaria and is still listed an essential medicine by WHO (WHO World Malaria Report, 2015). 
However, over time the protozoan developed resistance against it, making it less effective (Le 
Bras and Durand, 2003). This quinoline alkaloid was first isolated from the bark of the Cinchona 
officinalis tree (Rubiaceae) and is still used against chloroquine-resistant P. falciparum when the 
artemisinin-derivative (artesunate) is not available (Esu et al., 2014). The current malaria vaccine 
(called RTS,S) has low efficacy against P. falciparum and is not recommended by WHO to prevent 





Figure 1. World malaria distribution 2018. Countries under the threat of malaria (in blue). Note that the 
disease level varies substantially within the 91 countries with reported cases. The Sub-Saharan region in 
Africa accounts for more than 90% of the global cases, mostly due to Plasmodium falciparum. Source: 
Global Health - Division of Parasitic Diseases and Malaria - Center for Disease Control (CDC) (2018). 
 
Artemisia annua and the sesquiterpene lactone, artemisinin 
 
Artemisia annua is the only commercial source for artemisinin (ART), the precursor for 
main component of the malaria treatment recommended by WHO against P. falciparum: 
Artemisinin combination therapy (ACT). Due to diverse reasons, this plant remains the most 
important source of artemisinin in the market. However, the supply has consistently not met the 
global demand for the medicine (Kindermans et al., 2007; Shretta and Yadav, 2012; Pandey and 
Pandey-Rai, 2016). 
Species of the genus Artemisia (family Asteraceae  subfamily Asteroideae  
supertribe Asterodae  tribe Anthemideae) are well known for their medicinal, cosmetic, 
pharmaceutical and culinary values. It consists of a large clade encompassing 200-400 species, 
including wormwood (A. absinthium), an ingredient of absinthe, the culinary herb tarragon (A. 
dracunculus), and the anti-malarial herb, sagewort or sweet wormwood (A. annua). The exact 
number of species is unknown due to a plethora of synonyms. The name of this genus refers to 
the wilderness goddess Artemis in the Greek pantheon (she is the equivalent to Diana in the 
Roman mythology).  
This genus consists of annual, biennial and perennial herbs and shrubs distributed in Asia, 
North America, Africa, and Europe (Pandey and Singh, 2017) with a greatest concentration in 
Asia (Abad et al., 2012). Because of copious secondary metabolite production, many species are 
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bitter and have strong odor that evolved to overcome herbivory and that have been harnessed 
to treat human maladies and other uses. Many metabolites synthesized in Artemisia spp. is 
known to have antimalarial, cytotoxic, antibacterial, antifungal, and antioxidant properties 
(Abad et al., 2012; Pandey and Singh, 2017). And among them, A. annua is well known and 
researched for its principle component Artemisinin (ART), the antimalarial drug precursor for 
recommended for multi- drug resistance to P. falciparum. 
Artemisia annua L. is native to temperate Asia (China and Vietnam) used in traditional 
Chinese medicine for thousands of years as treatment for malaria. It has been naturalized to 
North America, South America and Europe (Ferreira and Janick, 1995).  It is an annual short-day 
plant with a critical day length of 13.5-h. The species is allogamous and naturally cross-pollinated 
by wind (Ferreira and Janick, 1995). Currently, A. annua is the only natural source of ART, the 
precursor of semi-synthetic anti-malarial drugs. In 2015, Youyou Tu was awarded the Nobel Prize 
of Medicine for the discovery of artemisinin (ART) as the anti-malarial active compound in A. 
annua (Su and Miller, 2015). 
ART is a highly oxygenated sesquiterpene with a 1,2,4-trioxane ring structure (Figure 2) 
that is believed to be the reaction center that confers its antimalarial activity (Brown, 2010) 
against the asexual stage of the P. falciparum (Bryant et al., 2015). ART-based semi-synthetic 
drugs are used in the so-called Artemisinin Combination Therapies (ACTs) as the standard 
treatment for chloroquine- and quinine-resistant P. falciparum, which causes cerebral malaria, 
as well as against other Plasmodium species (Weathers et al., 2006; Covello, 2008; Pandey and 
Pandey-Rai, 2016). ART is not only effective against malaria but also other parasitic diseases, 
such as schistosomiasis (Schistosoma spp.), and leishmaniasis (Leishmania spp.) (Krishna et al., 
2008). ART was also effective to treat some viral diseases, such as hepatitis B (Nguyen et al., 
2011; Rai et al., 2011). Additionally, ART was indicated to be effective against several cancer cell 
lines and drug-resistant cancers (Weathers et al., 2006).  
A. annua genotypes can be classified into two chemotypes based on their geographic 
origin that produce different levels of artemisinin and its precursors: dihydroartemisinic acid 
(DHAA) and artemisinic acid (AA). The chemotype clones high in ART and DHAA but low in AA is 
from Vietnam while the Chinese (which includes the European-American clones) are high in AA 




Figure 2. Structure of artemisinin. The endoperoxide group in the 1,2,4-trioxane ring is 
considered as the active site of this 15-C sesquiterpene molecule.  
 
As the main component of ACT, there is a very high global demand for ART (Shretta and 
Yadav, 2012). It is estimated that the global demand for ART in 2017 reached 176 metric tons 
with an expected demand of 216 metric tons for 2021 (Global malaria diagnostic and artemisinin 
treatment commodities demand forecast, 2018). However, due to the difficulties in cultivating 
A. annua as a field crop, since this species can remain highly undomesticated, ART demands are 
hardly met (Graham et al., 2010). There have been research efforts to find alternatives to ART 
production, including the use of biotechnology, such as yeast, bacteria, and algae bioreactors 
(Ro et al., 2006; Chang et al., 2007; Paddon and Keasling, 2014; Ikram and Simonsen, 2017; Choi 
et al., 2017; Badshah et al., 2018) as well as tobacco leaves (Farhi et al., 2011; Fuentes et al., 
2016). Indeed, the entire artemisinin pathway up to DHAA has been introduced into prokaryotic 
(E. coli) and unicellular eukaryotic systems (budding yeast), as well as moss (Physcomitrella 
patens) and artemisia hairy roots for bioreactor semi-synthesis of DHAA (Paddon and Keasling, 
2014; Khairul Ikram et al., 2017; Patra and Srivastava, 2016) in addition to tobacco (Fuentes et 
al., 2016). However, ART produced in bioreactors becomes too expensive for governments in 
developing countries and the target populations that need the medicine the most. In planta 
production by A. annua field cultivation still remains the cheapest and most economically viable 
method of producing ART (Delabays et al., 2001; Ikram and Simonsen, 2017).  
As a secondary metabolite, ART is synthesized in low quantities in plants (0.01-3% dry 
weight). Due to the complex nature of its molecular structure, the complete chemical synthesis 
is not economically viable (Kumar et al., 2004). ART semisynthesis in transgenic yeast has been 
achieved recently (Paddon et al., 2013). During its semisynthesis in yeast, the natural mevalonic 
acid (MVA) pathway was improved to increase the biosynthesis of farnesyl pyrophosphate (FPP 
– the precursor of all sesquiterpenes) and lower the endogenous sterols production(Meadows 
et al., 2016). Subsequently, by introducing the gene amorpha-4,11-diene synthase (ADS) along 
with a novel cytochrome P450 from A. annua (CYP71AV1) to first cyclize FPP to amorpha-4,11-
diene (AD), which is the first committed metabolite of the ART pathway, and further oxidize it 
to artemisinic acid (AA), respectively. Finally, the extracted AA can be converted to ART in vitro 
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via catalytic hydrogenation to yield dihydroartemisinic acid (DHAA), and further processed by 
esterification of the carboxyl bond in DHAA, a reaction with chemically generated singlet oxygen 
(1O2), to produce an allylic hydroperoxide, and finally a series of acid-catalyzed reactions and 
oxygen to finally yield ART (Paddon et al., 2013). Even though the semisynthesis of ART has been 
successful industrially, ART extraction from A. annua is much more economically viable: the 
semi-synthetic ART costs US$350-400/kg vs. US$250/kg of the naturally extracted from A. annua 
(Peplow, 2016). 
 
Glandular secretory trichomes  
Trichomes are epidermal protrusions found on aerial organs of plants to provide physical 
and chemical protection. As a general feature of the Asteraceae family, A. annua bears two types 
of trichomes: glandular secretory trichomes (GST) (Figure 3), as well as filamentous T-shaped 
non-glandular (tector) trichomes (Ferreira and Janick, 2009). Trichomes are found on the aerial 
organs of A. annua such as stems and leaves (Duke and Paul, 1993) as well as on the corolla and 
floral receptacles (Ferreira and Janick, 1995). GSTs are evenly distributed on both leaf surfaces, 
except the leaf margin, but with a higher density on the abaxial surface. A. annua GSTs are 
stalkless (sessile) and consist of ten cells arranged in a biseriate manner. Each GST consists of a 
pair of basal cells, a pair of stalk cells, three pairs of secretory cells, and a bilobed sac made by 
the cuticle of six secretory cells (Duke and Paul, 1993). Stalk cells contain smaller chloroplasts 
compared to mesophyll chloroplasts with an average area of 6.1 µm2 compared to 6.5 µm2 of 
subapical cells containing large, amorphous plastids lacking starch grains (modified 
chloroplasts), and the apical cells that contain no chloroplasts (Kjaer et al., 2014). All GST cells 
have a large amount of smooth endoplasmic reticulum associated with secondary metabolite 
synthesis and exporting (Duke and Paul, 1993). The main role of GST is considered as a protection 
against various biotic stresses by producing a large array of secondary metabolites. GSTs protect 
the plants from herbivores by releasing irritant secondary metabolites by excretion or rupturing 
the sac upon touch or by ingestion of bitter or poisonous metabolites (Kjaer et al., 2014). 
A. annua GSTs are the synthesis site of about 600 secondary metabolites, mostly 
terpenoids, including ART. Based on evidence of transcription activity of key ART biosynthesis 
genes, GST are considered as the sole sites of ART biosynthesis. A GST laser dissection study 
showed that the expression of four genes (ADS, CYP7AV1, DBR2 and ALDH1) occurs in both, 
apical and subapical cells (Olofsson et al., 2012). Despite of the importance of GST to synthesize 
and store ART, and plethora of compounds in diverse species, the molecular mechanisms of GST 
development remain generally poorly understood. Duke and Paul (1993) reported the 
initiation of GST from foliar cells begins in the youngest leaf primordia and complete the 
differentiation into the 10-cell structure before the start of the leaf development meaning 
that the final number of the GST is predetermined regardless of the final leaf size. The GST 
density peaks in the young, fully expanded leaf and decreases rapidly due to rupturing of the 
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subcuticular sac (Duke and Paul, 1993) caused by mechanical damage. Singh et al. (2016) 
showed that the overexpression of -glucosidase increased the trichome density in A. annua 
(Singh et al., 2016). Similarly, Shi et al. (2018) demonstrated that the overexpression of 
AaMIXTA1, a MYB transcription factor that is expressed mainly in basal cells of GST, increased 
the number of GSTs and ART content in A. annua (Shi et al., 2018). On the other hand, 
attempts to increase GST densities by applying abiotic stresses have not been successful 




Figure 3. Structure of the glandular trichome of A. annua. Left: A schematic diagram of GST indicating cell 
arrangements. Right: Fluorescence microscopic image of GSTs on the abaxial side of the A. annua leaf 
(Scale bar = 500 µm). 
 
The artemisinin biosynthesis pathway  
ART is a sesquiterpene lactone made up of three isoprene units. It originates in the 
cytosol from precursors derived from the cytosolic mevalonate (MVA) pathway as well as the 
plastidial methylerythritol phosphate (MEP) pathway (Weathers et al., 2011) (Figure 4). 
Although there are two independent pathways that synthesize the two basic isoprene units 
[isopentenyl pyrophosphate (IPP) and dimethyallyl pyrophosphate (DMAPP)], the predominant 
route in plants is the cytosolic MVA pathway, which originates from acetyl-CoA, whereas the 
plastidial MEP pathway originates from pyruvate and glyceraldehyde 3-phosphate (G3P) 















 Figure 4. Biosynthesis pathway of the sesquiterpene lactone, artemisinin in glandular trichomes of 
Artemisia annua. 1. Plant terpenoids are synthesized via two distinct pathways, the cytosolic mevalonate 
pathway in the cytosol and methyl-erythritol phosphate pathway in plastids, with both contributing with 
IPP and DMAPP isomeric moieties. 2. Interconversion of IPP into DMAPP is carried out by IPP isomerase. 
The steady-state IPP: DMAPP isomeric ratio in A. annua cells is estimated in 6:1. Therefore, the availability 
of the more reactive moiety (DMAPP) is a major bottleneck of the general terpenoid pathway. 3. In the 
cytosol, GPP synthase (GPS) fuses IPP and DMAPP to produce GPP, which is the precursor of all terpenoids. 
4. FPP is produced by farnesyl synthase (FPS) by the fusion of GPP and IPP. FPP is the precursor of all ≥15-
carbon terpenes. 5. Amorpha-4,11-diene synthase (ADS) synthesized the first committed product of the 
artemisinin pathway, AD. ADS is a limiting enzyme and key to increase the flux of the pathway. 6. 
Following, the cytochrome P450 monooxygenase CYP71AV1 oxidases AD to AA in three successive 
reactions (7 and 11). CYP71AV1 is the main rate-limiting enzyme of the committed artemisinin pathway. 
Moreover, the associated cytochrome P450 reductase (CPR) is necessary to restore the active state of 
CYP71AV1. 7. Whereas AO can be produced by the CYP71AV1/CRP enzymatic system, the alcohol 
dehydrogenase 1 (ADH1) can also AO using AOH as a substrate. 8. AO is disputed by the enzyme 
artemisinic aldehyde Δ11(13) reductase (DBR2), which generates DHAO, and the third reaction of 
CYP71AV1 (11), which is unproductive and generates AA. 9. DHAO is converted into DHAA by aldehyde 
dehydrogenase 1 (ALDH1). 10. The conversion of DHAA into ART is carried non-enzymatically, possibly by 
ultraviolet light and/or reactive oxygen species generated in the cell by stress. 11. The third reaction of 
CYP71AV1 turns AO into AA, deviating the pathway from producing ART. 12. AA can be converted non-
enzymatically into AB. (Chemical structures were captured from www.molview.org).  
However, unlike most of other plant terpenes, ART is composed of basic isoprene units 
originated from both pathways. First, Towler and Weathers (2007) showed that inhibition of 
MVA and MEP pathways respectively with mevinolin and fosmidomycin, decreased ART 
biosynthesis (Towler and Weathers, 2007). Later, Schramek et al. (2010) brought up a possible 
scenario for the contribution of both pathways to synthesize the artemisinin precursor (FPP) by 
isotopologue profiling of A. annua plants with 13CO2. From the 13C NMR spectroscopy results, 
they proposed that mostly DMAPP of MVA origin is first transferred to the plastid and then used 
to synthesize geranyl diphosphate (GPP), which is subsequently exported to the cytosol for 
further elongation to form farnesyl diphosphate (FPP) with a unit of IPP from the MVA pathway 
(Schramek et al., 2010; Wen and Yu, 2011). Even though the ART pathway is not completely 
understood yet, as a sesquiterpene, its biosynthesis can be split into two stages, namely the 
synthesis of the linear precursor (FPP), followed by cyclization and modifications into the final 
product. While the enzymes for the first stage are evolutionarily conserved across species, 
enzymes for the second stage are species-specific and result in distinct terpenoid profiles (Wen 
and Yu, 2011).   
Therefore, FPP is synthesized via the activity of several enzymes using precursors from 
both, MVA and MEP pathways. In the MVA pathway, 3-hydroxyl-3-methylglutaryl-CoA reductase 
(HMGR) catalyzes HMG-CoA to MVA and is considered the first rate limiting enzyme in the 
terpenoid pathway (Wen and Yu, 2011). Transgenic and chemical studies using plant hormones 
(e.g., auxin and gibberellin) showed that HMGR is a direct regulator of ART biosynthesis in A. 
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annua (Wen and Yu, 2011). In the MEP pathway, 1-deoxy-D-xylulose-5-phosphate synthase 
(DXS) and 1-deoxy-D-xylulose-5-phosphate reductoisomerase (DXR) catalyze the two rate-
limiting steps and were also shown to be regulated in ART biosynthesis (Wen and Yu, 2011).  
The first committed step towards ART biosynthesis is the cyclization of FPP to amorpha-4 
,11-diene by the trichome-specific sesquiterpene cyclase called amorpha-4,11-diene synthase 
(ADS) (Bouwmeester et al., 1999; Mercke et al., 2000; Wang et al., 2011). This volatile amorpha-
4,11-diene is subsequently oxidized to artemisinic alcohol and then to artemisinic aldehyde by 
the trichome-specific cytochrome P450 monooxygenase, CYP71AV1 along with its redox partner, 
the cytochrome P450 reductase (CPR) (Teoh et al., 2006; Fuentes et al., 2016). Artemisinic 
aldehyde can be oxidized further by the same enzyme pair and continue to synthesize arteannuin 
B (AB) via artemisinic acid (AA).  AB and AA are side products of the pathway without an anti-
malarial effect. Therefore, they compete with the productive ART pathway. 
Alternatively, artemisinic aldehyde can be used as a substrate to artemisinic aldehyde D11 
(13) reductase (DBR2) in order to form dihydroartemisinic aldehyde (Zhang et al., 2008). 
Dihydroartemisinic aldehyde is then oxidized by aldehyde dehydrogenase (ALDH1) to form 
dihydroartemisinic acid (DHAA) (Zhang et al., 2008), which is considered the immediate precursor 
for ART in vivo. Conversion of DHAA to ART is believed to be a non-enzymatic photooxidative 
reaction that occurs in the subcuticular space of glandular trichomes (Sy and Brown, 2002; Tang 
et al., 2014). The presence of large number of oxygenated terpenoid compounds in A. annua, 
such as terpene allylic hydroperoxides and endoperoxides, is evidence used to support this 
hypothesis, because these compounds are assumed to be intermediates of auto-oxidized terpene 
precursors (Brown, 2010; Fuentes et al., 2016). On the other hand, some reports suggest the 
possibility of enzyme-mediated reactions in the final steps of ART biosynthesis (Ferreira et al., 
2018).  
Genetic regulation of the ART biosynthesis pathway in Artemisia annua 
Apart from the structural genes that code for enzymes directly involved in the 
biosynthesis pathway, there are a number of transcription factors found to control artemisinin 
biosynthesis and accumulation (Shen et al., 2016). The first transcription factor to be isolated 
and characterized in A. annua was AaWRKY1, which is highly expressed in glandular trichomes. 
AaWRKY1 is strongly induced by methyl jasmonate and has the ability to bind to the W-box of 
the ADS promoter in order to activate gene expression in both, transgenic tobacco as well as 
transiently in A. annua leaf system (Ma et al., 2009). Also, AaWARKY1 overexpression enhanced 
the expression of the trichome-specific CYP71AV1. HPLC metabolite profiling of AaWRKY1–
overexpressing A. annua leaves showed a twofold increase of ART compared to the control line 
(Han et al., 2014).  
In A. annua, four AP2/ERF transcription factors have been related to ART biosynthesis: 
AaORA, AaERF1, AaERF2, and AaTAR1. AaORA is highly expressed in both GSTs as well as tector 
trichomes. Its overexpression in A. annua highly induced the transcription of ADS, CYP71AV1 and 
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DBR2 genes (Lu et al., 2013). Two other jasmonic acid response AP2/ERF transcription factors, 
AaERF1 and AaERF2, identified from GST cDNA libraries are highly expressed in the inflorescence 
and have a similar spatial expression pattern as ADS and CYP71AV1 genes (Yu et al., 2012). Lastly, 
TAR1 is expressed at high levels in young leaves and inflorescence and is involved with wax 
deposition, cuticle permeability, trichome morphology as well as ART biosynthesis. TAR1 
overexpression resulted in increased ART, DHAA and AA in leaves and flower buds, 
demonstrating its important role as a regulator of ART biosynthesis and trichome development 
(Tan et al., 2015).  
Additional transcription factors are involved in ART biosynthesis. AaBbZIP1 regulates ART 
biosynthesis by binding to ABRE motifs in the promoters of ADS and CYP7AV1 to increase their 
expression (Zhang et al., 2015). AabHLH1 enhances ART biosynthesis by binding to E-box cis-
elements in ADS and CYP71AV1 promoters (Ji et al., 2014). AaMYC2 binds to the G-box-like cis-
elements in CYP71AV1 and DBR2 gene promoters in order to boost the ART biosynthesis in A. 
annua (Tang et al., 2014).  
 
Flavonoids in A. annua  
A. annua is a species abundant in secondary metabolites. So far about 600 secondary 
metabolites belonging to eight categories have been described in A. annua. Out of these, 
terpenoids form the largest group whereas flavonoids are the second largest category (Brown, 
2010). In fact, A. annua is reported to be one of the four medicinal plants with highest ORAC 
(oxygen radical absorbance capacity) value, with 1,125 and 1,234 µmoles of Trolox equivalents/g 
in leaf and inflorescence extracts, respectively (Ferreira et al., 2010). The high antioxidant 
capacity of A. annua is attributed to the high phenolic content of A. annua, greatly encompassed 
by flavones and flavonols (Ferreira et al., 2010). Eleven flavones and 29 flavonols have been 
reported mainly constituting the flavonoid portion of the profile, including diverse 
polymethoxylated flavonoids (Ferreira et al., 2010). 
Different flavonoids are known to play different biological functions, including protection 
against ultraviolet radiation and as ROS scavengers during biotic and abiotic stress conditions 
(Agati et al., 2011). Flavonoids offer an antioxidative protection by preventing the formation of 
ROS through their ability to chelate transition metal ions such as Fe2+ and Cu2+, as well as 
scavenging ROS once they are generated (Di Ferdinando et al., 2012), and by inhibiting ROS 
generating enzymes (Kumar and Pandey, 2013). Although the flavonoid in vivo mode of action 
regarding ROS scavenging remains unclear, their subcellular localization, on or in close proximity 
to the location of ROS generation, is consistent with their ROS scavenging role (Di Ferdinando et 
al., 2012). 
Similar to ART, DHAA and AA, the flavonoid content of A. annua is related to the genetic 
composition of the two chemotypes (Ferreira et al., 2010). Therefore, their capacity to scavenge 
the ROS produced during stress conditions vary depending on the chemotype. Recently, 
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lyophilized powder of A. annua whole plants was shown to be efficient in treating malaria caused 
by artemisinin-resistant plasmodium, as well as to slow the evolution of drug resistance (Elfawal 
et al., 2015; Daddy et al., 2017). It is thought that, a set of secondary metabolites in the plant 
chemical profile, potentially including flavonoids, is acting synergistically to enhance the anti-
malarial effect of ART. This is a testable hypothesis that deserves a systematic analysis. 
 
Goal of this Research  
This thesis aimed to characterize the differences between the twelve genotypes of the A. annua 
germplasm collection at West Virginia University regarding their physiological, biochemical and 
genetic properties.  This characterization will lead us to better understand the genetic 
underpinnings leading to the development of favorable characteristics in order to improve 









Artemisia annua is an Asteraceae short-day annual herb that naturally grows to about 30-100 cm 
in height with alternate branches. The aromatic leaves of the plant are pinnately dissected with 
a varying number of sections per leaf, depending on the maturity of the organ. The length and 
width of the leaves can vary between 2.5-5 and 1-3 cm, respectively. The flowers are miniscule 
and yellow, arranged in loose panicles with capitula (World Health Organization, 2006). Plants 
prefer cross pollination via insects and wind over selfing, making them highly allogamous 
(Ferreira and Janick, 1995). 
Even though A. annua is the main commercial source for artemisinin (ART), the main component 
of Plasmodium falciparum malaria treatment, current commercial hybrids produce ART in 
relatively low quantities, 1.4% d.w. (Ferreira et al., 2018). Therefore, understanding the 
properties of the plant favorable toward a high ART yield is essential. As dihydroartemisinic acid 
(DHAA), which is the immediate precursor of ART, can be easily converted to ART in vitro, aiming 
for A. annua genotypes with high dihydroartemisinic acid (DHAA) and ART will not only improve 
the natural ART yield from plants but also the total yield by also taking into account DHAA yield 
(Ferreira et al., 2018).  
West Virginia University (WVU) is home to twelve different genotypes of A. annua (Table 1, 
Figure 1) generated from different origin cultivars. Originally, the germplasm collection was 
compiled and maintained by Dr. Jorge F. S. Ferreira when working at USDA/ARS in Beaver, WV. 
Seeds of a high ART yielding Brazilian cultivar, 3M and the Swiss cultivar, Artemis were grown 
and plants that were high in ART and DHAA were selected. Similarly, seeds from cv. Sandeman 
were grown and a genotype was selected with high artemisinic acid (AA) levels. All of these seed-
generated genotypes were maintained vegetatively under the greenhouse conditions. The 
collection was passed down to Prof. Vagner Benedito at WVU when the research station closed 
down in 2012. The most striking difference among these genotypes is in the accumulation levels 
of ART and its precursor DHAA, as well as the non-productive byproduct AA. The twelve 
genotypes were named A to L for the ease of use and their genotype identification number and 










Table1. Identification codes for A. annua 
genotypes in the germplasm collection at 
the West Virginia University. 
Genotype Code Origin 
3M13 A Brazilian 
3M29 B Brazilian 
3M39 C Brazilian 
3M49 D Brazilian 
3M51 E Brazilian 
3M83 F Brazilian 
3M85 G Brazilian 
Sandeman H United Kingdom 
MDP4 I Swiss 
MDP7 J Swiss 
MDP31 K Swiss 




Figure 1. Germplasm collection of A. annua (Asteraceae) at the West Virginia University. The images 





Morphological analyses of A. annua genotypes in the WVU germplasm collection: Four main 
morphological characteristics that are important in determining ART production were analyzed: 
height of the plants, biomass of the aerial system of the plants, leaf shape and leaf area, and 
trichome densities.  
 
MATERIAL AND METHODS 
Maintenance of germplasm collection: stock plants were cultivated in 27-cm diameter round 
plastic pots with soilless medium (Sunshine Mix #1; Sun Gro Horticulture) under greenhouse 
conditions (25/20˚C, average relative humidity 50%) and long-day regimen (16-18h light, 
depending on the season) to repress flowering and subsequent senescence. Plants were irrigated 
daily, as needed. Fertilization was carried out every other day with 20-10-20 fertilizer at 200 ppm. 
The major pests (mealybug, thrips, and spider mites) were treated with insecticides by spraying 
or drenching of Safari® systemic insecticide, as needed. Alternatively, biological control with the 
mite predator, Mesoseiulus longipes, was used.  
Clonal propagation of stem cuttings: 10 cm cuttings were taken from healthy shoots of stock 
plants, dipped in rooting powder (Hormodin #3), transferred to 6-cell trays filled with soilless 
medium (Sunshine Mix #1; Sun Gro Horticulture) and placed in a mist room (21.6±2.6 ̊ C/ 19.4±1.9 
˚C day/night (mean±SD), average daytime relative humidity 57.5% ±10%, 18 h light, on 18±2˚C 
heating pad) for four weeks.  
Experimental design: Six well-rooted cuttings (around 13-15 cm height) from each genotype 
were transferred to pots (15-cm diameter) with soilless medium (Sunshine Mix #1; Sun Gro 
Horticulture) and arranged into a randomized block design in greenhouse for 45 days. Average 
greenhouse temperatures were 23.8±1.7/ 19.8±1.6 ˚C day/night (mean±SD) and the average 
relative daytime humidity was 38.9±10.5%. The plants were irrigated with 20-10-20 (NPK) 
fertilizer at 200 ppm, daily to the field capacity. Harvest was carried out after 45 days of growing.  
Plant height: Each plant was measured from the soil surface to apical meristem to the nearest 
millimeter after 45 days after transplanting. 
Biomass of aerial system: Plants were harvested at the soil level, put in paper bags, and placed 
in a 40 ˚C oven for 15 days, until the dry weights were constant. Biomass of dry material was 
carried out in an analytical scale. 
Leaf measurements: Leaf area was measured using young, fully expanded leaves (n=5) collected 
from random, lateral shoots of three representative stock plants for each genotype. Leaves were 
imaged with a HP6000 scanner and analyzed with ImageJ software (version 1.8.0).  
Glandular secretory trichome (GST) density: Cuttings were taken and their stems were quickly 
placed in water to avoid wilting. GSTs were quantified with small leaf sections removed from the 
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tips of ten fully expanded leaves collected from three stock plants for each genotype. 
Epifluorescence images of both adaxial and abaxial surfaces of the same leaf section for each leaf 
were taken with an Olympus MVX10 fluorescence microscope with GFP filter (2X Objective, 2X 
slider and 1.2X magnification). ImageJ (Version 1.8.0) software was used for counting the 
fluorescent spots (denoting individual glandular trichomes) and to measure the area of the leaf 
section in order to calculate the trichome densities. 
Statistical data analyses: Data were collected for each parameter with each plant representing 
an experimental unit, except for the trichome density measurements, for which each leaf 
represented an experimental unit. ANOVA and post-hoc multiple comparison analyses were 
carried out in JMP (v.13.2). 
 




Figure 2. Height of A. annua germplasm collection. Height of twelve different genotypes of A. annua 
grown under greenhouse conditions for 45 days were measured from the soil surface to the apical 
meristem (n=6). Error bars indicate standard error and genotypes not connected by same letter are 
significantly different (Tukey’s test, α=0.05).  
Average height for the collection ranged more than two folds, from 44.93 cm to 91.73 cm, with 
genotypes I and E, and J and E had the two most height differences among all twelve genotypes, 
46.80 cm and 44.72 cm, respectively (p<0.001). A. annua naturally grows to a height of 30-100 



































An interesting work by Thu et al. (2011) indicates the importance of environmental factors over 
the genetics, on vegetative growth and ART content (Thu et al., 2011). This study showed that 
two A. annua clones (TC1 and TC2) with characteristic late flowering and high ART yield (1-2%) 
responded differently to high (26.2-32.8 ˚C) and low (10.5-18.0 ˚C) temperatures by plants 
growing about four to five fold taller (TC1: 48.9 cm vs. 255.5 cm, TC2: 56.6 cm vs. 258.8 cm) for 
both clones and 4.3 and 3.4 fold higher ART content in TC1 and TC2, respectively, thus correlating 
to the robustness of the plants. They reasoned that the results attributed to high transpirational 
rates in warmer conditions caused the plants to grow shorter and spend more resources on root 
growth to increase water absorption (Thu et al., 2011). In an earlier experiment conducted by 
Elhag et al. (1992) to identify morphological characteristics associated with ART producing A. 
annua genotypes, they concluded that high ART chemotypes are associated with tall, robust 
plants with long internodes, open-branching, dense leaves and thick stems (Elhag et al., 1992), 
which is compatible with the data from our research. Interestingly, however, is that a recent 
research conducted by Czechowski et al. (2018) comparing the high-ART producing (HAP) hybrid 
Artemis and an open pollinated low-ART producing (LAP) A. annua variety mentioned that LAP 
plants are distinctly different from HAP for having taller and long internode plants with smaller 
leaves (Czechowski et al., 2018). It is likely that plant height, biochemical profiles, and ART 
accumulation are genetically unlinked traits, although there is a possibility that distinct loci 
involved in these processes are physically linked in the chromosomes of A. annua. Previous trait 
genetic mapping efforts (Graham et al., 2010) and the recent genome sequence and annotation 
(Shen et al., 2017) will likely help resolve this question and improve trait mapping in this species. 
Dry weight of aerial plant system  
The average dry weights (Figure 3) ranged more than three folds: from genotype A weighing an 
average of 7.51 g to genotype L weighing 23.81 g per plant.  Half of the collection (L, I, G, D, J 
and H) were not significantly different amongst themselves regarding biomass but were 
significantly distinct from genotypes A, F, C and E (p< 0.001). Genotypes B and K were the most 
similar in terms of biomass with only 0.173 g difference on average. To obtain a more accurate 
idea about the useful biomass of the plants, it will be ideal to rather measure specifically the 
weight of leaves without stems in future experiments since the weight of stems does not 





Figure 3.  Dry weight of A. annua germplasm collection. Aerial parts of twelve genotypes of A. annua 
grown under greenhouse conditions for 45 days were oven-dried and average weight (n=6) was 
determined. Error bars indicate standard error and levels not connected by the same letter are 
significantly different (Tukey’s test, α=0.05).  
Various factors affect biomass in both positive and negative ways. In a study conducted by 
Ferreira using the Artemis hybrid under greenhouse conditions (Ferreira, 2007), plants were 
provided 2 mg/kg soluble N, 28 mg/kg extractable P and 82, 439 and 192 mg/kg exchangeable K, 
Ca and Mg, respectively, with 5.08 soil pH level and grown for 90-102 days. These plants produced 
the highest biomass (70.3 g/plant) compared to untreated plants (6.18 g/plant). It was further 
shown that no-K treatment resulted in about 70% of leaf biomass of the complete nutrition 
treatment with higher ART levels (but not significant compared to complete treatment) whereas 
no-N supplementation resulted in about 20% of the leaf biomass of the complete treatment, 
which indicates the importance of N for biomass. Another study indicated that gradual increase 
of N application from 6 mg/L to 106 mg/L increased leaf and stem biomass as well as ART content. 
However, increasing N further up to about 206 mg/L and 306 mg/L did not increase biomass but 
impacted ART content negatively (Davies et al., 2009). In the same study, the authors showed 
that increased application of K had a positive impact on biomass without any effect on ART yield. 
Therefore, soil N level is likely to be a critical factor determining the biomass and the ART yield. 
Application of gibberellic acid has increased the biomass by stem elongation and leaf expansion 
with increased ART content (Banyai et al., 2011). Short-term drought did not affect negatively 
the biomass of container-grown A. annua plants but increased ART content (Marchese et al., 
2010). Yang et al. confirmed this result by showing increased levels of ADS in shoots induced by 
drought (Yang et al., 2010). Certain minerals such as B have little to no effect on biomass yet 
improved ART content (Aftab et al., 2010). Soil pH level in the range of 5.5-6 was found to be best 





































depends directly on leaf area, a high biomass production is an essential factor contributing to 
increase ART yield regardless of other factors. Therefore, in breeding programs, it is important to 
select genotypes with high biomass along with other factors that positively contribute to the high 
ART content.  
Leaf phenotypes 
Artemisinin accumulates in glandular trichomes (GTs) mostly on the leaf epidermis. Theoretically, 
a large leaf area can create more space for the development of GTs, and hence increase the 
accumulation of ART and precursors (Graham et al., 2010). Since the leaf is the most important 
tissue of the A. annua plant as a crop, identifying genotypes with larger and less serrated leaves 
can be helpful for breeding programs. Moreover, finding plants with high trichome densities is 
another key factor in achieving superior A. annua plants. Therefore, we analyzed the collection 
for differences in leaf shape, size and trichome density among the genotypes in the WVU 
collection. 
Leaf Morphology 
A. annua develops small leaves, usually presenting five to seven deep serrated sections (leaflets). 
This compound shape is true for all genotypes of the collection. The smallest leaves in the 
collection are developed in genotypes A and H (Figure 4). A less serrated leaf with more lamina 
area is ideal for A. annua, since these leaves could potentially bear more GTs per plant. Therefore, 
more research on external and internal factors that determines the leaf shape in the Asteraceae 
clade will be potentially helpful in breeding for a better crop.  
 
Figure 4. Leaf morphologies of A. annua germplasm collection. Scanned images of typical young, fully 
expanded leaves show the differences among the leaf size and shape of the genotypes.   
Leaf Area 
The trait leaf area ranged more than 20-fold in the germplasm collection (Figure 5). Out of the 
twelve genotypes, genotype H and genotype A have significantly the lowest leaf areas, 31.72 
mm2 and 141.27 mm2, respectively. On the other hand, genotype D, E, J and K had the highest 
leaf area. Regarding the leaf area, genotypes from both origins (Brazil and Switzerland) showed 
great phenotypical variation. This points out to the great phenotypical variability in leaf area in 
this collection, which should be followed up by the determination of genetic and environmental 
factors controlling the development of this trait in A. annua.  




Figure 5. Leaf area of A. annua genotypes. Measurements were determined using fully developed leaves 
(n=5). Leaves were scanned and area was determined using ImageJ software. Error bars indicate standard 
errors and levels not connected by same letter are significantly different (Tukey’s test, α=0.05).  
Glandular Trichome Densities 
Glandular secretory trichomes (GSTs) are the exclusive site of ART biosynthesis and accumulation 
in A. annua. Therefore, GSTs are considered the most important structure of the plant from the 
economic point of view. This way, GST density is an essential factor when breeding for high ART 
yields – the total number of trichomes per area, along with how full these trichomes are and the 
chemical profile stored in them, will determine the ultimate plant yield. We determined both the 
adaxial and abaxial trichome densities for each of the twelve genotypes in the collection (Figures 








































Figure 6. Adaxial trichome density of A. annua genotypes. Adaxial trichome density of young, fully 
expanded leaves (n=10) from three plants representing the twelve A. annua genotypes. Trichomes 
were determined using epifluorescence images taken using Olympus MVX10 fluorescence microscope 
with the GFP filter. Error bars indicate standard error and levels not connected by same letter are 
significantly different (Tukey’s test, α=0.05). 
 
Figure 7. Abaxial trichome density of A. annua genotypes. Abaxial trichome density of young fully 
expanded leaves (n=10) from three plants representing the twelve A. annua genotypes. Trichomes 
were determined using epifluorescence images taken using Olympus MVX10 fluorescence microscope 
with the GFP filter. Error bars indicate standard error and levels not connected by same letter are 


























































































In general, for A. annua genotypes in the collection, abaxial trichome densities were higher than 
the adaxial values (Figures 6-8). The adaxial trichome density ranged almost 5-fold, from 6.09 to 
29.05 mm-2 whereas abaxial trichome density ranged almost three-fold, from 16.95 to 47.66 mm-
2. On both surfaces, genotype L consistently ranked the lowest.  
Fluorescence microscopy is becoming popular to easily visualize GSTs as they auto-fluoresce due 
to the essential oils stored in them (e.g., Graham et al., 2010). We used the same approach to 
quantify GSTs in the A. annua collection. The epifluorescence micrographs indicated an even 
distribution of GSTs on the adaxial leaf surface whereas, GSTs are distributed leaving a groove 
like space around the leaf veins on the abaxial leaf surface (Figure 8). 
 
Figure 8. Leaf adaxial and abaxial trichome densities of A. annua germplasm collection. For each 
genotype (A-L), top rows indicate adaxial trichome and bottom rows indicate abaxial trichome densities. 
Scale Images were taken with Olympus MVX 10 fluoroscence microscope with the GFP filter (2X objective, 
2X slider and 1.2X magnification) and bars at the right bottom corners are 500 µm. 
The average trichome densities reported in more recent literature are between 10-75 mm-2 
(Kjaer et al., 2014) with significantly higher GST density on abaxial than the adaxial surface (Kjær 
et al., 2012), which is in agreement with our data. However, Hu et al. (1993) reported the 
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opposite pattern and the results of Arsenault et al. (2010) showed no difference between these 
densities (Hu et al., 1993; Arsenault et al., 2010).  
CONCLUSIONS 
In our morphological analysis of genotypes in the collection, the genotypes I, J, L, and G had the 
highest height and dry weight values. While genotype H was among the shortest plants, it showed 
high dry weight, which reveals a very dense plant architecture. Leaf area presented high variation 
among genotypes, with D, E, J and L showing highest values whereas A and H displayed the 
smallest leaf areas. Glandular trichomes were present on both leaf surfaces, but they were clearly 
more abundant in the abaxial surface. Genotypes A and K showed the highest adaxial densities 
whereas the genotypes A, K along with C, D and E are grouped with the highest abaxial trichome 
densities. Overall, genotype J had the best anatomical properties to support high ART yield.  
Graham et al. (2010) described several anatomical and physiological factors that determine the 
ART yield, which is a product of ART concentration and plant fresh weight (Graham et al., 2010). 
They documented high phenotypic variation in the Artemis pedigree, such as ART and other 
metabolite concentration, leaf area, glandular trichome density, and plant fresh weight. These 
are the main traits targeted for increasing ART yield. They also confirmed the phenotypic 
variation with high degree of genetic variation with a mean SNP frequency of 1 in 104 base pairs.  
Agronomic factors can also impact the secondary metabolite production in plants, since it is 
associated with the plant’s interaction with its environment (Davies et al., 2009). Therefore, there 
is a high likelihood for physiological characteristics to be dependent on the interaction of plant 
with its environment than the genetics of the plant. Even for high yielding varieties, the yield 
potential is closely related to field management standards in A. annua (RBM/UNITAID/WHO 
Artemisinin Conference Final Report, 2011). Literature related to A. annua physiology and 
environment often presents contrasting results regarding the same trait. The main reason for 
such discrepancies could be due to how this genetically and chemically complex plant interacts 
with its macro- and micro-environment. Also, as secondary metabolites are not directly involved 
with the normal growth and the development of the plant, but they are rather synthesized as a 
defense mechanism against biotic and abiotic stresses, manipulation of growth conditions in the 
field is important to force plants to use their genetic potential to synthesize DHAA and ART in 
maximum quantities.  
Currently, China and Vietnam produce about 80% of the global supply, with East Africa countries 
producing the remaining 20% (Shretta and Yadav, 2012). The average yield of A. annua varies 
between 1.5-2 tons of dry matter per hectare with varying 0.5-1.2% ART content, depending on 
seed quality, climate, altitude, soil, planting density (stand), and the farmers’ knowledge and 
technology used. Considering a 50-80% extraction efficiency and purification yield, 6-14 kg of 
ART, the starting material for active pharmaceuticals is produced  on average per hectare of A. 
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annua (Kindermans et al., 2007). Improving efficiencies in each step is a sine qua non condition 











CHAPTER 3  
Biochemical profiling of Artemisia annua genotypes in the germplasm collection at WVU 
 
INTRODUCTION 
Artemisia annua (Sweet wormwood, Qinghao) is a metabolite rich aromatic ethnomedicinal herb 
(Bhakuni et al., 2001). It has been used in Chinese culture since ancient times due to its strong 
aroma and in Chinese traditional medicine for more than 2,000 years to treat various ailments, 
such as cough, cold, and agues, including malaria (Wang et al., 2011). A. annua has been subject 
to intensive phytochemical evaluations since the discovery in 1970’s  of artemisinin (ART), the 
precursor to current WHO recommended treatment against Plasmodium falciparum malaria 
(Wang et al., 2011). Apart from ART, A. annua is a rich source of essential oils that gives the 
characteristic smell to the plant, and is used commercially in perfumery and cosmetics (Jain et 
al., 1996).  A. annua essential oil is known to have insecticidal properties (Jain et al., 1996). It is 
rich in secondary metabolites with almost 600 known compounds dominated by terpenoids, 
particularly sesquiterpene lactone, in addition to flavonoids, coumarins and other shikimate 
metabolites (Brown, 2010).  
Metabolomics can be defined as identification and quantification of metabolic responses of living 
systems to stimuli or genetic modifications (Worley and Powers, 2013). Therefore, metabolomics 
is the result of genomic, transcriptomic and proteomic responses in an organism to a given 
stimulus or change. It encompasses the final process in the cell resulted directly from enzymatic 
activities. Thus, metabolites are more proximal to the phenotype than genes, transcripts and 
proteins. Indeed,  minimal changes in gene expression or protein accumulation does not 
necessarily correlate with variation in protein activity, but alterations in metabolite accumulation 
only occurs through such changes (Worley and Powers, 2013). 
To study A. annua metabolites, various extraction, separation and identification methods have 
been tested (Christen and Veuthey, 2001; Van Nieuwerburgh et al., 2006; Peng et al., 2006; 
Czechowski et al., 2018). Among them, GC-MS approach is widely used (Ma et al., 2008). Various 
statistical methods are also used to simplify and extract more information from complex 
metabolomics data to understand key factors driving the metabolome. In our study, we used GC-
MS to separate and identify compounds and PLS-DA analysis to select and extract information to 
best describe the twelve genotypes of A. annua.  
Multivariate analysis methods are used in metabolomics studies to identify biologically relevant 
spectral features and two of the most common such methods are, principal component analysis 
(PCA) and partial least squares projection to latent structures (PLS) (Worley and Powers, 2013). 
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In this research, we used partial least squares discriminant analysis (PLS-DA) to differentiate the 
genotypes and to identify key features in characterizing each genotype.  
 
MATERIAL AND METHODS 
Plant material: The twelve genotypes that compose the Artemisia annua germplasm collection 
were used in this experiment. The experimental set up is described in Chapter 2.  Juvenile and 
young, fully expanded leaves, up to about 12th leaf from apical meristem of the main stem and 
from one branch from the upper third of the plant was carefully stripped from the stem and 
packed into a 50 mL plastic vial. Meristem from the main stem was not included as it was 
harvested for gene expression analysis. The material was flash frozen with liquid nitrogen and 
stored at -80 ˚C and freeze-dried within two weeks of storage. 
Metabolite extraction and analysis: Non-polar metabolites of 0.100 g freeze-dried leaf material 
were extracted with 5 mL hexane containing 50 µg/L tetracosane (C24H50) as an internal standard 
(IS). Extractions were analyzed using a GC-MS (Trace 1310 GC, Thermo Fisher Scientific) coupled 
to an MS detector system (ISQ QD, Thermo Fisher Scientific) with autosampler (Triplus RSH, 
Thermo Fisher Scientific). A capillary column (Rxi-5Sil MS, Restek, Bellefonte, PA, USA; 30 m × 
0.25 mm × 0.25 µm capillary column w/10 m Integra-Guard Column) was used to detect polar 
metabolites. After an initial temperature hold at 60 °C, the oven temperature was increased to 
200 °C at 7 °C/min, then increased to 320 °C at 15 °C/min and held for 5 min. Injector, MS transfer 
line, and ion source temperatures were set at 275 °C, 280 °C, and 300 °C, respectively. An aliquot 
of 1 μL was injected with the split ratio of 1:4. The helium carrier gas was kept at a constant flow 
rate of 1.2 mL/min. The mass spectrometer was operated in positive electron impact mode (EI) 
at 70.0 eV ionization energy at m/z 40–500 scan range. Metabolite identification was based on 
mass spectra of standard compounds and retention time or comparison with the in the National 
Institute of Standards and Technology (NIST). The metabolites ART, DHAA, AA, camphor and 
endo-borneol were confirmed using standards. The areas of the identified peaks were normalized 
to the IS area and the relative abundance of each predicted compound were calculated and 
normalized to the exact dry weight measurements. The data were statistically analyzed with 
MetaboAnalyst software (v.4.0) (Chong et al., 2018). 
 
RESULTS AND DISCUSSION 
A total of 52 peaks were identified using the NIST library database. During initial assessment, 
camphor and endo-borneol appeared as the two main metabolites that could be used to 
characterize the collection due to their significantly high F values and significantly low p values 
(Appendix 2: Supplemental Table 1) and due to high VIP (Variable Importance in Performance) 
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values (Appendix 2: Supplemental Table 3). Therefore, those two metabolites were further 
confirmed with authentic standards. 
 
Figure 1. Relative abundance of 52 compounds detected by GC-MS analysis from 12 different Artemisia 
annua genotypes. Compounds on or below the solid line on the graph are not significantly different by 
Tukey’s HSD, α=0.05.  
From the 52 compounds identified, one-way analysis of ANOVA and Tukey’s post-hoc test at 
α=0.05 (Figure 1) revealed that 50 compounds were significantly different among the genotypes. 
Based on the PLS-DA analysis, the first, second and third components described 49.3%, 19.8% 
and 9.7% of the variability in the dataset respectively (Figure 2). Camphor, endo-borneol, and 
(potentially) eucalyptol had the three highest impacts on the first three components with 0. 8893, 
-0.92878 and 0.62501 loading values, respectively (Appendix 2: Supplemental Table 2). Loading 
values are coefficients of the linear combination of original variables that makes up the 
components. Therefore, they indicate the weights that each original variable has on the principal 
components in PLS-DA analysis; i.e., the higher the loading value, the higher the significance of 





Figure 2. 3D score plot from PLS-DA analysis for the 12 different genotypes of the Artemisia annua 





Figure 3.  Loading plots from PLS-DA analysis for the 12 different genotypes of the Artemisia annua 
germplasm collection. Camphor and endo-borneol had a significant contribution in describing the 
germplasm collection 
The importance of camphor and endo-borneol on genotypic identification of the collection was 
further shown with 5.3055 and 3.6694 VIP (Variable Importance in Projection) scores, 
respectively (Appendix 2: Supplemental Table 3). For small datasets (<100), VIP values above 1 







Figure 4. Relative abundance of the monoterpenoid camphor (C10H16O) in A. annua genotypes. Relative 
abundance of camphor was measured by comparing the peak intensity with the internal standard and 
normalized to dry weight. Average camphor content (n=6) within genotypes was statistically analyzed and 
error bars indicate standard error. Genotypes not connected by same letter are significantly different 
(Tukey’s test, α=0.05).  
 
(-)-Camphor (C10H16O) is a bicyclic monoterpene ketone with strong odor naturally found in 
essential oils from diverse taxonomic plant groups. Camphor has been present in the human 
pharmacopoeia since ancient times due to its numerous pharmacological uses as an anti-
inflammatory, anti-oxidant, and decongestant agent (Tian et al., 2015). Camphor is derived from 
geranyl diphosphate (GPP) undergoing three enzymatic reactions. First, the linear GPP is cyclized 
to bornyl diphosphate with bornyl diphosphate synthase and then hydrolyzed to borneol with 
borneol synthase. Finally, borneol is oxidized to camphor via borneol dehydrogenase (BDH).  
Camphor relative abundance values varied from a maximum of 3.048 µg/g to undetectable levels 
for the genotypes in the germplasm collection (Figure 4; Appendix 2: Supplemental Table 6). The 
genotypes D, E and F did not show any detectable amount of camphor in the analysis. 
In a recent work by Czechowski et al., camphor was the most abundant monoterpene in Artemis, 
the commercial hybrid recently introduced by the Swiss company Mediplant, which is considered 
as a high ART chemotype (Czechowski et al., 2018). Indeed, we also observed high camphor levels 
in the high-ART chemotypes of our collection. All but one of the Swiss genotypes, I, J, K showed 










































relationship between camphor and ART has been well documented in A. annua metabolite 
analysis studies. Detailed studies on essential oils from A. annua from Vietnamese and Chinese 
origins showed that camphor and germacrene D as the main components in the Vietnamese oil 
whereas artemisia ketone as the main component in the Chinese oil (Bilia et al., 2014). This 
difference in essential oil composition is thought to reflect ART content in Vietnamese plants and 
Chinese plants with 1.0% and 0.17% dry weight, respectively (Brown, 2010). 
In our analysis, correlation coefficient between camphor and ART was 0.63271 (Appendix 2: 
Supplemental Tables 4 and 5). On the other hand, camphor and DHAA had a correlation 
coefficient of 0.3698. Considering that DHAA is the immediate precursor to ART, and the current 
hypothesis that DHAA to ART conversion is non-enzymatic (Czechowski et al., 2016), the 
association between ART and camphor was not expected to be independent of DHAA levels, since 
ART production depends only on DHAA and ROS levels. Therefore, a strong positive correlation 
between camphor and DHAA was also expected. The lack of strong correlation between DHAA 
and camphor can be interpreted as a possible enzymatic intervention of DHAA to ART reaction, 
in which the genes responsible for this enzyme could be genetically linked to key camphor 
biosynthesis genes. A recent work by Wang et al. indicated that the terpene synthases 
responsible for borneol and camphor biosynthesis are located in the plastidial genome of 
Amomum villosum (Zingiberaceae) (Wang et al., 2018). If this is true for A. annua as well, then 
camphor and ART pathway precursor competition may not be intense, as ART uses 5C precursors 
2:1 from MVA and MEP pathways, respectively (Schramek et al., 2010) whereas camphor uses 
both 5C precursors from MEP pathway (Wang et al., 2018). Further, the relationship between 
camphor and ART is shown in genotypes E, F and G with lack of camphor and low accumulation 
of ART. Therefore, it could be worth investigating the positive correlation between camphor and 




Figure 5. Relative abundance of the monoterpenoid endo-borneol (C10H16O) in A. annua genotypes. 
Relative abundance of endo-borneol was measured by comparing the peak intensity with the internal 
standard and normalized to dry weight. Average endo-borneol content (n=6) within genotypes was 
statistically analyzed and error bars indicate standard error and genotypes not connected by same letter 
are significantly different (Tukey’s test, α=0.05).   
 
endo-Borneol is a bicyclic monoterpene alcohol and an immediate biosynthesis precursor of 
camphor. It was also identified as a distinctive compound in our biochemical profiling study 
(Figure 5). The maximum mean relative abundance found amongst the genotypes in our 
collection was 1.61 µg/g (genotype A). Similar to camphor, the genotypes D, E and F had no 
detectable levels of endo-borneol (Appendix 2: Supplemental Table 6), indicating that the 
impairment of the camphor pathway lies either in the very first or this second enzymatic step. 
Tian et al. (2015) characterized the gene encoding for borneol dehydrogenase in A. annua 
(AaBDH). They found that the enzyme is specific for the substrate borneol and acts in the last 
step of camphor biosynthesis. It has a higher activity compared to alcohol dehydrogenase 
(AaADH2), which is an enzyme specific to glandular trichomes that catalyzes the production of 
various secondary alcohols in vitro, including borneol (Polichuk et al., 2010). Therefore, we 
suggest that genotype A may lack a functional AaBDH allele but has the activity of AaADH2 








































genotypes (B-C, G-L) with high levels of camphor may have higher AaBDH activity so that they 
have significantly lower borneol levels. 
 
Figure 6. Correlation coefficients between camphor and other metabolites in Artemisia annua germplasm 
collection. The graph indicates the top 25 tentatively identified compounds correlated with camphor.  
  
Among other tentatively identified compounds, two potential monoterpenes (camphene, 
cymene) and two sesquiterpenes (germacrene D, cedren-13-ol) also showed VIP scores above 
the threshold value of 1 (Appendix 2, Supplemental Table 3). Two additional compounds that 
were highlighted as markers still need further identification. The compounds highlighted in the 
VIP score plot are mono- and sesquiterpenes. These results underscore the terpenoid-rich nature 
of the A. annua metabolome. Surprisingly, none of the compounds of particular focus in our 
study, i.e. ART and its chemical relatives, had a significant impact on the genotype separation of 
the germplasm collection. The VIP values for ART, DHAA and AA were 0.24454, 0.35902, and 
0.042541, respectively (Appendix 2, Supplemental Table 3). The compounds describing the 
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genotypes are components of the A. annua essential oil, mainly monoterpenoids synthesize 
potentially in larger quantities compared to ART, DHAA and AA (Brown 2010).  
Generally, there was a positive correlation between ART and camphor levels (Figure 6). The 
positive correlation coefficient (PCC=0.632) and the correlation probability of 4.20E-09 indicate a 




Figure 7. Relative abundance of the anti-malarial sesquiterpene, artemisinin (ART), in the twelve 
genotypes of the Artemisia annua germplasm collection at the West Virginia University. Relative 
abundance of ART content was measured by comparing the peak intensity with the internal standard and 
normalized to dry weight. Average ART content (n=6) within genotypes was statistically analyzed and error 
bars indicate standard error and genotypes not connected by the same letter are significantly different 
(Tukey’s test, α=0.05). 
ART levels within the collection ranged from 0.024 µg/g (genotype J) to 0.004 µg/g (genotype F) 
(Figure 7). The genotype with highest average level of ART was J. Genotypes F and H had the least 
levels of ART. ART has a strong positive Pearson correlation with DHAA (PCC=0.75296). 
Additionally, chiapin B, β-copaene, deoxyartemisinin, and camphor showed high positive 
correlations (Figure 8). On the other hand, ART and AA had an overall low, significant negative 










































Figure 8.  Correlation coefficients between artemisinin and other metabolites in Artemisia annua 









Figure 9. Relative abundance of the artemisinin precursor, dihydroartemisinic acid (DHAA) in A. annua 
genotypes. Relative abundance of DHAA content was measured by comparing the peak intensity with 
the internal standard and normalized to dry weight. Average DHAA content (n=6) within genotypes was 
statistically analyzed and error bars indicate standard error and genotypes not connected by the same 
letter are significantly different (Tukey’s test, α=0.05). 
 
The levels of the ART immediate precursor, dihydroartemisinic acid (DHAA) within the genotypes 
in the collection varied more than nine-fold, from 0.0077 to 0.071 µg/g. Genotype J showed 
distinctively the highest level (Figure 9). Together with biomass (Chapter 2), Genotype J is the 
best genotype in terms of ART and DHAA yield because of its high biomass and ART high ART and 
DHAA accumulations. Next to genotype J, genotypes G and I had next highest levels of ART yield.  
DHAA and ART showed a similar, highly correlated accumulation pattern in the metabolic 
profiling (Figure 10). DHAA is converted to ART via a potentially non-enzymatic oxidation step 
that forms the peroxide bridge directly involved in the mechanism of action against the 
Plasmodium parasite (Wen and Yu, 2011) 
In a recent publication by Ferreira et al., the potential of high DHAA accessions for semi-synthesis 
of ART, as well as plant breeding for high ART producing varieties, was discussed (Ferreira et al., 
2018). High DHAA accumulation indicates a strong pull of C skeletons from competing terpenoid 
pathways in general, including specifically other concurrent sesquiterpenoid compounds, toward 












































The very final step of ART conversion still needs further elucidation. If this is indeed a non-
enzymatic process triggered by reactive oxygen species (ROS) generated by O2 in the presence of 
light, and one would expect most of the accumulation to occur as ART in physiological conditions, 
not as DHAA. But it has shown ex-vivo and suggested the hydrophobic environment in the sub 
cuticular cavitiy favours the conversion of DHAA to ART (Czechowski et al., 2016).  
Figure 10. Correlation coefficients between dihydroartemisinic acid (DHAA) and other metabolites in 12 
different Artemisia annua genotpes. The graph shows the top 25 tentatively identified compounds 







Figure 11. Relative abundance of the non-productive artemisinic acid (AA) in A. annua genotypes. Relative 
abundance of AA content was measured by comparing the peak intensity with the internal standard and 
normalized to dry weight. Average AA content (n=6) within genotypes was statistically analyzed and error 
bars indicate standard error and genotypes not connected by the same letter are significantly different 
(Tukey’s test, α=0.05). 
Artemisinin acid (AA) biosynthesis competes for substrate with the ART pathway at the level of 
artemisinic aldehyde. To maximize ART accumulation levels, AA is expected to be low.  Genotype 
H accumulated significantly higher levels of AA (0.005 µg/g) compared to all other genotypes 
analyzed, which have relatively low AA levels (Figure 11). Like the Chinese genotypes, Sandman 
(genotype H) can be categorized as a low ART-producing chemotype because of its high AA and 
low ART levels. The rest of the collection can be categorized as high ART-producing chemotypes 
because of their low AA and high ART profiles. Even though genotypes such as D, E, and F have 
low ART levels, they are still categorized under the high ART-producing chemotypes because of 
their low AA content. As previously mentioned, the levels of ART and other metabolites are 
known to vary widely due to high degree of genetic variation in this species. For example, a 
variation between 0.93 and 20.65 µg/mg was observed in the famous high ART-producing 
Artemis hybrid cultivar (Graham et al., 2010).  
Eucalyptol and a yet unidentified compound showed strong positive correlation coefficients with 
AA - 0.81179 and 0.77667, respectively (Figure 12). The strong positive correlation between AA 








































the coincidence that genotypes that utilize most of artemisinic aldehyde towards AA conversion 
also have strong alleles (e.g., coding for functional enzymes with enhanced kinetic properties) for 
monoterpenoid biosynthesis. 
The deviation of the ART precursors toward the non-productive formation of AA is a complex 
problem to tackle. The cytochrome P450 monooxygenase CYP71AV1 plays a role in two 
consecutive conversions from amorpha-4, 11-diene (AD) to artemisinic aldehyde (Shen et al., 
2012). However, it can convert artemisinic aldehyde to AA, thus redirecting substrates to the 
non-productive pathway. Ideally, breeding programs will select for CYP71AV1 alleles with high-
affinity for substrates in the first two reactions, but with low activity in converting artemisinic 
aldehyde to AA. It is possible that genotype J (highest ART and highest DHAA, and low AA) carries 
an interesting CYP71AV1 allele for breeding purposes. An enzymological analysis of natural 
variation of the CYP71AV1 gene in A. annua germplasm could be valuable in finding ideal alleles 
for breeding. Moreover, for biotechnological purposes (e.g., ART production in bioreactors) the 
use of directed evolution to engineer an optimal cytochrome P450 monooxygenase with high 
affinity to productive substrates but with very little affinity to artemisinic aldehyde could start 




Figure 12. Correlation coefficients between artemisinic acid (AA) and other metabolites in 12 A. 
annua germplasm collection. The graph shows the top 25 tentatively identified compounds 
correlated with AA.  
 
CONCLUSION 
Genotype J had the highest accumulation of ART and DHAA compare to the rest of the collection. 
Furthermore, genotypes G, I and C showed high ART content whereas G, I and E presented high 
DHAA content.  Genotype H had the highest accumulation of AA compared to the rest of the 
collection, which showed low AA accumulation levels. Because of high AA accumulation and low 
DBR2 gene expression (Chapter 3), we concluded that H belongs to the low ART-producing 
chemotype. Even though there are genotypes with low ART in the collection, they are still 
considered as high ART-producing genotypes because of the low AA levels. Along with other 
published research, we also observed metabolite variation within descendants of A. annua in the 
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data collected in this research as well. For example, the Brazilian genotypes are descendants of 
the cultivar 3M while the Swiss genotypes are descendants of the cultivar Artemis (Chapter 1). 
The relationship between camphor and ART was also highlighted from the data collected. The 
two heterozygous parent lines (C1 and C4) that is used in producing Artemis are of Vietnamese 
origin (Graham et al., 2010, Czechowski et al., 2016) and the Vietnamese genotypes are known 
be high in camphor and ART (Brown, 2010). Futher High levels of monoterpenoids indicates the 
retaining potential of the A. annua metabolome that can be used achieve high DHAA and ART 
genotypes content by improving the C flux towards ART biosynthesis via breeding.  
Altogether, this chapter presented and discussed the biochemical profiles of the genotypes in the 
A. annua germplasm collection at WVU. This profiling is the key to characterize the germplasm 
collection as well as provide information on how to use the phenotypical variability within to 











Transcriptional analysis of genes involved in the artemisinin pathway in the Artemisia annua 
germplasm collection at WVU 
 
INTRODUCTION 
The enzymes, genes, and many transcriptional regulators involved in the biosynthesis pathway 
for artemisinin (ART) are quite well known (Lu et al., 2013), except for the last reaction, which is 
believed to be non-enzymatic (Czekowski et al., 2016), i.e. the conversion of dihydroartemisinic 
acid (DHAA) to ART. Even though there is a large body of research showing the possibility of auto-
oxidation of DHAA via dihydroartemisinic acid tertiary peroxide (DHAAOOH) into ART in the 
presence of light (Sy and Brown, 2002; Wallaart et al., 1999; Brown and Sy, 2004; Czechowski et 
al., 2016), strong evidence demonstrating that this reaction happens in vivo remains missing. ART 
is a sesquiterpenoid that accumulates in the subcuticular space of glandular secretory trichomes 
(GSTs). The immediate ART precursor (DHAA) is synthesized in the GST sub-apical and apical cells 
(Olofsson et al., 2011). 
Briefly, the ART biosynthesis pathway starts in the general terpenoid pathway. Dimethylallyl 
diphosphate (DMAPP) from the cytosolic mevalonate pathway (MVA) is transferred to plastid 
and condenses with another 5-C isoprenoid (IPP) from the plastidial methylerythritol pathway 
(MEP) to generate geranyl pyrophosphate (GPP), which is subsequently imported by the cytosol 
for further elongation with an isopentyl pyrophosphate (IPP) from the MVA pathway to form the 
15-C farnesyl pyrophosphate (FPP), the precursor of all sesquiterpenes in the plant (Wen and Yu, 
2011). In the ART committed pathway, FPP is cyclized to amorpha-4,11-diene (AD) by amorpha 
diene synthase (ADS) and oxidized with the CYP7AV1/CPR pair to form artemisinic alcohol 
(AAOH). At this point, the pathway divides into two branches leading to the artemisinic acid (a 
non-productive compound) via artemisinic aldehyde with additional activity of ADH1. Meanwhile 
in the productive branch, the double bonds at 11 and 13 positions of AAOH are reduced by DBR2 
and then oxidized to DHAA by ALDH1 (Weathers et al., 2017). 
Herein, we analyzed the transcriptional activity of 16 genes in the 12 genotypes of the Artemisia 
annua germplasm collection at the West Virginia University - 10 structural genes from the 
biosynthetic pathway, 5 transcription factors previously described as regulators of this pathway, 
as well as GAPDH as the constitutive housekeeping gene for data normalization. By comparing 
gene expression of key genes in the ART pathway with the metabolite profile of these genotypes 
under the same conditions, we are able to better understand how this pathway is regulated at 




MATERIAL AND METHODS 
Sampling and cDNA synthesis 
The same samples collected for the biochemical profiling (Chapter 2) were used for this 
experiment. In brief, young leaves with the apical meristem were flash frozen in liquid N2 and 
stored at -80˚C until processing. Total RNA was extracted with TRIzol reagent and purified with 
Direct-zol™ RNA Miniprep plus kit (Zymo Research) following the manufacture’s instruction.  
Isolated total RNA was treated with DNase I (DNA-free TURBO kit, Ambion), quantified with a 
NanoDrop™ spectrophotometer (Nanodrop), and used for cDNA synthesis. cDNA synthesis was 
carried out with 1 µg of DNase treated RNA and SuperScript®IV first-strand synthesis system 
(Invitrogen) with oligod(T) primer, according to the manufacture’s instruction in 10-uL reactions. 
Synthesized cDNA was diluted 10 times with RNase free water to a final volume of 100 µL and 
stored at -80 ˚C.  
Quantitative RT-PCR 
Primers were designed as described by (Mock et al., 2017) (Table 1). cDNA was used in qPCR 
amplification using SybrGreen fluorescence. Fifteen genes were amplified and GAPDH was used 
as an internal control for normalization. qPCR was performed using 1 µL diluted cDNA, 0.5 µL 
RNA free water, 2.5 µL 2X Power SYBR® Green master mix (ThermoFisher Scientific) and 1 µL mix 
of 10 mM each forward and reverse primers. Each sample was run in technical triplicates, and 
each treatment was run in three biological replicates. The reactions were performed with ABI 
7500 instrument (Applied Biosystems) and CFX96 Touch™ (Bio-Rad) with appropriate clear 96 
well plates. 
 

















ACCGGACAACGTGAAATACC GGCTTTCTCGTTAGCTGCAC 100 
AF142473.1 HMG-CoA reductase 
(AaHMGR1) 




TGATTTTGAGTCTAGCGAGTGG TACAGACAACATCGGCTTGC 70 
KR445687.1 Amorpha-4,11-diene 
synthase (AaADS) 






CAACTGGAAACTCCCCAATG CTCGGTCTTTCTTTGCATCG 85 
JN594507.1 Cytochrome P450 
reductase (AaCPR) 




genotype CL8 Contig 
1 
GGCTAGTGTGGCCATTAACAG GGTTCTTACGCCACCAAAAG 79 
EU704257.1 Artemisinic aldehyde 
delta-11(13) 
reductase (AaDBR2) 




CGAGATCTATTCGAGCAGGTG TCCTTGTTCTCGTCCAAACC 107 
JQ797708.1 Octadecanoid-
derivative responsive 
AP2 domain protein 
(AaORA) 
TGAGGAGCTTCGGATGGTAG GTCATGATCTGTTCCCACCTC 79 
FJ390842.1 WRKY transcription 
factor 1 (AaWRKY1) 




GCCGAGTGGTAGATAGGATTTG AAATCCAGACCCGATACCATC 101 
KP119607.1 MYC2 transcription 
factor 
GGTAAGCTCGTCTTTCTCATGG CACCCAAATCCTGCTTTTTG 61 
JQ617313.1 ABA receptor 
(AaPYL9) 




TGGTGACAGTAGGTCAAGCATC GGGTGCTGTATCCCCATTC 107 
 
Data analysis 
The geometric means of Ct values were used to calculate the relative mRNA abundance according 
to a formula provided in Jacometo et al. with a slight modification by assuming 100% 
amplification of mRNA instead of using the primer efficiency in the equation (Jacometo et al., 
2014). The dataset was subjected to ANOVA and, when appropriate, to post-hoc testing using 
Tukey’s range test (=0.05). 
RESULTS AND DISCUSSION 
A description of the enzymes involved in the ART pathway is reported in the Introduction section 
of this thesis. To understand the relationship between biochemical phenotypes of the genotypes, 
ten enzymatic genes and five genes encoding transcription factors were analyzed.  
Genes which expressed were found not significantly different among the genotypes in the 
collection were HMGR from the general MVA pathway, DXR1 and DXS1 from the MEP pathway, 
and the ART biosynthesis genes, CYP7AV1 and ADH1 along with all five transcription factors, 
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WRKY1, MYC2, PYL9, TAR1 and ERF1 (cf. Appendix 3). Among the ten structural genes of 
biosynthesis pathway, only three (FPS, CPR, and DBR2) showed significant differences in mRNA 
abundance among the genotypes tested. 
According to (Olofsson et al., 2012), most ART biosynthesis genes are expressed in sub- and apical 
cells of glandular trichomes (GST). FPS is the key enzyme to enter the sesquiterpenoid pathway 
and acts on the synthesis of 15-C farnesyl pyrophosphate (FPP) by condensation of geranyl 
pyrophosphate (GPP) and IPP in the cytosol. Even though FPP is the starting point for wide variety 
of other sesquiterpenes, such as squalene and β-farnesene, the overexpression of FPS showed a 
moderate to high influence on the ART yield (Wang et al., 2011; Banyai et al., 2011). The relative 
abundance of FPS expression among the genotypes in our materials ranged from 0.480468 
(genotype C) to 2.439918 (genotype K) units, compared to GAPDH expression level, which is set 
as 1 unit by definition (Figure 1). According to our data, FPS mRNA abundance of genotypes K 
and L were significantly higher compared to genotypes B, J, A, H and C. Considering the alleles 
present in all genotypes have comparable kinetic levels (e.g., substrate affinity, turnover rates, 
inhibitor levels), we would expect a stronger C flow towards the general sesquiterpene synthesis 
and a lower monoterpene accumulation in genotypes K and L compared to A, B, C, H, and J but 
we could not observe this assumption. Therefore we can assume unfavorable allelic versions of 
genes encoding ART pathway enzymes in K and L that are inefficient in converting the C flow 
created by FPS towards DHAA and ART.   
  
Figure 1. Relative mRNA abundance of FPS gene within the A. annua genotypes of the WVU germplasm 
collection. mRNA abundance was measured and averaged (n=3) with young, unexpanded leaf materials 
collected from plants grown for 45 days.  Error bars indicate standard error and genotypes not connected 








































Figure 2. Relative mRNA abundance of CPR gene within the A. annua genotypes of the WVU germplasm 
collection. mRNA abundance was measured and averaged (n=3) with young, unexpanded leaf materials 
collected from plants grown for 45 days. Error bars indicate standard error and genotypes not connected 
by the same letter are significantly different (Tukey’s test, α=0.05). 
The cytochrome P450 reductase (CPR) (Figure 2) is the redox partner of the cytochrome P450 
monooxygenase (CYP71AV1) that carries out the oxidation steps from amorpha-4,11-diene into 
artemisinic aldehyde (Shen et al., 2012) as well as a third, non-productive step to artemisinic acid 
(AA) (Shen et al., 2012). The CPR reduction activity restores the catalytic properties of CYP7AV1 
and can be seen a single enzymatic complex. Whereas we have not observed transcriptional 
differences for CYP71AV1 amongst the genotypes in the collection, we did for CPR. The largest 
CPR mRNA abundance differences were between the genotypes expressing the highest levels (A 
and C) compared to the group with lowest transcriptional activity (K and C).  
Since genotype H had significantly high content of AA compared to the rest of the collection (cf. 
Chapter 3), one would expect significantly higher expression levels of enzymes CYP7AV1, CPR and 
ALDH1 genes. However, none of these genes were significantly high for genotype H. Therefore, 
we reason that the high AA accumulation in genotype H is more due to allelic variation with 
enhanced properties towards conversion of artemisinic aldehyde to AA, which is highly 










































Figure 3. Relative mRNA abundance of DBR2 gene within the A. annua genotypes of the WVU germplasm 
collection. mRNA abundance was measured and averaged (n=3) with young, unexpanded leaf materials 
collect from plants grown for 45 days.  Error bars indicate standard error and genotypes not connected 
by same letter are significantly different (Tukey’s test, α=0.05). 
Among all the genes tested, the artemisinic aldehyde-Δ11 (13) reductase (DBR2) was the most 
drastically differently expressed amongst the genotypes. DBR2 mRNA abundance values ranged 
30-fold, from 2.97599 (genotype K) to 0.101044 relative units (genotype H). A. annua is divided 
into two chemotypes based on the content of ART and its precursors (Wallaart et al., 2000). ART, 
DHAA, and AA content along with DBR2 expression levels are parameters used to categorize A. 
annua chemotypes, the high-ART (HAP) and low ART-producing (LAP) groups. In LAP, the AA 
content is high (Lommen et al., 2006; Arsenault et al., 2010; Larson et al., 2013; Czechowski et 
al., 2018). A study by Yang et al. deduced that the difference between HAP and LAP chemotypes 
are due to DBR2 differential expression and specifically due to the insertions and deletions of 
certain cis-elements in the DBR2 promoter in LAP, leading to a lower transcriptional activity of 
the gene coding for this enzyme (Yang et al., 2015). In our germplasm collection, our biochemical 
profiling data categorized the genotype H as a LAP, which is congruent with the lowest expression 
level of the DBR2 gene seen in this study for H (Figure 3). The remaining genotypes of the 
collection can be categorized under HAP chemotype because of their low AA levels and high DBR2 
expression compared to genotype H. Notwithstanding, the DBR2 expression level of H was not 
statistically different from genotypes C-J and L, possibly due to the high data variation amongst 
the biological replicates and warrant the inclusion of additional replicates and a re-analysis of the 






































Notwithstanding, given that the ART committed pathway is localized in glandular trichomes, the 
significant differences in trichome densities amongst the genotypes (cf. Chapter 2) may be 
contributing to muddle the gene expression results. Currently, our group is considering the 
addition of another level of normalization to the gene expression dataset according to glandular 
trichome density values. For that, we will need to establish the number of glandular trichomes 
occurs per dry weight mass of sampled leaves. 
ART biosynthesis pathway is considered to correlate with leaf development (Liu et al., 2016). The 
early steps of the pathway occur in glandular trichomes of young juvenile leaves and the later 
steps happening in mature leaves (Czechowski et al., 2016). Another study by the same group 
tested for the gene expression of young leaves of HAP and LAP chemotypes and found 
significantly higher expression of DBR2 in HAP compared to LAP and, conversely, significantly 
higher expression of ALDH1 in LAP compared to HAP. Additionally, they also showed that there 
was no significant differences between ADS and CYP7AV1 gene expression in young leaves of 
both chemotypes (Czechowski et al., 2018), which corroborate our findings. Expression of ALDH1 
specific promoter with GUS expression in different tissues showed strong expression in GSTs of 
young leaves and reduced to no expression in mature and old GSTs, respectively. In our study, 
we used young, juvenile leaf samples to study gene expression, and our results are compatible 
with recent reports: the genotype H can be classified as chemotype LAP (chapter 3) and shows 
low DBR2 expression levels whereas a high transcription of ALDH1. On the other hand, the 
transcriptional levels for genotypes belonging to the HAP chemotype group are also compatible 
with the results reported by Czechowski et al. (2018), however with some deviations that could 
be attributed to environmental variations (Ferreira et al., 2018). 
CONCLUSION 
Considering the results from biochemical analysis of the genotypes, genotype J was expected to 
have significantly higher mRNA levels for biosynthesis pathway genes compared to the rest of 
the collection, specifically for DBR2, since DHAA levels of the genotype J was significantly high. 
However, transcriptional levels were not necessarily high for genotype J. This could be because 
of the different (multi)alleles may be encoding for enzyme isoforms with different levels of 
affinities to the substrate and other catalytic properties. An experiment conducted by Graham et 
al. using the Artemis hybrid showed that the mean SNP frequency between plants within  this 
hybrid was extremely high, 1 in 104 bp (Graham et al., 2010). Therefore, depending on the SNP 
locations, the process from gene expression to protein structure and catalytic activity can be 
affected. The other factor can be the highly convoluted nature of the terpene biosynthesis 
pathway. The high biochemical complexity of A. annua is attributed to promiscuous enzymes 
encoded by multiple members of gene families expressed in glandular trichomes (Wang et al., 
2009; Graham et al., 2010; Soetaert et al., 2013). On the other hand, terpenoid pathway 
intermediates act as substrates for different types of terpene synthases. For example, DHAA is 
the precursor to 16 other compounds including ART (Brown, 2010).  This means that there can 
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be other unidentified enzymes contributing to ART biosynthesis pathway as well as unidentified 
enzymes that use intermediates of ART biosynthesis pathway reducing the flow towards the end 
products such as ART, DHAA and AA. Therefore, the chemical phenotypes and the genotypes may 
not be compatible with each other in these plants.   
Further, mRNA abundance of none of the transcription factors which we tested were significantly 
different among the genotypes analyzed. Importantly, some of the primers designed for 
transcription factors did not amplify consistently within genotypes. This could be due to the 
genotypical constitution of the genotypes that deviates from the sequences available for primer 
design. In conclusion, apart from DBR2, the gene expression data does not completely explain 
the biochemical phenotype of the collection. Therefore, an analysis of the allelic variation of the 
genes of interest in each genotype through whole-genome sequencing could be a valid approach 




















Genetic improvement of Artemisia annua: honing domestication and boosting yields of 
artemisinin and dihydroartemisic acid 
INTRODUCTION 
Artemisia annua is an annual herb with hermaphrodite composite flowers (Wetzstein et al., 2014) 
and a self-incompatible outcrossing reproduction strategy (allogamy) (Ferreira et al., 2005). 
Despite of some breeding efforts to improve it as a viable crop, one can consider it as an 
undomesticated species that has been selected from crossings of wild accessions growing in 
South Asia. The main features that typifies this species as undomesticated are especially its 
flowering induction promptly triggered by short days, the high degree of genetic polymorphism, 
an incapability of self-pollinating (which would facilitate cultivation and development of true 
varieties by stabilizing the genotype), and the high variability of economically relevant traits, such 
as leaf morphology and size (especially total leaf area).  
In this diploid species (2n=2X=18; 1.74Gb per haploid set; (Shen et al., 2018), flowering is 
promptly induced under a photoperiod threshold of 16 hours or less, depending on the genotype 
(Ferreira et al., 1995), highly restricting the latitude of field cultivation. The genetic identity of 
this plant cannot be preserved by self-pollination, and the genotype (i.e., the exact allelic 
combination of an organism) is permanently lost via sexual propagation. Due to the high degree 
of genetic heterozygosity conferred by the obligatory allogamy, artemisia breeding is challenging. 
Notwithstanding, artemisia breeding is feasible, as already illustrated by many successful 
examples in allogamous crops in the Asteraceae family (e.g., sunflower, artichoke) as well as a 
plethora of cases in other plant families (e.g., corn, rye, alfalfa, tobacco, cotton), and especially 
in species which value, like artemisia, resides in the accumulation of terpenoids inside of 
glandular trichomes (e.g., hop, cannabis). 
Conventional plant breeding implicates basically the creation of genome-wide allelic 
combinations for all genes contributing to the relevant phenotypes, followed by selection of the 
best assortment. In conventional crop breeding of allogamous species, the strategies used 
employ either highly inbred lines to generate commercial F1 hybrids (like corn) or use an open-
pollination strategy with two populations with stable alleles for the most important traits of the 
crop (Souza Jr., 2011). For artemisia, given that self-crossing is not a viable option for most 
genotypes, the second case applies. The parental lines of commercial hybrids remain highly 
heterozygous and must be maintained by vegetative propagation, or as two distinct populations. 
Although many efforts have been made on the molecular genetics front to understand the ART 
biosynthesis and genetic regulation of the pathway, conventional breeding programs of artemisia 
have traditionally been performed by only a few companies and institutions around the world, 
such as Médiplant in Switzerland (Simonnet et al., 2008), Bionexx in Madagascar (Townsend et 
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al., 2013; Suberu et al., 2016), the University of York in the UK (Townsend et al., 2013; Czechowski 
et al., 2016), North Carolina State University in the U.S. (Alejos-Gonzalez et al., 2011), and some 
places in China, such as the Institute of Medicinal Plants in Kunming (Yang et al., 2010; Liu et al., 
2010a) and the Academy of Chinese Materia in Chongqing (Li et al., 2010, 2017). In order to 
generate commercial lines able to achieve the genetic potential of the species for ART production 
in different cropping environments, more concerted efforts and investment are required. 
ART yield is a function of leaf ART content as well as leaf biomass production. Moreover, besides 
the plant genetic constitution, crop management and environmental conditions also influence 
the final yield (Ferreira, 2007). Breeding goals are to boost ART content from 1-1.4% (g ART per 
100 g total leaf dry weight) to ~2% (Delabays et al., 2001; van der Kooy and Sullivan, 2013; Suberu 
et al., 2016) or even more. Two Chinese varieties, ‘Anamed’ and ‘Chongqing’, produce ~1% ART 
(Yang et al., 2015; Han et al., 2014). The F1 hybrid ‘Artemis’ achieves 1.3% ART (Simonnet et al., 
2008) and a reported yield of 37.8 kg/ha. ‘Artemis’ is produced by crossing of two Vietnamese 
populations (Graham et al., 2010). It was developed by the Centre for Novel Agricultural Products 
(CNAP) at the University of York, UK in collaboration with East-West Seed International. Most 
recently, ‘Hyb8001r’ was develop and introduced by CNAP as a new hybrid, which is now 
commercialized by East-West Seed International. In field trials worldwide, ‘Hyb8001r’ produced 
high ART concentration (up to 1.44%), high biomass (up to 4.4 kg/ha dry leaf), reaching high ART 
yields (54 kg/ha) (Suberu et al., 2016 – in this work, ‘Hyb8001r’ is referred to as CNAP8001). 
Being the raw material of conventional breeding, the genetic basis of artemisia is fortunately 
quite broad (Li et al., 2017). Artemisia shows great phenotypic diversity for important traits, 
including leaf morphology, trichome density, plant size, as well as terpenoid profile, and 
artemisinin (ART) yield. As an example of this advantage for genetic breeding, a basic genetic 
map was produced with a segregating population developed from a crossing between two 
commercial parental populations that are used to produce the ‘Artemis’ F1 hybrid (Graham et al., 
2010). In the segregating population, ART content ranged extensively between 0.1-2.1%. 
Furthermore, doubling the artemisia ploidy (4X=36), may have a positive effect on yield, although 
the results are not conclusive (Lin et al., 2011; Wallaart et al., 1999), and the impact on 
susceptibilities to biotic and abiotic stresses or flower induction remain untested. 
 
Boosting the terpenoid as well as the committed ART biosynthesis in glandular trichomes can be 
achieved by selecting alleles with strong promoters or optimized protein sequences that lead to 
a stronger flux of photosynthates towards these pathways as well as most substrates flowing 
towards sesquiterpene biosynthesis, and ensuring that the pathway does not branch off to 
synthesis of other products than DHAA and ART. 
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ART is a sesquiterpene lactone that holds an uncharacteristic peroxide bridge. It is synthesized in 
multicellular glandular trichomes that develop on the epidermis of aerial organs of the plant 
(Olofsson et al., 2012). The co-accumulation of its precursor dihydroartemisinic acid (DHAA) is 
often an overlooked aspect in artemisia breeding. DHAA is converted non-enzymatically into ART 
by UV light exposure, even during post-harvest sun drying (Ferreira and Luthria, 2010). Thus, it is 
reasonable to consider both, ART and DHAA, in genetic gain models for ART yields (Ferreira et al., 
2018). In considering breeding for high ART yields, it is important to appreciate the genetic 
aspects involved in the ART pathway and consider not only the allelic variation and regulation of 
structural genes coding for enzymes or enzymatic units, but also the regulatory components, 
such as transcription factors.  
Below, we briefly introduce the most relevant aspects of the general terpenoid biosynthesis 
pathway and leading to the committed ART pathway.  
 
The general isoprenoid/terpenoid biosynthesis pathway 
Quite exceptionally, plant terpenoids (a.k.a. isoprenoids) are synthesized via two distinct 
pathways in different compartments of the plant cell from precursors derived from sugar 
catabolism. The mevalonate pathway (MVA) uses acetyl-CoA as a precursor and occurs in the 
cytosol, possibly with some contribution by the ER. There have been suggestions that the MVA 
pathway also receives contributions from peroxisomes (Sapir-Mir et al., 2008; Clastre et al., 
2011). In turn, the methylerythritol phosphate (MEP or DOXP) pathway occurs in plastids and 
utilizes glyceraldehyde-3-P (G3P) and pyruvate as precursors. Importantly for breeding purposes, 
the structural genes of the plastidial MEP pathway are encoded in the nucleus and the enzymes 
are imported into the plastid. Therefore, they display Mendelian segregation and are not 
cytoplasmically (unilaterally) inherited. In both cases, the general terpenoid pathways produce 
the 5-carbon compounds isopentenyl diphosphate (IPP or IDP) and its isomer dimethylallyl 
diphosphate (DMAPP) as building blocks of all isoprenoids. The steady state of IPP to DMAPP in 
plastids is estimated to be 6:1 (Eisenreich et al., 2004; Ma et al., 2016), which makes DMAPP a 
limiting substrate for terpenoid biosynthesis. Following the synthesis of IPP and DMAPP, the 
remaining steps of the terpene biosynthesis occurs in the cytosol for sesqui- and triterpenes, 
whereas mono-, di- and tetraterpenes are synthesized in the plastid (Chen et al., 2011). IPP and 
DMAPP are used to synthesize the 10-carbon compound geranyl diphosphate (GPP), the 15-
carbon compound farnesyl diphosphate (FPP), and the 20-carbon compound geranylgeranyl 
diphosphate (GGPP) as terpenoid building blocks. In the first steps committed to sesquiterpene 
synthesis in the cytosol, GPP is produced by the fusion of IPP and DMAPP, to which another IPP 




The committed ART biosynthesis pathway 
Since FPP is the precursor of all sesquiterpenes, for maximum accumulation, it is important that 
in glandular trichomes most FPP rather flows towards FFP synthesis and then ART synthesis. The 
entry point of the committed ART pathway occurs with FPP conversion to amorpha-4,11-diene 
(AD) by its synthase (ADS) in the cytosol. Consequently, it is the ADS sink strength - as defined by 
its gene expression level and catalytic properties of the enzyme (AD affinity and turnover rate) – 
that will determine how much of the cytosolic FPP pool will flow towards ART biosynthesis. 
Terpene synthases (TPS) encompass a large class of enzymes that utilize GPP, FPP, or GGPP to 
synthesize mono-, sesqui- and tri-, or di- and tetraterpenes, respectively. Four phylogenetically 
TPS clades contain enzymes with sesquiterpene synthase activities: TPS-a-1, some in TPS-c, TPS-
e/f, and TPS-g (Chen et al., 2011). Although an ADS gene from artemisia responsible for AD 
synthesis has been identified (Lommen et al., 2007; Zhang et al., 2015), attention must be paid 
for alternate ADS isozymes to could cooperate with FPP flux to ART, as well as other TPS 
competing for substrate in glandular trichomes. In the next step in the pathway, the cytochrome 
P450 monooxygenase CYP71AV1, in association with the cytochrome P450 reductase (CPR), 
oxidizes AD to AA in three successive reactions via the intermediates artemisinic alcohol (AOH) 
and artemisinic aldehyde (AO). CYP71AV1 is the main rate-limiting enzyme of the committed ART 
biosynthesis (Lv et al., 2016; Chen et al., 2017). Although the CYP71AV1/CPR enzymatic system 
does not produce dihydroartemisinic aldehyde (DHAO), it can convert DHAO into 
dihydroartemisinic acid (DHAA). Therefore, ART biosynthesis competes with the AA pathway for 
AO. Manipulating this step is key to invert the high-AA, low-ART profile of certain genotypes. In 
the ART pathway, AO is reduced by the AO 11(13) reductase encoded by the DOUBLE BOND 
REDUCTASE 2 (DBR2) gene into DHAO, which can be further reduced by either the CYP71AV1/CPR 
system or AOH dehydrogenase (ALDH1) into DHAA. In these convoluted, promiscuous enzymatic 
systems involved in the late pathway, it is critical to define allelic variants with higher affinity to 
substrates largely favoring ART biosynthesis, rather than AA. Finally, the last step of ART 
biosynthesis is the conversion of DHAA into ART, which is thought to occur non-enzymatically in 
the trichome subcuticular space (oil sac) through photo-oxidation by UV light (Czechowski et al., 
2016). Alternatively, reactive oxygen species (ROS) that generated by abiotic stresses may be also 
contributing to this conversion (Nguyen et al., 2011).  
  
Furthermore, several transcription factors activating the expression of structural genes of the 
ART biosynthesis, especially between FPP and AO, have been identified, such as TAR1, AabZIP1, 
AaERAF1/2, AaORA, AaWORKY, AabHLH1, and AaMYC2 (Shen et al., 2016; Lv et al., 2017). These 
are obvious candidates for having a large impact on ART synthesis and accumulation and mapping 




Despite being a crucial element in this pathway, the plasma membrane transporter that secretes 
DHAA from the apical secretory cells to the subcuticular sac has not been characterized yet. 
 
Transmembrane transport - plastid to cytosol delivery of IPP and artemisinin efflux to the secretory 
reservoir 
Plastidial contribution with IPP to the cytosolic terpenoid biosynthesis is facilitated by 
unidentified proton symporters present in the envelope membrane (Bick and Lange, 2003; 
Dudareva et al., 2005; Pick and Weber, 2014; Henry et al., 2015). At a fundamental level, the 
molecular identification of such plastidial transporters could help streaming the IPP pool towards 
sesquiterpene biosynthesis. Moreover, the fact that ART, or its immediate precursor DHAA, is 
synthesized in the secretory cells of glandular trichomes and then stored in the subcuticular 
reservoir, a transmembrane efflux system for ART or DHAA is required but remains unidentified. 
In plants, two members of the ABC transporter family were characterized as terpene transporters 
at the plasma membrane: ABC1 Nicotiana plumbaginifolia (Jasiński et al., 2001) and ABCG/PDR 
from N. benthamiana (Shibata et al., 2016).  
 
Indeed, the coordination of the ten cells that compose the peltate glandular trichome towards 
ART biosynthesis in artemisia is not fully understood (Xiao et al., 2016). Only the four sub-apical 
cells contain chloroplasts, and it appears that only the two apical secretory cells express the late 
enzymes of the ART pathway (Nguyen et al., 2011; Xiao et al., 2016). It would be valuable to have 
a better resolution of gene expression of each enzyme in specific cell types of the glandular 
structure, such as by using RNA in situ hybridization or confocal microscopy with a fluorescent 
protein fusion under native promoter. How substrates are trafficked from one cell to another is 
also largely unknown, including how ART is secreted to the trichome subcuticular oil storage 
cavity (i.e., the cuticular sac or gland tip), as aforementioned. In the Chinese herb Tripterygium 
wilfordii, an MDR transporter (TwMDR1) was recently identified with affinity to the 
sesquiterpene pyridine alkaloids, wilforine and wilforgine. This opens up the possibility that an 
MDR transporter, in addition to ABC transporters, could be involved in the export of DHAA to the 
subcuticular sac (Miao et al., 2017). An analysis of membrane transporters exclusively expressed 
in secretory cells of glandular trichomes could lead to potential candidates that play these 
essential yet neglected functions in ART accumulation. 
 
Breeding for high ART accumulation via targeted allelic selection of natural variants 
By and large, for plant selection programs aiming at boosting ART+DHAA in artemisia should 
primarily focus on the following main traits: 
1. Enhanced general terpenoid and ART accumulation in glandular trichomes: Most of the 
rate-limiting enzymes and many transcriptional regulators of the ART pathway have already been 
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characterized. The first key enzyme in the MVA pathway is 3-hydroxy-3-methylglutaryl-CoA 
reductase (HMGR), which gene expression is positively correlated with ART content in artemisia 
(Alam and Abdin, 2011). The transcription factor AabHLH1 was shown to induce HMGR as well as 
some enzymes of the committed ART pathway, such as ADS and CYP71AV1 (Ji et al., 2014). To 
tackle DMAPP limitations for sesquiterpene biosynthesis, over-expression of the type-I IPP 
isomerase (AaIPPI1) in the cytosol in artemisia leaf cells led to a 1:7 IPP-to-DMAPP ratio, which 
considerably increased the levels of arteannuin B (4%) along with yields of ~0.20% ART and 1% 
AA (Ma et al., 2016). 
 
The sesquiterpene biosynthesis occurs in the cytosol with a terpene synthase fusing two IPP units 
to form farnesyl diphosphate (FPP or FDP) the primordial sesquiterpene (15C) molecule. Then, 
the first committed reaction of ART pathway is a cyclization catalyzed by ADS to produce 
amorpha-4,11-diene by a synthase (ADS). Virtually all structural genes of this pathway have been 
identified, along with various regulators. However, additional unknown genes may be 
contributing or competing with the ART pathway. For example, in the tomato genome, there are 
44 terpene synthases (TPS) with 14 expressing in trichomes (Matsuba et al., 2013). The functional 
characterization of potential sesquiterpene synthases expressed in tomato glandular trichomes 
as a model organism could lead to the identification of TPS genes coding for enzymes with 
sesquiterpene synthase activity as well as their transcriptional regulators. Undoubtedly, the 
genome-wide identification of all TPS members in the artemisia genome would be highly 
beneficial and is now within reach with the availability of high-quality genome sequence and 
annotation (Shen et al., 2018). 
Mapping of these genes on the artemisia genome will enable selection of allelic versions that 
may function as molecular markers for high ART accumulation. Combining an optimal set of 
alleles for enzymes and transcriptional regulators in the committed biosynthesis pathway may 
lead to major gains in yield. Moreover, the availability of a gene expression atlas for all different 
organs and main structures, the generation of regulatory gene networks and genome-wide 
association studies (GWAS) will be highly beneficial to further explore its genome for breeding 
purposes. 
 
2. Improved final ART+DHAA profile and low accumulation of side products: For best 
results, the pathway must flow towards producing ART+DHAA, and not stray precursors to make 
compounds with no or little anti-malarial effects. The main products that drain artemisinic 
aldehyde (AO) from the final steps of ART biosynthesis, lowering the yield, are artemisinic acid 
(AA) and arteannuin B (AB). Expectedly, ART+DHAA yields are negatively correlated with AA+AB 
content. The accessions for which data are available show phenotypical variation leading to 
massive yield differences for each of these compounds. For example, a recent study showed very 
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distinct chemical profiles of Chinese accessions (Zhang et al., 2017). Therefore, selection of allelic 
variants with high ART+DHAA and low in AA+AB is feasible. This goal can be accomplished by 
optimizing gene expression and/or catalytic activity of DBR2 to compete for the AO substrate in 
order to maximally produce DHAA. Moreover, the use of high AA variants to compare at the gene 
variation (at expression and/or protein sequence levels) potentially responsible for the variation 
in chemical profiles could reveal the most important genetic variations that define ART/AA 
branching of the pathway. 
 
3. High glandular trichome density on leaves and floral calyx: Glandular trichomes are 
multicellular epidermal appendices on aerial organs of a plant. They are generally regarded as 
chemical factories of the plant (Glas et al., 2012; Huchelmann et al., 2017). The development of 
higher densities of glandular trichomes on the surface of aerial organs directly causes higher 
accumulation of ART. The density of glandular trichomes in Artemisia annua can vary from none 
(glandless mutants) up to over 25 glands per mm2 for the adaxial side of fully expanded leaves. 
However, it will be interesting in future to compute trichome densities on both, adaxial and 
abaxial sides of the leaf, in mathematical models predicting ART yields. Recently, the closely-
related species, A. deserti was reported as having much higher glandular trichome densities 
amongst five species analyzed in the genus (Salehi et al., 2018), which could make it an ideal 
material for introgression of the trait in breeding programs. 
 
Much has been unveiled in recent years about the developmental pathway of non-glandular 
(tector) trichomes in Arabidopsis at the molecular genetics level (Pattanaik et al., 2014). Although 
relatively little has been achieved regarding glandular trichome developmental pathways, recent 
advances are quickly changing this landscape. For example, the MYB transcription factor 
AmMYBML3 from Antirrhinum majus and the bHLH transcription factor PIGMENT GLAND 
FORMATION (PGF) from cotton were identified as key regulators of glandular trichome formation 
(Jaffé et al., 2007; Ma et al., 2016). Very recently, the R2R3 MYB transcription factor AaMIXTA1 
was identified in artemisia as an inducer of glandular trichome development as well as cuticle 
biosynthesis (Shi et al., 2018). Additionally, besides inducing enzymatic genes, the AP2 
transcription factor AaTAR1 is also involved in trichome development (Tan et al., 2015). Which 
other players are involved with glandular trichome development and whether these pathways 
are conserved in Artemisia annua remains to be discovered. Studies using a related Asteraceae 
model species with genome sequence available, such as sunflower (Aschenbrenner et al., 2015; 
Badouin et al., 2017), which belongs to the same Asteroideae subfamily, could help elucidate 
these questions. 
 
4. Total leaf area (size and shape): Leaf size is a highly variable trait in Artemisia annua, 
varying at least ten-fold, from about 500 to 5,000 mm2 (Graham et al., 2010). A key QTL for leaf 
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area was mapped to the linkage group 8, although the exact gene remains to be identified 
(Graham et al., 2010). Further studies to identify the genetic determination of leaf size in 
Artemisia annua will be very informative to increase ART yield.  
 
As a common feature found in members of the Asteraceae family, the shape of the leaf lamina in 
Artemisia annua is highly subdivided into 5-7 leaflets connected by the rachis. This conformation 
dramatically reduces the total area available for the development of glandular trichomes, not to 
mention limiting photosynthesis for biomass accumulation. Leaf complexity is a function of 
continued meristematic activity at the leaf margins in the shoot apical meristem and in plant 
models, such as Arabidopsis, involves a complex genetic network coordinated by several 
transcription factors, including NO APICAL MERISTEM (NAM), ARABIDOPSIS TRANSCRIPTION 
ACTIVATON FACTOR 1 and 2 (ATAF1/2), CUP-SHAPED COTYLEDON 2 (CUC2), not to mention small 
RNA regulators, such as miR164 (Wang et al., 2016). A better understanding of the molecular 
basis of compound leaf development in Artemisia annua could lead to the development of tools 
to generate a genotype with a simpler leaf pattern with increased lamina area. Therefore, 
recognizing the functional homologs of these transcription factors in the Asteraceae, and 
especially in Artemisia annua could lead to an important breakthrough in leaf reshaping for leap 
yield increases. Moreover, genome sequencing of A. annua and further narrowing of loci 
associated with relevant traits to ART yield via genome-wide association studies (GWAS) will 
greatly speed up gene discovery and breeding. 
 
5. High biomass production and high leaf-to-stem ratio: Along with leaf parameters (area, 
perimeter and specific area), the total plant size (height and stature) and fresh weight were 
associated with artemisinin yields (Graham et al., 2010). A QTL for stature fell in linkage group 2 
where a gene homolog of the shoot branching regulator and strigolactone biosynthesis, MORE 
AXILLARY BRANCHING 3 (MAX3/CCD7), is located (Bennett et al., 2006). Meanwhile, a QTL for 
fresh weight was mapped in linkage group 4, albeit no obvious gene was found in that genomic 
interval (Graham et al., 2010). In this species, flowering is induced under short-day conditions. 
The day length threshold for flower induction depends on the genotype and show genetic 
variability in the range of 12 to 16 hours (Ferreira et al., 1995). Thus, a better characterization of 
the genetic pathways associated with vegetative and reproductive development in A. annua, 
starting with the identification of flowering gene homologs will lead to the design of molecular 
tools to advance breeding to expand the latitude range of this crop. 
 
6. Resistance to biotic and abiotic stresses: in addition to high ART yields, crop production 
requires plants to be tolerant to edaphoclimatic stresses (extreme temperatures, poor soils, 
drought) and pests. So far, there has been little evaluation of tolerance of accessions to diverse 
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stresses. The main diseases of artemisia in the field have not been reported. In greenhouse 
conditions, the main pests we observed are mealybugs, thrips, and spider mites. Selecting for 
accessions tolerant to stresses in field conditions is essential to generating successful field 
varieties. 
 
The genome size of A. annua is 1.74 Gb and its sequence has been published recently (Shen et 
al., 2018). The artemisia genome is only slightly larger than the human genome, twice that of 
tomato and almost 13-fold of Arabidopsis. Very recently, the sequence of its plastid genome was 
published (Shen et al., 2017), which can be useful to explore the MEP pathway that contributes 
to ART biosynthesis. An initial genetic mapping of loci contributing to important traits was 
produced with a segregating population (Graham et al., 2010), but the resolution was low and in 
most cases, it did not allow for the identification of candidate genes within each locus. Revisiting 
this dataset in the light of the newly published genome sequence might be revealing. The use of 
genetic transformation can be used to boost ART and DHAA yields (Elfahmi et al., 2014; Tang et 
al., 2014). Genetic transformation and in vitro regeneration protocols for A. annua are available 
(Alok et al., 2016; Alam et al., 2014). For example, substrate channeling was obtained by 
expressing ADS-FDS fused enzymatic system under constitutive expression or the trichome-
specific promoter of the CYP71AV1 gene in order to converge the general terpene intermediates 
(IDP and DMADP) into directly producing amorpha-4,11-diene. This strategy more than doubled 
ART yields (Han et al., 2016). Further, making a gene expression atlas available would be 
invaluable to move forward with gene discovery and potentially lead to leaps and bounds of 
breeding advancement in the crop. 
 
Genome editing as a potential approach 
The CRISPR/Cas9 genome editing system has revolutionized the way we think of crop breeding. 
Now it is feasible to quickly engineer a plant genome to result in the desirable phenotypes. And 
this can be accomplished without the final product being transgenic, especially when only gene 
knockout is desired. Once the transgenic cassette carrying out the T-DNA coding for the Cas9 and 
gRNAs (and, when the case, other additional elements), once the genome is edited (usually 
already in the T0 generation, which the T-DNA is in hemizygosity), the transgenic regenerant line 
can be allowed to sexually reproduce and segregate the T-DNA out, thus resulting in a non-
transgenic plant (for all practical and scientific purposes, although policies and politics may 
dispute this notion) with its genome edited. Albeit still challenging, but within reach in near 
future, manipulation of expression of inherent genes under certain conditions (inducing, 
repressing transcription) will become feasible. In this case, CRISPR/Cas9-driven systems with 
modified nucleases (fused of other proteins and with the nuclease activity dead) still able to 
recognize and bind to promoter regions of the genes of interest but instead of cutting the DNA, 
59 
 
they call (or hinder) the transcriptional machinery to the promoter, or base-editing enzymes to 
the site to be mutated (Pandiarajan and Grover, 2018; Murovec et al., 2017; Demirci et al., 2018). 
The de novo domestication of crop species was suggested as a potential novel approach to create 
varieties that are highly resilient to environmental stresses (Zsögön et al., 2017). More recently, 
the approach was experimentally demonstrated for tomato (Zsögön et al., 2018) and gooseberry 
(Lemmon et al., 2018). In the first case, knockout of just six genes of the closest relative of the 
cultivated tomato (Solanum pimpinellifolium) resulted in a more condensed plant architecture 
(half of the wild-type stature, and with half of the sympodial index) that produced more flowers 
(six-fold increase), and larger fruits (three times heavier) with a preferred shape (more oblong) 
and higher nutritional content (five-fold increase in lycopene). 
For genome editing of plant species, sequence of target genes (preferably, information on the 
whole genome is useful to prevent off-targeting) as well as efficient transformation and 
regeneration protocols are required. The nuclear and plastidial genome sequences of artemisia 
has been made available recently (Shen et al., 2017, 2018). An efficient method of genetically 
transforming artemisia via Agrobacterium tumefaciens has also been described (Alam et al., 
2014). 
In artemisia, key genes to be targeted are the early structural genes in the terpenoid pathway 
that compete for C skeletons with the committed ART pathway – the main structures drained from 
the main ART pathway are IPP/DMAPP to make hemiterpenes, GPP to make monoterpenes, and 
FPP to make other sesquiterpenes and higher-order terpenoid compounds. The main enzymes 
identified to deviate FPP from ART biosynthesis are CPS (towards -carophyllene), SQS (towards 
squalene and sterols), BFS (towards -farnesene), and GAS (towards germacrene A) (Chen et al., 
2011). In addition, blocking the RED1 enzyme, which competes for dihydroartemisinic aldehyde 
(Shi et al., 2017) could also be beneficial to increase the ART biosynthesis flux.  
In addition, enabling the plant to self-pollinate would be highly beneficial to create true varieties 
with stable genetics (i.e., in homozygosity to virtually the whole gene set) that can be propagated 
by seeds. A self-pollinating genotype was reported for A. annua (Alejos-Gonzalez et al., 2011), 
although the molecular genetics mechanism behind this trait remains unknown. In tomato 
(Solanaceae), pollen rejection and self-incompatibility involves an S-RNase (gene 
Solyc01g055200) and HT proteins (Tovar‐Méndez et al., 2017) – such mechanisms should be 
identified in the Asteraceae ((Allen et al., 2011; Koseva et al., 2017) in order to design self-




Boosting ART and DHAA yields in Artemisia annua through crop management and post-harvest 
practices 
Moreover, understanding the phenology of the crop is important to optimize biochemical yields. 
For example, glandular trichomes reach their plumpness maximum after the leaf reaches 
maturity and tend to thin out as the organ gets older. The best harvesting time for maximum ART 
yield has been identified as at the anthesis (Ferreira et al., 1995; Arsenault et al., 2010). The 
nutritional and physiological conditions of the crop can affect ART accumulation. A mild K 
deficiency increased 75% ART content (Ferreira, 2007). Cold shock treatment (4oC for 6h) 
improved ART yields threefold to about 5% (Liu et al., 2017). Sun drying the leaves for one to 
three weeks was effective in converting almost all DHAA into ART and increased ART yield in 
almost 50% compared to freeze-drying. On the other hand, drying leaves in a forced-air oven at 
45oC for 12-16h led to 40% conversion of DHAA into ART (Ferreira and Luthria, 2010).  
 
Conclusions 
Compared to crops that have been domesticated over millennia, Artemisia annua can be 
considered still a wild species that requires concerted efforts to be tamed as a viable, easy to 
grow crop. Metabolic engineering and plant design via genome editing can be of great help to 
speed up the process of making it self-compatible, less-inducible to flowering, and maximally 
channel C skeletons towards ART biosynthesis. ART yields of 5% have been reported and may be 
an achievable goal. 
In toto, combining ideal varieties, environmental conditions, crop management and post-harvest 
practices will make artemisia a more viable cash crop to supply the demand for ART to the anti-




SUMMARY AND CONCLUSION 
 
In our study, the genotype J showed best performance regarding the anatomical characters 
important for high ART yield. J was among the tallest genotypes, with heaviest aerial biomass, 
and also among the genotypes with largest leaf areas. However, it was not among the genotypes 
with highest trichome densities.  
Next to J, the genotypes I and G also showed high performance in height, biomass and leaf area 
categories, but they were not among the genotypes with high trichome densities neither. The 
genotypes with highest trichome density were A, C, D, E and K. Genotype D was among the one 
with highest biomass and leaf area whereas the genotype E was amongst those with highest leaf 
area.  
We identified camphor and endo-borneol as key compounds to distinguish the genotypes in the 
collection by biochemical profiling. We could also classify genotype H as the only one belonging 
to chemotype LAP, whereas all other genotypes are considered of chemotype HAP. 
The genotype J had the highest accumulation of ART+DHAA accumulation compared to the rest 
of the collection. Considering these active compounds separately, the genotypes G, I and C had 
the highest ART content whereas G, I and E had the highest DHAA content.  
From the 15 genes tested for gene expression variation among the collection, only three (FPS, 
CPR, and DBR2) were differentially expressed. However, the biological variation observed within 
genotypes was too high to identify genotypes with the highest transcriptional activities.  
Based on anatomical, biochemical and genotypic data, the genotype J were the best performer 
for high ART and DHAA yield as well as morphological features. Next, I and G were best genotypes 
in terms of ART and DHAA yield.  
We discussed parameters to be considered in breeding programs of Artemisia annua, make a 
case that this species remains undomesticated and propose biotechnological tools to speed up 
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(g) SD SE 
A 7.511667 3.885303 1.586168 
B 15.288 2.274021 1.016973 
C 11.83 1.911565 0.780393 
D 18.81833 1.215523 0.496235 
E 12.65167 1.852559 0.756304 
F 12.65167 4.173055 1.703643 
G 19.31667 5.372097 2.193149 
H 18.08 2.635762 1.076045 
I 20.905 2.368702 0.967019 
J 18.38833 2.28124 0.931312 
K 15.115 2.966174 1.210936 





(cm) SD SE 
A 67.42 16.43706 6.710402 
B 62.16667 8.822396 3.601728 
C 51.61667 11.40832 4.657425 
D 58.75 4.688177 1.91394 
E 44.93333 3.509226 1.432635 
F 67.1 9.962931 4.06735 
G 78.36667 5.273203 2.152776 
H 50.35 3.254996 1.328847 
I 91.73333 9.978109 4.073546 
J 89.65 15.78135 6.442709 
K 61.65 8.871246 3.621671 
L 74.66667 5.16901 2.11024 
 
Leaf Area 
Leaf Area (mm2) 
Genotype Average SD SE 
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A 141.266 34.15129 15.27292 
B 290.238 96.48973 43.15152 
C 340.84 135.2585 60.48942 
D 699.6 125.2167 55.99862 
E 691.466 94.76308 42.37934 
F 270.784 84.45247 37.76829 
G 340.65 73.78729 32.99868 
H 20.77042 20.77042 9.288816 
I 338.646 80.14543 35.84213 
J 652.01 55.04141 24.61527 
K 253.886 49.97252 22.34839 
L 552.962 62.89215 28.12622 
 
Adaxial and abaxial trichome density 
 Trichome Density/mm2)   
Genotype Abaxial SD SE Adaxial SD SE 
A 47.66733 3.841648 1.214836 29.05378 2.965062 0.937635 
B 30.18174 5.0327 1.591479 15.95805 2.398 0.758314 
C 43.94468 13.14686 3.795172 20.12748 5.327932 1.606432 
D 40.41052 5.907275 1.868044 15.43737 2.578836 0.815499 
E 37.13038 6.295646 1.990858 18.0763 3.463788 1.095346 
F 25.88249 5.468571 1.729314 16.3587 3.17513 1.004064 
G 23.97742 6.301147 1.992598 12.94511 4.117952 1.302211 
H 28.24997 7.457773 2.358355 18.50155 4.571628 1.445676 
I 29.12951 8.267891 2.755964 20.46048 6.009572 2.003191 
J 29.64868 4.004197 1.513444 19.17322 3.933026 1.486544 
K 41.90864 8.288223 3.132654 25.55991 5.669946 2.004629 
















 f.value p.value #NAME? FDR Tukey's LSD 
Cedren-13-ol, 8- 640.61 2.93E-56 55.533 1.55E-54 
F - A; F - B; F - C; F - D; F - E; F - 
G; F - H; F - I; F - J; F - K; F - L 
Camphor 268.32 1.84E-45 44.736 4.87E-44 
A - B; C - A; A - D; A - E; A - F; A - 
G; A - H; I - A; J - A; K - A; C - B; 
B - D; B - E; B - F; G - B; H - B; I - 
B; J - B; K - B; L - B; C - D; C - E; C 
- F; C - G; C - H; C - I; J - C; K - C; 
C - L; G - D; H - D; I - D; J - D; K - 
D; L - D; G - E; H - E; I - E; J - E; K 
- E; L - E; G - F; H - F; I - F; J - F; K 
- F; L - F; I - G; J - G; K - G; L - G; I 
- H; J - H; K - H; L - H; J - I; K - I; I 
- L; J - L; K – L 
endo-Borneol 198.89 8.67E-42 41.062 1.53E-40 
A - B; A - C; A - D; A - E; A - F; A - 
G; A - H; A - I; A - J; A - K; A - L 
Butanoic acid, 2-methyl-, 
phenylmethyl ester 189.33 3.46E-41 40.461 4.58E-40 
A - B; A - C; A - D; A - E; A - F; A - 
G; A - H; A - I; A - J; A - K; A - L; B 
- C; B - D; B - E; B - F; B - G; B - 
H; B - I; B - J; B - K; B - L; C - F; C 
- G; C - H; C - I; C - J; C - K; C - L; 
D - F; D - G; D - H; D - I; D - J; D - 
K; D - L; E - F; E - G; E - H; E - I; E 
- J; E - K; E - L; F - G; F - H; F - I; F 
- J; F - K; G - I; G - J; L - G; H - I; H 
- J; L - H; K - I; L - I; K - J; L - J; L – 
K 
cis-p-mentha-17,8-dien-2-ol 147.8 3.53E-38 37.452 3.75E-37 
A - B; A - D; A - E; A - F; A - G; A 
- H; A - I; J - A; K - A; A - L; C - B; 
B - D; B - E; G - B; B - H; B - I; J - 
B; K - B; C - D; C - E; C - F; C - G; 
C - H; C - I; J - C; K - C; C - L; G - 
D; J - D; K - D; F - E; G - E; J - E; K 
- E; L - E; G - F; F - H; F - I; J - F; K 
- F; G - H; G - I; J - G; K - G; G - L; 
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J - H; K - H; L - H; J - I; K - I; L - I; J 
- L; K – L 
cis-beta-Terpineol 143.94 7.39E-38 37.132 6.52E-37 
A - B; A - C; A - D; A - E; A - F; A - 
G; A - H; A - I; A - J; A - L; C - B; B 
- D; B - E; B - F; G - B; H - B; J - B; 
K - B; L - B; C - D; C - E; C - F; C - 
G; C - H; C - I; C - L; G - D; H - D; 
I - D; J - D; K - D; L - D; G - E; H - 
E; I - E; J - E; K - E; L - E; G - F; H - 
F; I - F; J - F; K - F; L - F; H - G; G - 
I; J - G; K - G; H - I; J - H; K - H; H 




enylbut-3-en-2-ol 118.29 1.70E-35 34.771 1.28E-34 
B - A; A - C; D - A; E - A; A - F; G - 
A; A - H; A - I; A - J; A - K; A - L; B 
- C; D - B; B - E; B - F; B - G; B - 
H; B - I; B - J; B - K; B - L; D - C; E 
- C; G - C; C - H; J - C; C - L; D - E; 
D - F; D - G; D - H; D - I; D - J; D - 
K; D - L; E - F; E - H; E - I; E - J; E - 
K; E - L; G - F; F - H; F - L; G - H; 
G - I; G - J; G - K; G - L; I - H; J - 
H; K - H; L - H; I - L; J - K; J - L; K 
– L 
Phenol, 2-methoxy-3-2-
propenyl- 113.58 5.20E-35 34.284 3.45E-34 
C - A; D - A; E - A; G - A; A - H; I - 
A; J - A; K - A; A - L; C - B; D - B; 
E - B; G - B; B - H; I - B; J - B; K - 
B; B - L; C - F; C - H; I - C; J - C; K 
- C; C - L; D - F; D - H; I - D; J - D; 
K - D; D - L; E - F; E - H; I - E; J - 
E; K - E; E - L; G - F; F - H; I - F; J - 
F; K - F; F - L; G - H; I - G; J - G; K 
- G; G - L; I - H; J - H; K - H; I - J; 
K - I; I - L; K - J; J - L; K - L 
Artemisinin 102.07 9.74E-34 33.011 5.74E-33 
A - B; C - A; A - D; A - E; A - F; G - 
A; A - H; I - A; J - A; C - B; B - F; G 
- B; B - H; I - B; J - B; K - B; L - B; 
C - D; C - E; C - F; G - C; C - H; I - 
C; J - C; C - K; C - L; D - F; G - D; 
D - H; I - D; J - D; K - D; L - D; E - 
F; G - E; E - H; I - E; J - E; K - E; L - 
E; G - F; I - F; J - F; K - F; L - F; G - 
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H; G - I; J - G; G - K; G - L; I - H; J 
- H; K - H; L - H; J - I; I - K; I - L; J - 
K; J – L 
Caryophylene oxide 101.14 1.25E-33 32.903 6.63E-33 
A - B; A - C; A - D; A - E; A - F; A - 
G; A - H; A - I; A - J; A - K; A - L; B 
- D; B - E; F - B; G - B; H - B; I - B; 
J - B; K - B; L - B; C - D; C - E; F - 
C; G - C; H - C; I - C; J - C; K - C; L 
- C; F - D; G - D; H - D; I - D; J - D; 
K - D; L - D; F - E; G - E; H - E; I - 
E; J - E; K - E; L - E; G - F; H - F; F 
- J; F - L; G - H; G - I; G - J; G - K; 
G - L; H - I; H - J; H - K; H - L; K - 
J; K – L 
Cyclohexanol, 1-methyl-4-1-
methylethenyl-, cis- 82.15 3.56E-31 30.448 1.72E-30 
A - B; A - C; A - D; A - E; A - F; A - 
G; A - H; A - I; A - J; A - L; C - B; 
G - B; H - B; J - B; K - B; L - B; C - 
D; C - E; C - F; C - G; C - H; C - I; 
K - C; C - L; G - D; H - D; J - D; K - 
D; L - D; G - E; H - E; J - E; K - E; L 
- E; G - F; H - F; J - F; K - F; L - F; 
H - G; G - I; J - G; K - G; L - G; H - 
I; J - H; K - H; J - I; K - I; L - I; K - J; 
J - L; K – L 
beta-copaene 74.567 4.82E-30 29.317 2.13E-29 
A - B; A - D; A - E; A - F; A - H; K - 
A; A - L; C - B; B - E; B - F; G - B; 
B - H; I - B; J - B; K - B; B - L; C - 
D; C - E; C - F; C - H; K - C; C - L; 
D - E; D - F; G - D; D - H; I - D; J - 
D; K - D; D - L; E - F; G - E; E - H; I 
- E; J - E; K - E; G - F; F - H; I - F; J 
- F; K - F; L - F; G - H; K - G; G - L; 
I - H; J - H; K - H; L - H; K - I; I - L; 
K - J; J - L; K – L 
Artemisinic acid 62.475 5.34E-28 27.272 2.18E-27 
C - A; D - A; E - A; G - A; H - A; J - 
A; D - B; E - B; G - B; H - B; J - B; 
G - C; H - C; C - I; C - L; G - D; H - 
D; D - I; D - K; D - L; G - E; H - E; 
E - I; E - K; E - L; G - F; H - F; H - 
G; G - I; G - J; G - K; G - L; H - I; H 
- J; H - K; H - L; J - I; J - K; J - L 
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Eucalyptol 58.844 2.59E-27 26.588 9.79E-27 
A - B; A - D; A - E; A - F; A - G; H 
- A; A - I; A - J; A - K; A - L; B - D; 
B - E; H - B; B - L; C - D; C - E; C - 
F; H - C; C - I; C - J; C - L; G - D; H 
- D; G - E; H - E; K - E; H - F; H - 
G; G - L; H - I; H - J; H - K; H - L; K 
– L 
Isoaromadendrene 
epoxide.1 55.728 1.07E-26 25.969 3.80E-26 
B - A; D - A; E - A; A - H; A - I; A - 
K; A - L; B - C; D - B; B - E; B - F; 
B - G; B - H; B - I; B - J; B - K; B - 
L; D - C; E - C; F - C; G - C; C - H; 
C - I; C - K; C - L; D - E; D - F; D - 
G; D - H; D - I; D - J; D - K; D - L; 
E - F; E - G; E - H; E - I; E - J; E - 
K; E - L; F - H; F - I; F - J; F - K; F - 
L; G - H; G - I; G - J; G - K; G - L; I 
- H; J - H; J - I; I - K; I - L; J - K; J – 
L 
Corymbolone 49.756 2.04E-25 24.691 6.76E-25 
B - A; A - C; D - A; A - F; A - H; A 
- I; A - J; A - K; A - L; B - C; D - B; 
B - E; B - F; B - G; B - H; B - I; B - 
J; B - K; B - L; D - C; E - C; G - C; C 
- H; C - L; D - E; D - F; D - G; D - 
H; D - I; D - J; D - K; D - L; E - F; E 
- H; E - I; E - J; E - K; E - L; G - F; F 
- H; F - L; G - H; G - I; G - J; G - K; 
G - L; I - H; J - H; K - H; L - H; I - 
L; J - L; K – L 
Cymene 45.034 2.63E-24 23.579 8.21E-24 
A - B; A - C; D - A; E - A; F - A; A - 
G; A - H; A - J; A - L; D - B; E - B; 
F - B; I - B; K - B; L - B; D - C; E - 
C; F - C; I - C; K - C; L - C; D - G; D 
- H; D - I; D - J; D - K; D - L; E - G; 
E - H; E - I; E - J; E - K; E - L; F - G; 
F - H; F - I; F - J; F - K; F - L; I - G; 
K - G; L - G; I - H; K - H; L - H; I - 
J; K - J; L - J; K – L 
Cubenol 42.74 9.95E-24 23.002 2.93E-23 
B - A; A - C; A - E; F - A; I - A; K - 
A; A - L; B - C; B - D; B - E; B - G; 
B - H; I - B; B - J; K - B; B - L; D - 
C; F - C; G - C; H - C; I - C; J - C; K 
- C; C - L; F - D; H - D; I - D; K - D; 
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D - L; F - E; G - E; H - E; I - E; K - 
E; E - L; F - G; I - F; F - J; K - F; F - 
L; I - G; K - G; G - L; I - H; H - J; K 
- H; H - L; I - J; K - I; I - L; K - J; J - 
L; K – L 
Neointermedeol 42.597 1.08E-23 22.965 3.02E-23 
A - C; D - A; A - F; A - G; A - H; A 
- K; A - L; B - C; B - F; B - G; B - 
H; B - I; B - K; B - L; D - C; E - C; 
G - C; C - H; I - C; J - C; K - C; C - 
L; D - E; D - F; D - G; D - H; D - I; 
D - J; D - K; D - L; E - F; E - G; E - 
H; E - L; F - H; I - F; J - F; K - F; F - 
L; G - H; J - G; G - L; I - H; J - H; K 
- H; L - H; I - L; J - L; K - L 
Terpineol 37.195 3.26E-22 21.487 8.63E-22 
A - B; A - C; A - D; A - E; A - F; A - 
G; A - I; A - J; K - A; A - L; B - D; B 
- E; B - F; H - B; K - B; C - D; C - E; 
C - F; H - C; K - C; C - L; G - D; H - 
D; I - D; J - D; K - D; G - E; H - E; I 
- E; J - E; K - E; G - F; H - F; I - F; J 
- F; K - F; L - F; H - G; K - G; G - L; 
H - I; H - J; K - H; H - L; K - I; I - L; 
K - J; J - L; K – L 
Dihydroartesmisinic acid 35.272 1.21E-21 20.916 3.06E-21 
E - A; G - A; I - A; J - A; E - B; G - 
B; I - B; J - B; E - C; G - C; I - C; J - 
C; D - F; G - D; D - H; J - D; D - L; 
E - F; E - H; J - E; E - K; E - L; G - 
F; I - F; J - F; G - H; G - I; J - G; G - 
K; G - L; I - H; J - H; K - H; J - I; I - 
K; I - L; J - K; J – L 
Terpinen 32.557 8.64E-21 20.064 2.08E-20 
A - B; A - C; A - G; A - H; A - I; A - 
J; A - L; D - B; E - B; F - B; I - B; K 
- B; D - C; E - C; F - C; I - C; K - C; 
E - D; F - D; D - G; D - H; D - J; D 
- L; E - G; E - H; E - I; E - J; E - L; F 
- G; F - H; F - I; F - J; F - L; I - G; K 
- G; I - H; K - H; I - J; K - I; I - L; K 
- J; K – L 
Isoaromadendrene 
epoxide.3 31.972 1.34E-20 19.872 3.09E-20 
A - B; A - D; A - E; A - G; H - A; K 
- A; A - L; C - B; B - E; F - B; G - B; 
H - B; I - B; J - B; K - B; B - L; C - 
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D; C - E; H - C; K - C; C - L; D - E; 
F - D; G - D; H - D; I - D; J - D; K - 
D; F - E; G - E; H - E; I - E; J - E; K 
- E; H - F; K - F; F - L; H - G; K - G; 
G - L; H - I; H - J; H - L; K - I; I - L; 
K - J; J - L; K – L 
3-buten-2-one, 4-5,5-
dimethyl-1-oxaspiro2.5oct-
4-yl 31.185 2.46E-20 19.61 5.43E-20 
A - B; A - C; A - D; A - E; A - F; J - 
A; A - L; C - B; G - B; H - B; I - B; J 
- B; K - B; C - D; C - E; C - F; G - 
C; J - C; K - C; C - L; G - D; H - D; I 
- D; J - D; K - D; G - E; H - E; I - E; 
J - E; K - E; G - F; H - F; I - F; J - F; 
K - F; J - G; G - L; J - H; K - H; H - 
L; J - I; I - L; J - L; K - L 
Chiapin B 25.6 2.67E-18 17.574 5.66E-18 
A - B; A - D; A - E; A - F; A - H; J - 
A; A - L; C - B; G - B; B - H; I - B; J 
- B; K - B; C - D; C - E; C - F; C - H; 
J - C; C - L; D - E; D - F; G - D; D - 
H; I - D; J - D; K - D; G - E; E - H; I 
- E; J - E; K - E; L - E; G - F; F - H; I 
- F; J - F; K - F; L - F; G - H; J - G; 
G - L; I - H; J - H; K - H; L - H; J - I; 
K - I; I - L; J - L; K – L 
Cholestan-3-ol, 2-
methylene-, 3beta,5a- 23.247 2.47E-17 16.607 5.03E-17 
A - B; A - D; A - E; A - F; A - G; A 
- H; A - I; A - J; K - A; A - L; B - H; 
K - B; B - L; C - E; C - F; C - G; C - 
H; K - C; C - L; D - H; K - D; D - L; 
E - H; K - E; E - L; F - H; K - F; F - 
L; G - H; K - G; G - L; I - H; J - H; K 
- H; H - L; K - I; I - L; K - J; J - L; K 
– L 
Pinene 21.478 1.48E-16 15.829 2.91E-16 
A - B; C - A; A - D; A - E; A - F; A - 
I; C - B; B - D; B - E; B - F; H - B; J 
- B; K - B; L - B; C - D; C - E; C - F; 
C - G; C - H; C - I; C - K; C - L; G - 
D; H - D; J - D; K - D; L - D; G - E; 
H - E; J - E; K - E; L - E; G - F; H - 
F; J - F; K - F; L - F; H - G; G - I; J - 
G; H - I; J - I; K - I; L - I; J - L 
Unkown alkane 20.366 4.85E-16 15.314 9.18E-16 
A - B; A - C; A - D; A - E; A - F; A - 
G; A - H; A - I; A - J; A - K; A - L; C 
83 
 
- B; D - B; B - F; G - B; H - B; B - I; 
C - F; H - C; C - I; C - J; C - L; D - 
E; D - F; H - D; D - I; D - J; D - L; E 
- F; G - E; H - E; E - I; G - F; H - F; 
I - F; J - F; K - F; L - F; H - G; G - I; 
G - J; G - L; H - I; H - J; H - K; H - 
L; K - I; L - I; K – J 
Elemen 20.243 5.55E-16 15.256 1.01E-15 
A - C; D - A; E - A; F - A; A - H; A - 
I; A - L; B - C; E - B; B - G; B - H; 
B - I; B - K; B - L; D - C; E - C; F - 
C; J - C; K - C; C - L; D - G; D - H; 
D - I; D - J; D - K; D - L; E - G; E - 
H; E - I; E - J; E - K; E - L; F - G; F - 
H; F - I; F - J; F - K; F - L; G - H; G 
- L; I - H; J - H; K - H; J - I; I - L; J - 
L; K – L 
Epiglobulol 19.389 1.43E-15 14.845 2.53E-15 
D - A; E - A; A - H; A - I; A - J; A - 
L; B - C; D - B; B - F; B - H; B - I; B 
- J; B - K; B - L; D - C; E - C; C - H; 
C - I; C - J; C - L; D - E; D - F; D - 
G; D - H; D - I; D - J; D - K; D - L; 
E - F; E - G; E - H; E - I; E - J; E - 
K; E - L; F - H; F - L; G - H; G - I; G 
- J; G - L; K - H; K - I; K - J; J - L; K 
– L 
Deoxyartemisinin 18.699 3.15E-15 14.502 5.38E-15 
A - B; A - D; A - E; A - F; A - H; A 
- L; C - B; B - F; G - B; B - H; I - B; 
J - B; K - B; C - D; C - E; C - F; C - 
H; C - L; D - F; G - D; D - H; I - D; 
J - D; K - D; G - E; E - H; I - E; J - 
E; K - E; G - F; F - H; I - F; J - F; K - 
F; G - H; G - L; I - H; J - H; K - H; L 
- H; I - L; J - L; K – L 
compound 1 18.66 3.30E-15 14.482 5.46E-15 
A - F; H - A; I - A; B - F; H - B; C - 
F; H - C; D - F; H - D; I - D; E - F; 
H - E; G - F; H - F; I - F; J - F; K - 
F; H - G; H - I; H - J; H - K; H - L; I 
– L 
beta-Guaiene 18.083 6.49E-15 14.188 1.04E-14 
F - A; G - A; I - A; J - A; K - A; A - 
L; F - B; G - B; I - B; J - B; K - B; B 
- L; G - C; C - H; I - C; J - C; K - C; 
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C - L; F - D; G - D; I - D; J - D; K - 
D; D - L; F - E; G - E; I - E; J - E; K 
- E; F - H; K - F; F - L; G - H; K - G; 
G - L; I - H; J - H; K - H; K - I; I - L; 
K - J; J - L; K - L 
Olean-12-en-3-one 13.739 1.88E-12 11.725 2.94E-12 
B - A; C - A; D - A; A - H; I - A; L - 
A; B - E; B - F; B - G; B - H; I - B; L 
- B; C - E; C - F; C - G; C - H; C - J; 
C - K; D - E; D - F; D - G; D - H; D 
- J; D - K; E - H; I - E; J - E; L - E; I 
- F; J - F; K - F; L - F; G - H; I - G; L 
- G; I - H; J - H; K - H; L - H; I - J; I 
- K; L - J; L - K 
Camphene 13.213 4.06E-12 11.392 6.14E-12 
A - B; A - D; A - E; A - F; A - G; J - 
A; A - L; H - B; I - B; J - B; K - B; C 
- D; C - E; C - F; I - C; J - C; K - C; 
G - D; H - D; I - D; J - D; K - D; L - 
D; G - E; H - E; I - E; J - E; K - E; L 
- E; G - F; H - F; I - F; J - F; K - F; L 
- F; H - G; I - G; J - G; K - G; J - H; 
H - L; I - L; J - L; K - L 
Heptacosane 12.255 1.73E-11 10.762 2.55E-11 
A - B; A - C; A - D; A - E; A - F; A - 
G; A - H; A - I; A - J; A - K; A - L; B 
- F; G - B; B - J; C - D; C - F; C - I; 
C - J; C - K; C - L; D - F; G - D; D - 
J; E - F; G - E; E - I; E - J; G - F; H - 
F; G - H; G - I; G - J; G - K; G - L; 
H - I; H - J; H - L 
Farnesene epoxide, E- 11.563 5.15E-11 10.289 7.37E-11 
B - A; D - A; A - H; A - I; A - L; B - 
C; B - F; B - G; B - H; B - I; B - J; B 
- K; B - L; D - C; E - C; C - H; C - L; 
D - F; D - G; D - H; D - I; D - J; D - 
K; D - L; E - H; E - I; E - J; E - K; E 
- L; F - H; F - I; F - K; F - L; G - H; 
G - I; G - K; G - L; J - H; K - H; J - 
L; K - L 
2H-Pyran, 2-7-
heptadecynyloxytetrahydro-
.1 9.3023 2.47E-09 8.6081 3.44E-09 
A - B; A - D; A - F; A - H; A - L; G - 
B; B - H; I - B; J - B; K - B; C - D; C 
- F; C - H; C - L; G - D; D - H; I - D; 
J - D; K - D; E - F; E - H; K - E; G - 
F; F - H; I - F; J - F; K - F; G - H; G 
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- L; I - H; J - H; K - H; L - H; I - L; J 
- L; K - L 
Cyclohexane, 1-ethenyl-1-
methyl-2-1-methylethenyl-
4-1-methyle 9.2301 2.81E-09 8.5507 3.82E-09 
A - B; I - A; L - A; C - B; D - B; G - 
B; I - B; K - B; L - B; C - E; C - F; C 
- H; I - C; C - J; L - C; D - E; D - F; 
D - H; I - D; D - J; L - D; I - E; L - 
E; I - F; L - F; G - H; I - G; L - G; I - 
H; L - H; I - J; I - K; L - J; L - K 
Isoaromadendrene 
epoxide.2 8.8949 5.23E-09 8.2814 6.93E-09 
A - C; A - F; A - H; K - A; A - L; B - 
C; B - F; B - H; K - B; B - L; D - C; I 
- C; K - C; C - L; D - F; D - H; K - 
D; D - L; I - E; K - E; E - L; I - F; K - 
F; F - L; I - G; K - G; G - L; I - H; K 
- H; H - L; I - J; I - L; K - J; J - L; K - 
L 
Ylangene 7.9522 3.21E-08 7.4938 4.15E-08 
D - A; G - A; H - A; I - A; L - A; B - 
J; L - B; I - C; L - C; D - E; D - F; D 
- J; L - D; G - E; H - E; I - E; L - E; 
G - F; H - F; I - F; L - F; G - J; L - 
G; H - J; L - H; I - J; I - K; L - I; L - 
J; L - K 
Aromadendrene oxide-2 7.8245 4.14E-08 7.3835 5.22E-08 
A - E; A - F; A - J; A - L; B - E; B - 
F; B - J; B - L; C - E; C - F; C - J; C - 
L; D - E; D - F; D - J; D - L; H - E; K 
- E; E - L; H - F; K - F; F - L; K - G; 
G - L; H - J; H - L; K - I; I - L; K - J; 
J - L; K - L 
cis-beta-Farnesene 7.7941 4.39E-08 7.3571 5.42E-08 
B - A; D - A; E - A; F - A; G - A; I - 
A; L - A; B - C; B - H; B - J; B - K; 
D - C; F - C; D - H; D - I; D - J; D - 
K; F - E; E - H; E - J; E - K; F - G; F 
- H; F - I; F - J; F - K; F - L; G - H; 
G - J; G - K; I - H; L - H; I - J; I - K; 
L - J; L - K 
Isoaromadendrene 
epoxide.4 7.7366 4.93E-08 7.307 5.94E-08 
A - B; A - C; A - H; A - I; J - A; A - 
K; A - L; D - B; E - B; F - B; G - B; J 
- B; E - C; F - C; G - C; J - C; E - D; 
D - H; J - D; D - K; E - H; E - I; E - 
K; E - L; F - H; F - I; F - K; F - L; G 
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- H; G - I; J - G; G - K; G - L; J - H; 
J - I; J - K; J - L 
Copaene 7.2251 1.40E-07 6.8539 1.65E-07 
D - A; G - A; H - A; I - A; L - A; B - 
J; L - B; L - C; D - E; D - F; D - J; L 
- D; G - E; H - E; I - E; L - E; G - F; 
H - F; I - F; L - F; G - J; L - G; H - J; 
L - H; I - J; L - I; L - J; L - K 
Ocimene 6.835 3.18E-07 6.4982 3.66E-07 
A - D; A - E; A - F; A - I; C - B; H - 
B; J - B; C - D; C - E; C - F; C - I; G 
- D; H - D; J - D; K - D; L - D; G - 
E; H - E; J - E; K - E; L - E; G - F; H 
- F; J - F; K - F; L - F; G - I; H - I; J 
- I; K - I 
Germacrene D 6.1279 1.48E-06 5.8299 1.67E-06 
D - A; G - A; H - A; I - A; L - A; B - 
J; L - B; I - C; L - C; D - E; D - F; D 
- J; L - D; G - E; H - E; I - E; L - E; 
G - F; H - F; I - F; L - F; G - J; L - 
G; H - J; L - H; I - J; L - I; L - J; L - 
K 
cis-Z-alpha-Bisabolene 
epoxide 4.7692 3.50E-05 4.4564 3.86E-05 
A - C; A - D; A - G; E - B; F - B; I - 
B; K - B; E - C; F - C; I - C; J - C; K 
- C; L - C; E - D; F - D; I - D; K - D; 
E - G; E - H; F - G; F - H; I - G; K - 
G; I - H; K - H 
2H-Pyran, 2-7-
heptadecynyloxytetrahydro- 3.6658 0.000558 3.2536 0.00060325 
A - B; A - F; A - H; A - L; E - B; J - 
B; K - B; J - C; J - D; E - F; E - H; E 
- L; J - F; K - F; J - G; J - H; K - H; J 
- I; K - I; J - L; K - L 
Aromadendrene oxide-2.1 3.2349 0.001717 2.7653 0.0018198 
A - B; A - D; A - F; A - L; C - B; G - 
B; I - B; J - B; K - B; C - D; C - F; C 
- L; G - D; I - D; J - D; K - D; G - F; 
H - F; I - F; J - F; K - F; G - L; H - L; 
I - L; J - L; K - L 
Caryophyllene 2.7765 0.005775 2.2384 0.0060018 
D - A; L - A; D - B; L - B; D - C; L - 
C; D - E; D - G; D - H; D - J; F - J; 







  Comp 1 Comp 2 Comp 3 Comp 4 Comp 5 Comp 6 Comp 7 Comp 8 
Pinene 0.15539 -0.04311 0.22212 0.11636 -0.09019 0.1623 -0.19174 0.22311 
Ocimene 0.13127 -0.03066 0.21406 0.095667 -0.1071 0.13923 -0.1355 0.15533 
Camphene 0.23821 -0.05493 0.076524 -0.14344 0.041644 -0.22284 0.4492 -0.56282 
Cymene -0.13499 -0.12051 -0.35505 -0.35159 0.33068 -0.28554 -0.43608 -0.03273 
Eucalyptol 0.029457 -0.04424 0.62501 -0.19478 -0.00361 -0.40318 0.072068 0.1207 
Terpinen -0.04571 -0.07608 -0.13548 -0.24581 0.082954 -0.135 -0.12881 0.013952 
cis-beta-Terpineol 0.080037 -0.05563 0.040733 0.010408 -0.01441 0.013961 -0.06832 0.11954 
Cyclohexanol, 1-methyl-4-1-
methylethenyl-, cis- 0.066173 -0.04645 0.025478 -0.01781 0.020649 0.001819 -0.1107 0.11224 
Camphor 0.8893 0.097887 -0.1497 -0.09759 0.082124 0.042853 -0.13553 0.087376 
endo-Borneol 0.088222 -0.92878 -0.00019 0.040971 0.10807 0.12239 0.094711 -0.08624 
Terpineol 0.041736 -0.03187 0.04964 -0.0487 0.010841 -0.13071 -0.00584 0.1192 
cis-p-mentha-17,8-dien-2-ol 0.043943 -0.02312 -0.03239 -0.01099 -0.05461 0.035848 -0.03328 0.073203 
Cyclohexane, 1-ethenyl-1-methyl-2-1-
methylethenyl-4-1-methyle 0.011648 0.007621 -0.03348 0.098257 0.21991 0.008364 0.082358 0.012882 
Phenol, 2-methoxy-3-2-propenyl- 0.042979 0.035682 -0.14171 -0.07182 -0.00902 -0.16252 0.046334 0.067618 
Butanoic acid, 2-methyl-, phenylmethyl 
ester -0.04512 -0.18484 -0.01279 0.091187 -0.05794 0.031316 -0.07843 0.23194 
Elemen -0.03414 -0.02119 -0.09908 -0.05112 -0.11051 -0.06368 -0.00503 0.006088 
ylangene -0.0083 0.029671 0.044088 0.13366 0.2627 0.00106 0.11949 0.040054 
Caryophyllene -0.02427 0.008635 -0.06701 0.046353 0.29578 -0.07149 0.14625 0.16318 
copaene -0.00876 0.025329 0.034593 0.11346 0.23024 -0.00275 0.10784 0.044242 
cis-beta-Farnesene -0.07569 0.027982 -0.05553 0.026657 0.095168 0.069141 0.20722 0.091548 
Germacrene D -0.01997 0.060256 0.076734 0.3058 0.5847 -0.04132 0.31716 0.096969 
Isoaromadendrene epoxide 0.015426 0.003677 0.01257 0.024344 -0.02454 -0.02225 -0.03763 0.10701 
compound 1 0.006532 0.009259 0.068179 -0.01393 -0.00927 -0.08289 -0.00711 -0.03152 
Caryophylene oxide 0.023489 -0.09862 0.048198 -0.04423 0.004606 0.018485 0.12401 0.018002 
beta-Guaiene 0.022238 0.009677 -0.0429 -0.05912 -0.03083 -0.03302 0.064707 0.052409 
Isoaromadendrene epoxide.1 -0.04123 -0.01379 -0.05353 0.053011 -0.11393 -0.02767 0.057838 0.006993 
Farnesene epoxide, E- -0.03216 -0.01366 -0.05991 0.037653 -0.11017 -0.02764 0.004125 0.061102 
Cubenol 0.042447 0.013268 -0.06779 -0.24782 -0.00799 -0.31302 0.3224 0.28434 
Aromadendrene oxide-2 0.005672 -0.01058 -0.00034 -0.01226 -0.01633 -0.05775 0.024976 0.07526 
Isoaromadendrene epoxide.2 0.007183 -0.00363 -0.02591 -0.01755 -0.02132 -0.06982 0.043156 0.027345 
Neointermedeol -0.00458 -0.0278 -0.12177 0.015185 -0.09162 -0.0855 0.071115 -0.00506 
Epiglobulol -0.01864 -0.01136 -0.04568 0.025365 -0.05727 -0.06552 -0.01294 0.067203 
Corymbolone -0.04085 -0.04533 -0.15644 0.090919 -0.17288 -0.13653 0.053779 0.10206 
2H-Pyran, 2-7-
heptadecynyloxytetrahydro- 0.018011 -0.00934 -0.02058 -0.00464 -0.04535 -0.01275 -0.04825 -0.07685 
Cedren-13-ol, 8- -0.10485 0.016688 -0.05346 -0.55063 0.014982 0.55842 0.28511 0.24035 
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Isoaromadendrene epoxide.3 0.027353 -0.00981 0.040381 -0.07512 -0.00981 -0.04407 0.071402 0.063051 
cis-Z-alpha-Bisabolene epoxide 0.003393 -0.00885 -0.03131 -0.07652 0.036612 -0.0077 0.003156 -0.06297 
Cholestan-3-ol, 2-methylene-, 3beta,5a- 0.017834 -0.02133 -0.04032 -0.04212 -0.05001 -0.066 0.023203 0.10367 
2-Methyl-4-2,6,6-trimethylcyclohex-2-
enylbut-3-en-2-ol -0.07632 -0.05126 -0.22807 0.16152 -0.25294 -0.18787 0.12995 0.092119 
Artemisinic acid -0.00159 0.007181 0.061771 -0.01215 -0.01148 -0.03594 -0.01305 -0.0184 
3-buten-2-one, 4-5,5-dimethyl-1-
oxaspiro2.5oct-4-yl 0.04967 -0.01595 0.004783 -0.00853 -0.03836 -0.0594 0.079543 -0.0077 
Dihydroartesmisinic acid 0.042234 0.035244 -0.08376 0.032567 -0.18588 0.048915 0.040185 -0.38186 
Isoaromadendrene epoxide.4 -0.00857 -0.01822 -0.03121 -0.01906 -0.07922 0.10074 -0.02007 -0.16806 
beta-copaene 0.13552 -0.05259 -0.30549 0.12953 -0.09853 -0.14614 0.24144 0.24312 
Chiapin B 0.02584 -0.00795 -0.04012 0.018366 -0.01254 0.010665 0.01598 0.012756 
1-Heptatriacotanol 0.009999 -0.00793 0.0063 -0.03273 -0.0281 0.019288 0.014713 -0.05769 
Aromadendrene oxide-2.1 0.021556 -0.00785 0.003714 -0.00018 -0.02752 -0.02783 0.019371 -0.01302 
2H-Pyran, 2-7-
heptadecynyloxytetrahydro-.1 0.029007 -0.01853 -0.07876 0.05103 -0.03012 0.01098 0.045515 0.009667 
Deoxyartemisinin 0.047284 -0.0376 -0.12777 0.083603 -0.03686 -0.01318 0.12261 0.072315 
Artemisinin 0.042639 0.015261 -0.05153 0.073991 -0.05618 0.040156 0.06194 -0.11498 
Heptacosane 0.001487 -0.10667 0.038271 0.079432 -0.08786 -0.02515 -0.04585 0.11169 
Unkown alkane 0.009206 -0.11216 0.10645 0.11068 -0.05708 -0.17672 -0.14495 0.087599 
Olean-12-en-3-one 0.028023 0.058051 -0.15134 0.31603 0.2331 0.046794 0.01653 0.026604 
 













Pinene 0.33469 0.81716 0.77008 0.7311 0.73908 
Ocimene 0.43504 0.62129 0.54747 0.66974 0.6661 
Camphene 1.2714 1.1818 1.1996 1.1618 1.1684 
Cymene 0.40051 0.99114 1.6688 1.6065 1.5835 
Eucalyptol 0.10973 0.27355 0.27825 0.79406 0.79848 
Terpinen 0.2312 0.36534 0.72525 0.69297 0.69056 
cis-beta-Terpineol 
0.09971
4 0.39461 0.34975 0.33364 0.34058 
Cyclohexanol, 1-methyl-4-1-methylethenyl-, cis- 0.17679 0.27069 0.30171 0.28615 0.30709 
Camphor 5.3055 4.915 4.3541 4.1359 4.0742 
endo-Borneol 3.6694 3.7187 3.8495 3.6489 3.595 
Terpineol 0.11197 0.16704 0.19833 0.18923 0.28729 
cis-p-mentha-17,8-dien-2-ol 
0.02723
9 0.25545 0.23802 0.22569 0.23676 
Cyclohexane, 1-ethenyl-1-methyl-2-1-
methylethenyl-4-1-methyle 0.32761 0.34408 0.41982 0.49703 0.50955 
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Phenol, 2-methoxy-3-2-propenyl- 0.37822 0.32687 0.30027 0.32459 0.32482 
Butanoic acid, 2-methyl-, phenylmethyl ester 1.5518 1.5139 1.4119 1.4822 1.4709 
Elemen 0.45861 0.41324 0.44457 0.42718 0.42298 
Ylangene 0.43769 0.55647 0.65801 0.6285 0.62531 
Caryophyllene 0.20573 0.38534 0.45244 0.81836 0.80752 
Copaene 0.36449 0.47197 0.55478 0.5362 0.53235 
cis-beta-Farnesene 0.34819 0.33421 0.44229 0.87296 0.88198 
Germacrene D 0.89222 1.1483 1.3497 1.3201 1.3078 
Isoaromadendrene epoxide 
0.09594












Caryophylene oxide 0.15903 0.16128 0.53287 0.62886 0.72794 
beta-Guaiene 0.16831 0.14646 0.1294 0.13238 0.24361 
Isoaromadendrene epoxide.1 0.61063 0.57682 0.72313 0.70804 0.69969 
Farnesene epoxide, E- 0.51525 0.49202 0.60269 0.57285 0.56731 
Cubenol 0.35597 0.30444 0.27372 0.37165 0.851 
Aromadendrene oxide-2 0.12319 0.17913 0.23344 0.32696 0.32285 




6 0.08568 0.11014 
Neointermedeol 0.36123 0.39604 0.43763 0.41683 0.41679 
Epiglobulol 0.33775 0.33015 0.4092 0.41003 0.40399 





9 0.12562 0.15901 
Cedren-13-ol, 8- 0.21344 0.56296 0.51854 1.0661 1.0725 
Isoaromadendrene epoxide.3 0.10582 0.12627 0.1127 0.17248 0.20487 
cis-Z-alpha-Bisabolene epoxide 0.18676 0.24213 0.42099 0.44033 0.44404 
Cholestan-3-ol, 2-methylene-, 3beta,5a- 0.13843 0.25474 0.28934 0.34129 0.34199 
2-Methyl-4-2,6,6-trimethylcyclohex-2-enylbut-3-











4-yl 0.17441 0.22574 0.20663 0.23876 0.28025 
Dihydroartesmisinic acid 0.35902 0.30807 0.27724 0.87405 0.86185 
Isoaromadendrene epoxide.4 
0.08311
6 0.08244 0.18113 0.42988 0.42928 
beta-copaene 
0.05839
8 0.86027 0.887 0.8509 0.90279 












8 0.12429 0.12347 0.12617 0.15664 
2H-Pyran, 2-7-heptadecynyloxytetrahydro-.1 
0.01672
8 0.19216 0.18051 0.18153 0.18257 
Deoxyartemisinin 0.12033 0.40312 0.40868 0.39058 0.3989 
Artemisinin 0.24454 0.23854 0.2116 0.39021 0.3852 
Heptacosane 0.75598 0.81042 0.74468 0.70753 0.70246 
Unkown alkane 0.61706 0.65747 0.57997 0.61957 0.63301 
Olean-12-en-3-one 0.32813 0.28412 0.38382 0.56196 0.60996 
 






















 epoxide, Elemen 
cis-beta-Farnesene 1.00 0.43 0.34 0.17 0.13 0.16 0.49 0.34 0.34 
Cedren-13-ol, 8- 0.43 1.00 0.33 0.40 0.00 -0.06 0.12 0.09 0.27 
Cymene 0.34 0.33 1.00 0.87 0.26 0.40 0.26 0.29 0.55 
Terpinen 0.17 0.40 0.87 1.00 0.27 0.38 0.16 0.20 0.59 
Butanoic acid, 2-m 0.13 0.00 0.26 0.27 1.00 0.30 0.44 0.40 0.34 
Neointermedeol 0.16 -0.06 0.40 0.38 0.30 1.00 0.66 0.59 0.77 
Isoaromadendrene e 0.49 0.12 0.26 0.16 0.44 0.66 1.00 0.81 0.71 
Farnesene epoxide, 0.34 0.09 0.29 0.20 0.40 0.59 0.81 1.00 0.62 
Elemen 0.34 0.27 0.55 0.59 0.34 0.77 0.71 0.62 1.00 
Epiglobulol 0.31 -0.04 0.40 0.32 0.43 0.69 0.75 0.63 0.72 
Corymbolone 0.32 -0.07 0.39 0.32 0.48 0.86 0.84 0.75 0.79 
2-Methyl-4-2,6,6-t 0.39 -0.05 0.37 0.27 0.42 0.85 0.88 0.78 0.77 
cis-p-mentha-17,8- -0.49 -0.15 -0.22 -0.08 0.07 0.25 -0.22 -0.09 0.00 
cis-beta-Terpineol -0.65 -0.37 -0.40 -0.25 0.13 -0.13 -0.50 -0.38 -0.38 
Cyclohexanol, 1-me -0.65 -0.31 -0.25 -0.11 0.11 -0.15 -0.56 -0.42 -0.33 
3-buten-2-one, 4-5 -0.58 -0.37 -0.38 -0.23 -0.24 0.10 -0.35 -0.28 -0.24 
Camphene -0.52 -0.32 -0.34 -0.18 -0.28 -0.03 -0.49 -0.47 -0.32 
Camphor -0.63 -0.37 -0.42 -0.31 -0.36 -0.04 -0.60 -0.47 -0.40 
Pinene -0.56 -0.36 -0.61 -0.51 -0.04 -0.36 -0.49 -0.40 -0.51 
Ocimene -0.48 -0.31 -0.54 -0.43 -0.11 -0.30 -0.48 -0.33 -0.42 
Terpineol -0.57 -0.34 -0.19 0.03 0.03 -0.13 -0.50 -0.35 -0.26 
Isoaromadendrene e -0.47 0.06 -0.27 -0.05 -0.20 -0.20 -0.45 -0.36 -0.30 
Isoaromadendrene e -0.10 -0.16 0.16 0.32 -0.02 0.58 0.10 0.11 0.43 
Cholestan-3-ol, 2- -0.23 -0.04 0.18 0.38 0.20 0.58 0.09 0.16 0.43 
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Cubenol -0.12 0.11 0.15 0.34 -0.20 0.30 -0.18 -0.07 0.19 
Aromadendrene oxid -0.05 -0.14 0.04 0.18 0.23 0.29 0.11 0.13 0.21 
Dihydroartesmisini -0.21 -0.17 -0.22 -0.22 -0.39 0.38 0.12 0.07 0.18 
Artemisinin -0.33 -0.39 -0.40 -0.43 -0.36 0.26 -0.08 -0.07 -0.16 
Phenol, 2-methoxy- -0.17 -0.14 0.23 0.30 -0.39 0.47 -0.13 0.03 0.21 
beta-Guaiene -0.23 0.12 0.04 0.21 -0.37 0.40 -0.14 -0.07 0.22 
2H-Pyran, 2-7-hept -0.17 -0.26 -0.08 -0.04 0.01 0.38 -0.04 0.06 0.04 
Chiapin B -0.35 -0.28 -0.14 -0.10 -0.11 0.34 -0.17 0.00 -0.08 
beta-copaene -0.26 -0.35 -0.04 0.00 -0.01 0.59 -0.01 0.09 0.12 
Deoxyartemisinin -0.18 -0.30 -0.04 -0.03 0.12 0.55 0.09 0.16 0.06 
Olean-12-en-3-one 0.06 -0.34 -0.04 -0.26 -0.10 0.11 -0.01 0.06 -0.23 
Caryophyllene 0.59 0.07 0.39 0.21 -0.02 0.07 -0.01 -0.08 0.05 
Cyclohexane, 1-eth 0.29 -0.23 0.08 -0.10 -0.15 -0.12 -0.27 -0.32 -0.36 
Germacrene D 0.43 -0.21 -0.06 -0.24 -0.14 -0.30 -0.19 -0.30 -0.37 
Ylangene 0.39 -0.20 -0.09 -0.28 -0.15 -0.37 -0.24 -0.34 -0.44 
Copaene 0.42 -0.18 -0.06 -0.25 -0.15 -0.36 -0.22 -0.31 -0.42 
compound 1 -0.33 -0.31 -0.35 -0.27 -0.26 -0.42 -0.31 -0.37 -0.27 
Eucalyptol -0.29 -0.12 -0.37 -0.23 -0.03 -0.55 -0.32 -0.35 -0.41 
Artemisinic acid -0.23 -0.13 -0.35 -0.29 -0.24 -0.56 -0.22 -0.27 -0.34 
cis-Z-alpha-Bisabo -0.08 0.24 0.38 0.47 -0.10 0.09 -0.21 -0.09 0.10 
Isoaromadendrene e 0.05 0.26 0.08 0.11 -0.01 0.22 0.24 0.16 0.31 
Heptacosane -0.19 -0.22 -0.09 0.00 0.59 0.05 0.13 0.13 -0.02 
Unkown alkane -0.34 -0.45 -0.11 -0.07 0.47 -0.09 0.01 0.03 -0.13 
endo-Borneol -0.23 -0.09 0.18 0.28 0.73 0.21 0.02 0.03 0.07 
Caryophylene oxide -0.33 0.02 -0.08 0.11 0.36 -0.06 -0.25 -0.23 -0.18 
Isoaromadendrene e -0.20 -0.19 -0.22 -0.17 0.02 -0.10 -0.09 -0.09 -0.13 
Aromadendrene oxid -0.31 -0.26 -0.28 -0.14 -0.16 0.00 -0.27 -0.21 -0.17 
2H-Pyran, 2-7-hept -0.22 -0.20 -0.06 0.02 -0.09 0.24 -0.04 -0.05 0.13 




























cis-beta-Farnesene 0.31 0.32 0.39 -0.49 -0.65 -0.65 -0.58 -0.52 -0.63 
Cedren-13-ol, 8- -0.04 -0.07 -0.05 -0.15 -0.37 -0.31 -0.37 -0.32 -0.37 
Cymene 0.40 0.39 0.37 -0.22 -0.40 -0.25 -0.38 -0.34 -0.42 
Terpinen 0.32 0.32 0.27 -0.08 -0.25 -0.11 -0.23 -0.18 -0.31 
Butanoic acid, 2-m 0.43 0.48 0.42 0.07 0.13 0.11 -0.24 -0.28 -0.36 
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Neointermedeol 0.69 0.86 0.85 0.25 -0.13 -0.15 0.10 -0.03 -0.04 
Isoaromadendrene e 0.75 0.84 0.88 -0.22 -0.50 -0.56 -0.35 -0.49 -0.60 
Farnesene epoxide, 0.63 0.75 0.78 -0.09 -0.38 -0.42 -0.28 -0.47 -0.47 
Elemen 0.72 0.79 0.77 0.00 -0.38 -0.33 -0.24 -0.32 -0.40 
Epiglobulol 1.00 0.85 0.84 0.00 -0.26 -0.26 -0.17 -0.41 -0.40 
Corymbolone 0.85 1.00 0.97 0.06 -0.27 -0.29 -0.14 -0.31 -0.34 
2-Methyl-4-2,6,6-t 0.84 0.97 1.00 -0.03 -0.38 -0.41 -0.19 -0.39 -0.43 
cis-p-mentha-17,8- 0.00 0.06 -0.03 1.00 0.82 0.80 0.67 0.49 0.77 
cis-beta-Terpineol -0.26 -0.27 -0.38 0.82 1.00 0.97 0.73 0.63 0.80 
Cyclohexanol, 1-me -0.26 -0.29 -0.41 0.80 0.97 1.00 0.67 0.59 0.78 
3-buten-2-one, 4-5 -0.17 -0.14 -0.19 0.67 0.73 0.67 1.00 0.73 0.77 
Camphene -0.41 -0.31 -0.39 0.49 0.63 0.59 0.73 1.00 0.75 
Camphor -0.40 -0.34 -0.43 0.77 0.80 0.78 0.77 0.75 1.00 
Pinene -0.39 -0.39 -0.47 0.57 0.80 0.74 0.54 0.55 0.66 
Ocimene -0.38 -0.34 -0.40 0.46 0.64 0.59 0.49 0.48 0.54 
Terpineol -0.17 -0.24 -0.34 0.49 0.73 0.76 0.65 0.55 0.56 
Isoaromadendrene e -0.28 -0.38 -0.43 0.42 0.58 0.56 0.70 0.57 0.52 
Isoaromadendrene e 0.40 0.43 0.35 0.29 0.13 0.13 0.39 0.29 0.25 
Cholestan-3-ol, 2- 0.39 0.44 0.32 0.66 0.46 0.47 0.52 0.35 0.41 
Cubenol 0.05 0.08 0.02 0.20 0.14 0.17 0.39 0.36 0.30 
Aromadendrene oxid 0.34 0.29 0.22 0.32 0.34 0.34 0.42 0.21 0.19 
Dihydroartesmisini 0.02 0.15 0.18 0.36 0.09 0.01 0.41 0.30 0.37 
Artemisinin -0.13 0.04 0.05 0.51 0.35 0.25 0.60 0.45 0.63 
Phenol, 2-methoxy- 0.14 0.22 0.17 0.38 0.12 0.15 0.43 0.33 0.50 
beta-Guaiene 0.06 0.14 0.06 0.55 0.30 0.31 0.60 0.42 0.55 
2H-Pyran, 2-7-hept 0.15 0.21 0.19 0.52 0.34 0.27 0.44 0.25 0.43 
Chiapin B 0.03 0.13 0.08 0.75 0.57 0.53 0.66 0.47 0.71 
beta-copaene 0.22 0.37 0.31 0.70 0.49 0.44 0.65 0.44 0.64 
Deoxyartemisinin 0.18 0.33 0.31 0.58 0.40 0.34 0.52 0.31 0.49 
Olean-12-en-3-one -0.03 0.05 0.08 -0.04 -0.05 -0.07 -0.06 -0.01 0.19 
Caryophyllene 0.17 0.09 0.13 -0.18 -0.20 -0.13 -0.17 -0.17 -0.17 
Cyclohexane, 1-eth -0.18 -0.17 -0.14 -0.10 0.03 0.05 0.03 0.10 0.17 
Germacrene D -0.17 -0.22 -0.16 -0.34 -0.12 -0.10 -0.15 -0.06 -0.09 
Ylangene -0.22 -0.29 -0.23 -0.36 -0.11 -0.09 -0.15 -0.08 -0.08 
Copaene -0.20 -0.27 -0.21 -0.36 -0.13 -0.10 -0.16 -0.09 -0.10 
compound 1 -0.22 -0.41 -0.41 -0.19 0.16 0.14 0.29 0.30 0.10 
Eucalyptol -0.32 -0.49 -0.50 -0.15 0.27 0.24 0.23 0.23 0.03 
Artemisinic acid -0.27 -0.44 -0.40 -0.26 0.06 0.04 0.13 0.07 -0.10 
cis-Z-alpha-Bisabo -0.09 -0.10 -0.14 0.03 -0.05 0.04 0.08 0.16 0.10 
Isoaromadendrene e 0.14 0.12 0.19 0.15 -0.12 -0.15 0.02 -0.10 -0.13 
Heptacosane 0.25 0.16 0.14 0.24 0.37 0.30 0.18 -0.02 -0.05 
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Unkown alkane 0.18 0.06 0.03 0.17 0.44 0.40 0.26 0.09 0.00 
endo-Borneol 0.05 0.16 0.09 0.35 0.48 0.46 0.27 0.23 0.08 
Caryophylene oxide -0.21 -0.14 -0.18 0.35 0.55 0.52 0.51 0.39 0.21 
Isoaromadendrene e 0.00 -0.04 -0.09 0.20 0.29 0.26 0.16 0.07 0.22 
Aromadendrene oxid -0.04 -0.16 -0.18 0.41 0.44 0.38 0.60 0.42 0.45 
2H-Pyran, 2-7-hept 0.06 0.04 0.04 0.47 0.31 0.28 0.33 0.29 0.35 



























cis-beta-Farnesene -0.56 -0.48 -0.57 -0.47 -0.10 -0.23 
-
0.12 -0.05 -0.21 
Cedren-13-ol, 8- -0.36 -0.31 -0.34 0.06 -0.16 -0.04 0.11 -0.14 -0.17 
Cymene -0.61 -0.54 -0.19 -0.27 0.16 0.18 0.15 0.04 -0.22 
Terpinen -0.51 -0.43 0.03 -0.05 0.32 0.38 0.34 0.18 -0.22 
Butanoic acid, 2-m -0.04 -0.11 0.03 -0.20 -0.02 0.20 
-
0.20 0.23 -0.39 
Neointermedeol -0.36 -0.30 -0.13 -0.20 0.58 0.58 0.30 0.29 0.38 
Isoaromadendrene 
e -0.49 -0.48 -0.50 -0.45 0.10 0.09 
-
0.18 0.11 0.12 
Farnesene epoxide, -0.40 -0.33 -0.35 -0.36 0.11 0.16 
-
0.07 0.13 0.07 
Elemen -0.51 -0.42 -0.26 -0.30 0.43 0.43 0.19 0.21 0.18 
Epiglobulol -0.39 -0.38 -0.17 -0.28 0.40 0.39 0.05 0.34 0.02 
Corymbolone -0.39 -0.34 -0.24 -0.38 0.43 0.44 0.08 0.29 0.15 
2-Methyl-4-2,6,6-t -0.47 -0.40 -0.34 -0.43 0.35 0.32 0.02 0.22 0.18 
cis-p-mentha-17,8- 0.57 0.46 0.49 0.42 0.29 0.66 0.20 0.32 0.36 
cis-beta-Terpineol 0.80 0.64 0.73 0.58 0.13 0.46 0.14 0.34 0.09 
Cyclohexanol, 1-me 0.74 0.59 0.76 0.56 0.13 0.47 0.17 0.34 0.01 
3-buten-2-one, 4-5 0.54 0.49 0.65 0.70 0.39 0.52 0.39 0.42 0.41 
Camphene 0.55 0.48 0.55 0.57 0.29 0.35 0.36 0.21 0.30 
Camphor 0.66 0.54 0.56 0.52 0.25 0.41 0.30 0.19 0.37 
Pinene 1.00 0.87 0.52 0.43 -0.10 0.17 
-
0.07 0.15 0.09 
Ocimene 0.87 1.00 0.49 0.40 -0.05 0.13 
-
0.02 0.11 0.14 
Terpineol 0.52 0.49 1.00 0.75 0.42 0.53 0.56 0.59 -0.17 
Isoaromadendrene 
e 0.43 0.40 0.75 1.00 0.30 0.45 0.57 0.52 -0.03 
Isoaromadendrene 
e -0.10 -0.05 0.42 0.30 1.00 0.73 0.73 0.52 0.19 
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Cholestan-3-ol, 2- 0.17 0.13 0.53 0.45 0.73 1.00 0.67 0.67 0.09 
Cubenol -0.07 -0.02 0.56 0.57 0.73 0.67 1.00 0.52 -0.07 
Aromadendrene 
oxid 0.15 0.11 0.59 0.52 0.52 0.67 0.52 1.00 -0.16 
Dihydroartesmisini 0.09 0.14 -0.17 -0.03 0.19 0.09 
-
0.07 -0.16 1.00 
Artemisinin 0.31 0.27 -0.05 0.04 0.12 0.14 
-
0.07 -0.12 0.75 
Phenol, 2-methoxy- -0.09 -0.07 0.24 0.21 0.65 0.63 0.66 0.32 0.28 
beta-Guaiene 0.11 0.07 0.38 0.49 0.66 0.73 0.74 0.36 0.34 
2H-Pyran, 2-7-hept 0.11 0.04 0.09 0.02 0.43 0.42 0.13 0.02 0.36 
Chiapin B 0.35 0.28 0.25 0.23 0.32 0.48 0.17 0.22 0.43 
beta-copaene 0.22 0.16 0.28 0.20 0.54 0.69 0.40 0.35 0.37 
Deoxyartemisinin 0.13 0.06 0.14 0.08 0.34 0.52 0.20 0.24 0.31 
Olean-12-en-3-one -0.06 -0.08 -0.26 -0.36 -0.09 -0.20 
-
0.19 -0.24 0.01 
Caryophyllene -0.30 -0.26 -0.06 -0.13 0.12 -0.01 0.10 0.12 -0.27 
Cyclohexane, 1-eth 0.00 -0.05 -0.08 -0.17 -0.07 -0.21 
-
0.12 -0.10 -0.15 
Germacrene D -0.03 -0.02 -0.06 -0.16 -0.18 -0.42 
-
0.15 -0.11 -0.29 
Ylangene -0.01 -0.02 -0.08 -0.18 -0.26 -0.49 
-
0.20 -0.15 -0.31 
Copaene -0.03 -0.04 -0.08 -0.17 -0.25 -0.47 
-
0.18 -0.13 -0.32 
compound 1 0.30 0.31 0.46 0.44 0.07 -0.09 0.15 0.21 -0.06 
Eucalyptol 0.37 0.34 0.54 0.58 -0.11 -0.11 0.10 0.26 -0.31 
Artemisinic acid 0.25 0.29 0.33 0.42 -0.20 -0.27 
-
0.06 0.16 -0.12 
cis-Z-alpha-Bisabo -0.24 -0.19 0.07 0.15 0.24 0.17 0.35 -0.10 0.03 
Isoaromadendrene 
e -0.15 -0.08 -0.33 -0.17 0.00 -0.05 
-
0.31 -0.30 0.51 
Heptacosane 0.23 0.12 0.25 0.12 0.10 0.21 
-
0.16 0.24 -0.15 
Unkown alkane 0.32 0.23 0.44 0.23 0.06 0.14 
-
0.15 0.30 -0.21 
endo-Borneol 0.22 0.17 0.34 0.18 0.07 0.31 
-
0.04 0.22 -0.13 
Caryophylene oxide 0.37 0.35 0.54 0.53 0.09 0.28 0.19 0.26 -0.09 
Isoaromadendrene 
e 0.21 0.06 0.20 0.14 0.03 0.18 0.00 0.16 -0.07 
Aromadendrene 
oxid 0.31 0.25 0.39 0.42 0.40 0.33 0.18 0.29 0.28 
2H-Pyran, 2-7-hept 0.17 0.11 0.15 0.09 0.29 0.29 0.01 0.07 0.46 































cis-beta-Farnesene -0.33 -0.17 -0.23 -0.17 -0.35 -0.26 -0.18 0.06 0.59 
Cedren-13-ol, 8- -0.39 -0.14 0.12 -0.26 -0.28 -0.35 -0.30 -0.34 0.07 
Cymene -0.40 0.23 0.04 -0.08 -0.14 -0.04 -0.04 -0.04 0.39 
Terpinen -0.43 0.30 0.21 -0.04 -0.10 0.00 -0.03 -0.26 0.21 
Butanoic acid, 2-m -0.36 -0.39 -0.37 0.01 -0.11 -0.01 0.12 -0.10 -0.02 
Neointermedeol 0.26 0.47 0.40 0.38 0.34 0.59 0.55 0.11 0.07 
Isoaromadendrene e -0.08 -0.13 -0.14 -0.04 -0.17 -0.01 0.09 -0.01 -0.01 
Farnesene epoxide, -0.07 0.03 -0.07 0.06 0.00 0.09 0.16 0.06 -0.08 
Elemen -0.16 0.21 0.22 0.04 -0.08 0.12 0.06 -0.23 0.05 
Epiglobulol -0.13 0.14 0.06 0.15 0.03 0.22 0.18 -0.03 0.17 
Corymbolone 0.04 0.22 0.14 0.21 0.13 0.37 0.33 0.05 0.09 
2-Methyl-4-2,6,6-t 0.05 0.17 0.06 0.19 0.08 0.31 0.31 0.08 0.13 
cis-p-mentha-17,8- 0.51 0.38 0.55 0.52 0.75 0.70 0.58 -0.04 -0.18 
cis-beta-Terpineol 0.35 0.12 0.30 0.34 0.57 0.49 0.40 -0.05 -0.20 
Cyclohexanol, 1-me 0.25 0.15 0.31 0.27 0.53 0.44 0.34 -0.07 -0.13 
3-buten-2-one, 4-5 0.60 0.43 0.60 0.44 0.66 0.65 0.52 -0.06 -0.17 
Camphene 0.45 0.33 0.42 0.25 0.47 0.44 0.31 -0.01 -0.17 
Camphor 0.63 0.50 0.55 0.43 0.71 0.64 0.49 0.19 -0.17 
Pinene 0.31 -0.09 0.11 0.11 0.35 0.22 0.13 -0.06 -0.30 
Ocimene 0.27 -0.07 0.07 0.04 0.28 0.16 0.06 -0.08 -0.26 
Terpineol -0.05 0.24 0.38 0.09 0.25 0.28 0.14 -0.26 -0.06 
Isoaromadendrene e 0.04 0.21 0.49 0.02 0.23 0.20 0.08 -0.36 -0.13 
Isoaromadendrene e 0.12 0.65 0.66 0.43 0.32 0.54 0.34 -0.09 0.12 
Cholestan-3-ol, 2- 0.14 0.63 0.73 0.42 0.48 0.69 0.52 -0.20 -0.01 
Cubenol -0.07 0.66 0.74 0.13 0.17 0.40 0.20 -0.19 0.10 
Aromadendrene oxid -0.12 0.32 0.36 0.02 0.22 0.35 0.24 -0.24 0.12 
Dihydroartesmisini 0.75 0.28 0.34 0.36 0.43 0.37 0.31 0.01 -0.27 
Artemisinin 1.00 0.41 0.39 0.54 0.73 0.68 0.65 0.34 -0.22 
Phenol, 2-methoxy- 0.41 1.00 0.79 0.49 0.57 0.73 0.55 0.19 0.12 
beta-Guaiene 0.39 0.79 1.00 0.42 0.55 0.66 0.46 -0.13 -0.03 
2H-Pyran, 2-7-hept 0.54 0.49 0.42 1.00 0.68 0.73 0.67 0.28 0.07 
Chiapin B 0.73 0.57 0.55 0.68 1.00 0.85 0.77 0.31 -0.04 
beta-copaene 0.68 0.73 0.66 0.73 0.85 1.00 0.87 0.34 0.08 
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Deoxyartemisinin 0.65 0.55 0.46 0.67 0.77 0.87 1.00 0.40 0.03 
Olean-12-en-3-one 0.34 0.19 -0.13 0.28 0.31 0.34 0.40 1.00 0.27 
Caryophyllene -0.22 0.12 -0.03 0.07 -0.04 0.08 0.03 0.27 1.00 
Cyclohexane, 1-eth 0.20 0.14 -0.06 0.21 0.23 0.24 0.26 0.59 0.73 
Germacrene D -0.09 -0.19 -0.30 -0.10 -0.14 -0.12 -0.11 0.37 0.76 
Ylangene -0.08 -0.23 -0.33 -0.15 -0.15 -0.16 -0.13 0.37 0.69 
Copaene -0.09 -0.22 -0.32 -0.15 -0.15 -0.15 -0.12 0.36 0.72 
compound 1 -0.18 -0.17 -0.06 -0.34 -0.32 -0.34 -0.41 -0.30 -0.21 
Eucalyptol -0.35 -0.39 -0.20 -0.47 -0.39 -0.45 -0.45 -0.43 -0.19 
Artemisinic acid -0.27 -0.41 -0.24 -0.53 -0.45 -0.55 -0.55 -0.46 -0.21 
cis-Z-alpha-Bisabo -0.07 0.31 0.31 0.14 0.07 0.07 0.05 -0.13 -0.02 
Isoaromadendrene e 0.16 -0.13 0.03 0.41 0.13 -0.03 0.02 -0.22 -0.13 
Heptacosane -0.05 -0.23 -0.18 0.40 0.14 0.14 0.19 -0.16 -0.15 
Unkown alkane -0.12 -0.30 -0.26 0.14 0.02 0.02 0.03 -0.15 -0.12 
endo-Borneol -0.03 -0.19 -0.09 0.23 0.24 0.23 0.32 -0.14 -0.05 
Caryophylene oxide 0.05 -0.14 0.16 0.14 0.23 0.19 0.23 -0.37 -0.13 
Isoaromadendrene e 0.16 0.10 0.14 0.14 0.15 0.16 0.16 0.11 -0.12 
Aromadendrene oxid 0.28 0.28 0.33 0.65 0.41 0.37 0.31 -0.08 -0.05 
2H-Pyran, 2-7-hept 0.28 0.22 0.23 0.57 0.32 0.30 0.21 -0.13 -0.11 

























cis-beta-Farnesene 0.29 0.43 0.39 0.42 -0.33 -0.29 -0.23 -0.08 0.05 
Cedren-13-ol, 8- -0.23 -0.21 -0.20 -0.18 -0.31 -0.12 -0.13 0.24 0.26 
Cymene 0.08 -0.06 -0.09 -0.06 -0.35 -0.37 -0.35 0.38 0.08 
Terpinen -0.10 -0.24 -0.28 -0.25 -0.27 -0.23 -0.29 0.47 0.11 
Butanoic acid, 2-m -0.15 -0.14 -0.15 -0.15 -0.26 -0.03 -0.24 -0.10 -0.01 
Neointermedeol -0.12 -0.30 -0.37 -0.36 -0.42 -0.55 -0.56 0.09 0.22 
Isoaromadendrene e -0.27 -0.19 -0.24 -0.22 -0.31 -0.32 -0.22 -0.21 0.24 
Farnesene epoxide, -0.32 -0.30 -0.34 -0.31 -0.37 -0.35 -0.27 -0.09 0.16 
Elemen -0.36 -0.37 -0.44 -0.42 -0.27 -0.41 -0.34 0.10 0.31 
Epiglobulol -0.18 -0.17 -0.22 -0.20 -0.22 -0.32 -0.27 -0.09 0.14 
Corymbolone -0.17 -0.22 -0.29 -0.27 -0.41 -0.49 -0.44 -0.10 0.12 
2-Methyl-4-2,6,6-t -0.14 -0.16 -0.23 -0.21 -0.41 -0.50 -0.40 -0.14 0.19 
cis-p-mentha-17,8- -0.10 -0.34 -0.36 -0.36 -0.19 -0.15 -0.26 0.03 0.15 
cis-beta-Terpineol 0.03 -0.12 -0.11 -0.13 0.16 0.27 0.06 -0.05 -0.12 
Cyclohexanol, 1-me 0.05 -0.10 -0.09 -0.10 0.14 0.24 0.04 0.04 -0.15 
3-buten-2-one, 4-5 0.03 -0.15 -0.15 -0.16 0.29 0.23 0.13 0.08 0.02 
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Camphene 0.10 -0.06 -0.08 -0.09 0.30 0.23 0.07 0.16 -0.10 
Camphor 0.17 -0.09 -0.08 -0.10 0.10 0.03 -0.10 0.10 -0.13 
Pinene 0.00 -0.03 -0.01 -0.03 0.30 0.37 0.25 -0.24 -0.15 
Ocimene -0.05 -0.02 -0.02 -0.04 0.31 0.34 0.29 -0.19 -0.08 
Terpineol -0.08 -0.06 -0.08 -0.08 0.46 0.54 0.33 0.07 -0.33 
Isoaromadendrene e -0.17 -0.16 -0.18 -0.17 0.44 0.58 0.42 0.15 -0.17 
Isoaromadendrene e -0.07 -0.18 -0.26 -0.25 0.07 -0.11 -0.20 0.24 0.00 
Cholestan-3-ol, 2- -0.21 -0.42 -0.49 -0.47 -0.09 -0.11 -0.27 0.17 -0.05 
Cubenol -0.12 -0.15 -0.20 -0.18 0.15 0.10 -0.06 0.35 -0.31 
Aromadendrene oxid -0.10 -0.11 -0.15 -0.13 0.21 0.26 0.16 -0.10 -0.30 
Dihydroartesmisini -0.15 -0.29 -0.31 -0.32 -0.06 -0.31 -0.12 0.03 0.51 
Artemisinin 0.20 -0.09 -0.08 -0.09 -0.18 -0.35 -0.27 -0.07 0.16 
Phenol, 2-methoxy- 0.14 -0.19 -0.23 -0.22 -0.17 -0.39 -0.41 0.31 -0.13 
beta-Guaiene -0.06 -0.30 -0.33 -0.32 -0.06 -0.20 -0.24 0.31 0.03 
2H-Pyran, 2-7-hept 0.21 -0.10 -0.15 -0.15 -0.34 -0.47 -0.53 0.14 0.41 
Chiapin B 0.23 -0.14 -0.15 -0.15 -0.32 -0.39 -0.45 0.07 0.13 
beta-copaene 0.24 -0.12 -0.16 -0.15 -0.34 -0.45 -0.55 0.07 -0.03 
Deoxyartemisinin 0.26 -0.11 -0.13 -0.12 -0.41 -0.45 -0.55 0.05 0.02 
Olean-12-en-3-one 0.59 0.37 0.37 0.36 -0.30 -0.43 -0.46 -0.13 -0.22 
Caryophyllene 0.73 0.76 0.69 0.72 -0.21 -0.19 -0.21 -0.02 -0.13 
Cyclohexane, 1-eth 1.00 0.82 0.81 0.82 -0.19 -0.23 -0.27 -0.02 -0.25 
Germacrene D 0.82 1.00 0.98 0.98 0.04 0.05 0.05 -0.14 -0.31 
Ylangene 0.81 0.98 1.00 1.00 0.04 0.08 0.08 -0.16 -0.34 
Copaene 0.82 0.98 1.00 1.00 0.03 0.06 0.07 -0.16 -0.34 
compound 1 -0.19 0.04 0.04 0.03 1.00 0.78 0.78 -0.07 -0.19 
Eucalyptol -0.23 0.05 0.08 0.06 0.78 1.00 0.81 -0.17 -0.29 
Artemisinic acid -0.27 0.05 0.08 0.07 0.78 0.81 1.00 -0.22 -0.14 
cis-Z-alpha-Bisabo -0.02 -0.14 -0.16 -0.16 -0.07 -0.17 -0.22 1.00 0.13 
Isoaromadendrene e -0.25 -0.31 -0.34 -0.34 -0.19 -0.29 -0.14 0.13 1.00 
Heptacosane -0.15 -0.18 -0.19 -0.19 0.07 0.18 0.02 -0.17 0.29 
Unkown alkane -0.12 -0.04 -0.05 -0.05 0.36 0.44 0.32 -0.23 0.07 
endo-Borneol 0.02 -0.14 -0.15 -0.15 -0.14 0.09 -0.16 0.13 0.15 
Caryophylene oxide -0.05 -0.09 -0.08 -0.08 0.12 0.33 0.14 0.15 0.10 
Isoaromadendrene e 0.06 -0.09 -0.08 -0.09 0.15 0.14 0.09 -0.23 -0.19 
Aromadendrene oxid 0.00 -0.13 -0.18 -0.18 0.28 0.12 0.07 0.09 0.42 
2H-Pyran, 2-7-hept -0.13 -0.25 -0.30 -0.29 0.03 -0.12 -0.11 0.11 0.61 


























cis-beta-Farnesene -0.19 -0.34 -0.23 -0.33 -0.20 -0.31 -0.22 -0.15 
Cedren-13-ol, 8- -0.22 -0.45 -0.09 0.02 -0.19 -0.26 -0.20 0.09 
Cymene -0.09 -0.11 0.18 -0.08 -0.22 -0.28 -0.06 -0.12 
Terpinen 0.00 -0.07 0.28 0.11 -0.17 -0.14 0.02 0.00 
Butanoic acid, 2-m 0.59 0.47 0.73 0.36 0.02 -0.16 -0.09 -0.15 
Neointermedeol 0.05 -0.09 0.21 -0.06 -0.10 0.00 0.24 -0.07 
Isoaromadendrene e 0.13 0.01 0.02 -0.25 -0.09 -0.27 -0.04 -0.19 
Farnesene epoxide, 0.13 0.03 0.03 -0.23 -0.09 -0.21 -0.05 -0.14 
Elemen -0.02 -0.13 0.07 -0.18 -0.13 -0.17 0.13 -0.04 
Epiglobulol 0.25 0.18 0.05 -0.21 0.00 -0.04 0.06 -0.08 
Corymbolone 0.16 0.06 0.16 -0.14 -0.04 -0.16 0.04 -0.21 
2-Methyl-4-2,6,6-t 0.14 0.03 0.09 -0.18 -0.09 -0.18 0.04 -0.19 
cis-p-mentha-17,8- 0.24 0.17 0.35 0.35 0.20 0.41 0.47 0.19 
cis-beta-Terpineol 0.37 0.44 0.48 0.55 0.29 0.44 0.31 0.16 
Cyclohexanol, 1-me 0.30 0.40 0.46 0.52 0.26 0.38 0.28 0.13 
3-buten-2-one, 4-5 0.18 0.26 0.27 0.51 0.16 0.60 0.33 0.28 
Camphene -0.02 0.09 0.23 0.39 0.07 0.42 0.29 0.22 
Camphor -0.05 0.00 0.08 0.21 0.22 0.45 0.35 0.18 
Pinene 0.23 0.32 0.22 0.37 0.21 0.31 0.17 0.07 
Ocimene 0.12 0.23 0.17 0.35 0.06 0.25 0.11 0.12 
Terpineol 0.25 0.44 0.34 0.54 0.20 0.39 0.15 0.13 
Isoaromadendrene e 0.12 0.23 0.18 0.53 0.14 0.42 0.09 0.27 
Isoaromadendrene e 0.10 0.06 0.07 0.09 0.03 0.40 0.29 0.21 
Cholestan-3-ol, 2- 0.21 0.14 0.31 0.28 0.18 0.33 0.29 0.10 
Cubenol -0.16 -0.15 -0.04 0.19 0.00 0.18 0.01 0.05 
Aromadendrene oxid 0.24 0.30 0.22 0.26 0.16 0.29 0.07 0.01 
Dihydroartesmisini -0.15 -0.21 -0.13 -0.09 -0.07 0.28 0.46 0.23 
Artemisinin -0.05 -0.12 -0.03 0.05 0.16 0.28 0.28 0.06 
Phenol, 2-methoxy- -0.23 -0.30 -0.19 -0.14 0.10 0.28 0.22 0.06 
beta-Guaiene -0.18 -0.26 -0.09 0.16 0.14 0.33 0.23 0.16 
2H-Pyran, 2-7-hept 0.40 0.14 0.23 0.14 0.14 0.65 0.57 0.50 
Chiapin B 0.14 0.02 0.24 0.23 0.15 0.41 0.32 0.16 
beta-copaene 0.14 0.02 0.23 0.19 0.16 0.37 0.30 0.06 
Deoxyartemisinin 0.19 0.03 0.32 0.23 0.16 0.31 0.21 0.00 
Olean-12-en-3-one -0.16 -0.15 -0.14 -0.37 0.11 -0.08 -0.13 -0.18 
Caryophyllene -0.15 -0.12 -0.05 -0.13 -0.12 -0.05 -0.11 -0.05 
Cyclohexane, 1-eth -0.15 -0.12 0.02 -0.05 0.06 0.00 -0.13 -0.13 
Germacrene D -0.18 -0.04 -0.14 -0.09 -0.09 -0.13 -0.25 -0.19 
Ylangene -0.19 -0.05 -0.15 -0.08 -0.08 -0.18 -0.30 -0.24 
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Copaene -0.19 -0.05 -0.15 -0.08 -0.09 -0.18 -0.29 -0.24 
compound 1 0.07 0.36 -0.14 0.12 0.15 0.28 0.03 0.17 
Eucalyptol 0.18 0.44 0.09 0.33 0.14 0.12 -0.12 0.06 
Artemisinic acid 0.02 0.32 -0.16 0.14 0.09 0.07 -0.11 0.06 
cis-Z-alpha-Bisabo -0.17 -0.23 0.13 0.15 -0.23 0.09 0.11 0.21 
Isoaromadendrene e 0.29 0.07 0.15 0.10 -0.19 0.42 0.61 0.66 
Heptacosane 1.00 0.85 0.63 0.53 0.14 0.46 0.38 0.39 
Unkown alkane 0.85 1.00 0.54 0.49 0.16 0.37 0.27 0.22 
endo-Borneol 0.63 0.54 1.00 0.79 -0.01 0.16 0.14 0.11 
Caryophylene oxide 0.53 0.49 0.79 1.00 0.02 0.28 0.08 0.19 
Isoaromadendrene e 0.14 0.16 -0.01 0.02 1.00 0.22 -0.03 0.01 
Aromadendrene oxid 0.46 0.37 0.16 0.28 0.22 1.00 0.66 0.78 
2H-Pyran, 2-7-hept 0.38 0.27 0.14 0.08 -0.03 0.66 1.00 0.59 














































cis-beta-Farnesene NA 0.00 0.00 0.16 0.27 0.18 0.00 0.00 0.00 0.01 
Cedren-13-ol, 8- 0.00 NA 0.00 0.00 0.98 0.61 0.34 0.44 0.02 0.75 
Cymene 0.00 0.00 NA 0.00 0.03 0.00 0.03 0.01 0.00 0.00 
Terpinen 0.16 0.00 0.00 NA 0.02 0.00 0.17 0.09 0.00 0.01 
Butanoic acid, 2-m 0.27 0.98 0.03 0.02 NA 0.01 0.00 0.00 0.00 0.00 
Neointermedeol 0.18 0.61 0.00 0.00 0.01 NA 0.00 0.00 0.00 0.00 
Isoaromadendrene 
e 0.00 0.34 0.03 0.17 0.00 0.00 NA 0.00 0.00 0.00 
Farnesene 
epoxide, 0.00 0.44 0.01 0.09 0.00 0.00 0.00 NA 0.00 0.00 
Elemen 0.00 0.02 0.00 0.00 0.00 0.00 0.00 0.00 NA 0.00 
Epiglobulol 0.01 0.75 0.00 0.01 0.00 0.00 0.00 0.00 0.00 NA 
Corymbolone 0.01 0.55 0.00 0.01 0.00 0.00 0.00 0.00 0.00 0.00 
2-Methyl-4-2,6,6-t 0.00 0.67 0.00 0.02 0.00 0.00 0.00 0.00 0.00 0.00 
cis-p-mentha-17,8- 0.00 0.20 0.06 0.49 0.59 0.03 0.06 0.47 1.00 0.97 
cis-beta-Terpineol 0.00 0.00 0.00 0.04 0.30 0.27 0.00 0.00 0.00 0.03 
Cyclohexanol, 1-
me 0.00 0.01 0.04 0.38 0.35 0.21 0.00 0.00 0.00 0.03 
3-buten-2-one, 4-5 0.00 0.00 0.00 0.06 0.05 0.41 0.00 0.02 0.04 0.17 
Camphene 0.00 0.01 0.00 0.13 0.02 0.79 0.00 0.00 0.01 0.00 
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Camphor 0.00 0.00 0.00 0.01 0.00 0.74 0.00 0.00 0.00 0.00 
Pinene 0.00 0.00 0.00 0.00 0.76 0.00 0.00 0.00 0.00 0.00 
Ocimene 0.00 0.01 0.00 0.00 0.38 0.01 0.00 0.00 0.00 0.00 
Terpineol 0.00 0.00 0.12 0.82 0.78 0.29 0.00 0.00 0.03 0.15 
Isoaromadendrene 
e 0.00 0.65 0.02 0.70 0.10 0.10 0.00 0.00 0.01 0.02 
Isoaromadendrene 
e 0.42 0.19 0.18 0.01 0.84 0.00 0.39 0.38 0.00 0.00 
Cholestan-3-ol, 2- 0.05 0.76 0.13 0.00 0.09 0.00 0.47 0.18 0.00 0.00 
Cubenol 0.30 0.38 0.21 0.00 0.10 0.01 0.13 0.58 0.13 0.67 
Aromadendrene 
oxid 0.70 0.24 0.74 0.13 0.05 0.01 0.35 0.30 0.07 0.00 
Dihydroartesmisini 0.08 0.15 0.07 0.06 0.00 0.00 0.32 0.59 0.13 0.87 
Artemisinin 0.01 0.00 0.00 0.00 0.00 0.03 0.49 0.57 0.18 0.29 
Phenol, 2-
methoxy- 0.16 0.25 0.06 0.01 0.00 0.00 0.30 0.81 0.09 0.25 
beta-Guaiene 0.06 0.33 0.75 0.09 0.00 0.00 0.23 0.59 0.07 0.64 
2H-Pyran, 2-7-hept 0.15 0.03 0.51 0.74 0.96 0.00 0.73 0.61 0.77 0.23 
Chiapin B 0.00 0.02 0.23 0.39 0.38 0.00 0.15 0.99 0.52 0.81 
beta-copaene 0.03 0.00 0.77 1.00 0.94 0.00 0.96 0.45 0.33 0.07 
Deoxyartemisinin 0.13 0.01 0.75 0.81 0.33 0.00 0.48 0.18 0.65 0.13 
Olean-12-en-3-one 0.63 0.00 0.73 0.03 0.42 0.36 0.96 0.64 0.06 0.79 
Caryophyllene 0.00 0.55 0.00 0.07 0.87 0.59 0.93 0.49 0.68 0.16 
Cyclohexane, 1-
eth 0.02 0.06 0.49 0.42 0.21 0.33 0.03 0.01 0.00 0.13 
Germacrene D 0.00 0.09 0.64 0.04 0.25 0.01 0.11 0.01 0.00 0.16 
Ylangene 0.00 0.11 0.48 0.02 0.20 0.00 0.05 0.00 0.00 0.06 
Copaene 0.00 0.14 0.63 0.03 0.22 0.00 0.06 0.01 0.00 0.09 
compound 1 0.00 0.01 0.00 0.03 0.03 0.00 0.01 0.00 0.02 0.06 
Eucalyptol 0.01 0.33 0.00 0.05 0.81 0.00 0.01 0.00 0.00 0.01 
Artemisinic acid 0.05 0.30 0.00 0.01 0.05 0.00 0.07 0.03 0.00 0.02 
cis-Z-alpha-Bisabo 0.52 0.05 0.00 0.00 0.43 0.47 0.08 0.45 0.42 0.46 
Isoaromadendrene 
e 0.68 0.03 0.49 0.35 0.94 0.07 0.05 0.19 0.01 0.23 
Heptacosane 0.11 0.06 0.47 0.97 0.00 0.67 0.27 0.29 0.87 0.04 
Unkown alkane 0.00 0.00 0.36 0.54 0.00 0.47 0.90 0.83 0.28 0.13 
endo-Borneol 0.06 0.46 0.14 0.02 0.00 0.08 0.90 0.82 0.58 0.67 
Caryophylene 
oxide 0.01 0.84 0.51 0.35 0.00 0.62 0.03 0.06 0.15 0.08 
Isoaromadendrene 
e 0.09 0.12 0.07 0.16 0.86 0.43 0.43 0.46 0.28 0.97 
Aromadendrene 
oxid 0.01 0.03 0.02 0.26 0.18 0.99 0.02 0.07 0.15 0.73 
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2H-Pyran, 2-7-hept 0.07 0.10 0.65 0.88 0.45 0.04 0.77 0.70 0.27 0.61 
1-Heptatriacotanol 0.22 0.47 0.31 0.97 0.22 0.55 0.12 0.26 0.76 0.49 
 


































ene 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
Cedren
-13-ol, 
8- 0.55 0.67 0.20 0.00 0.01 0.00 0.01 0.00 0.00 0.01 
Cymen
e 0.00 0.00 0.06 0.00 0.04 0.00 0.00 0.00 0.00 0.00 
Terpine
n 0.01 0.02 0.49 0.04 0.38 0.06 0.13 0.01 0.00 0.00 
Butanoi
c acid, 
2-m 0.00 0.00 0.59 0.30 0.35 0.05 0.02 0.00 0.76 0.38 
Neoint
ermede
ol 0.00 0.00 0.03 0.27 0.21 0.41 0.79 0.74 0.00 0.01 
Isoaro
maden




e, 0.00 0.00 0.47 0.00 0.00 0.02 0.00 0.00 0.00 0.00 
Elemen 0.00 0.00 1.00 0.00 0.00 0.04 0.01 0.00 0.00 0.00 
Epiglob
ulol 0.00 0.00 0.97 0.03 0.03 0.17 0.00 0.00 0.00 0.00 
Corym




2,6,6-t 0.00 NA 0.77 0.00 0.00 0.12 0.00 0.00 0.00 0.00 
cis-p-
mentha
-17,8- 0.62 0.77 NA 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
cis-











4-5 0.26 0.12 0.00 0.00 0.00 NA 0.00 0.00 0.00 0.00 
Camph
ene 0.01 0.00 0.00 0.00 0.00 0.00 NA 0.00 0.00 0.00 
Camph
or 0.00 0.00 0.00 0.00 0.00 0.00 0.00 NA 0.00 0.00 
Pinene 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 NA 0.00 
Ocimen
e 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 NA 
Terpine
ol 0.05 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
Isoaro
maden
drene e 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
Isoaro
maden
drene e 0.00 0.00 0.02 0.29 0.27 0.00 0.01 0.04 0.41 0.71 
Cholest
an-3-ol, 
2- 0.00 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.15 0.27 
Cubeno
l 0.49 0.89 0.09 0.26 0.16 0.00 0.00 0.01 0.56 0.89 
Aroma
dendre
ne oxid 0.02 0.07 0.01 0.00 0.00 0.00 0.09 0.12 0.22 0.35 
Dihydr
oartes
misini 0.21 0.13 0.00 0.48 0.94 0.00 0.01 0.00 0.48 0.24 
Artemi




y- 0.07 0.17 0.00 0.32 0.21 0.00 0.00 0.00 0.47 0.58 
beta-
Guaien
e 0.26 0.61 0.00 0.01 0.01 0.00 0.00 0.00 0.36 0.55 
2H-






B 0.29 0.51 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.02 
beta-
copaen
e 0.00 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.06 0.18 
Deoxya
rtemisi
nin 0.01 0.01 0.00 0.00 0.00 0.00 0.01 0.00 0.29 0.64 
Olean-
12-en-
3-one 0.65 0.49 0.75 0.66 0.54 0.61 0.96 0.12 0.60 0.51 
Caryop
hyllene 0.48 0.30 0.13 0.09 0.28 0.15 0.16 0.17 0.01 0.03 
Cycloh
exane, 
1-eth 0.17 0.24 0.42 0.83 0.69 0.81 0.40 0.17 0.97 0.70 
Germa
crene D 0.07 0.17 0.00 0.31 0.40 0.22 0.60 0.46 0.79 0.86 
ylange
ne 0.02 0.05 0.00 0.36 0.48 0.20 0.51 0.49 0.96 0.86 
copaen
e 0.03 0.08 0.00 0.30 0.41 0.18 0.44 0.41 0.81 0.77 
compo
und 1 0.00 0.00 0.11 0.18 0.25 0.02 0.01 0.39 0.01 0.01 
Eucalyp
tol 0.00 0.00 0.23 0.02 0.05 0.06 0.05 0.80 0.00 0.00 
Artemi
sinic 
acid 0.00 0.00 0.03 0.64 0.75 0.27 0.59 0.43 0.03 0.02 
cis-Z-
alpha-
Bisabo 0.41 0.25 0.83 0.71 0.75 0.53 0.19 0.43 0.05 0.12 
Isoaro
maden
drene e 0.32 0.12 0.21 0.33 0.22 0.88 0.42 0.30 0.20 0.49 
Heptac
osane 0.17 0.25 0.05 0.00 0.01 0.13 0.86 0.66 0.06 0.34 
Unkow
n 
alkane 0.60 0.78 0.16 0.00 0.00 0.03 0.44 0.98 0.01 0.05 
endo-
Borneo





oxide 0.23 0.13 0.00 0.00 0.00 0.00 0.00 0.09 0.00 0.00 
Isoaro
maden
drene e 0.72 0.48 0.09 0.02 0.03 0.18 0.56 0.07 0.07 0.63 
Aroma
dendre








ol 0.09 0.11 0.11 0.18 0.28 0.02 0.07 0.15 0.57 0.32 



































ene 0.00 0.00 0.42 0.05 0.30 0.70 0.08 0.01 0.16 0.06 
Cedren
-13-ol, 
8- 0.00 0.65 0.19 0.76 0.38 0.24 0.15 0.00 0.25 0.33 
Cymen
e 0.12 0.02 0.18 0.13 0.21 0.74 0.07 0.00 0.06 0.75 
Terpine
n 0.82 0.70 0.01 0.00 0.00 0.13 0.06 0.00 0.01 0.09 
Butanoi
c acid, 
2-m 0.78 0.10 0.84 0.09 0.10 0.05 0.00 0.00 0.00 0.00 
Neoint
ermede
ol 0.29 0.10 0.00 0.00 0.01 0.01 0.00 0.03 0.00 0.00 
Isoaro
maden




e, 0.00 0.00 0.38 0.18 0.58 0.30 0.59 0.57 0.81 0.59 




ulol 0.15 0.02 0.00 0.00 0.67 0.00 0.87 0.29 0.25 0.64 
Corym




2,6,6-t 0.00 0.00 0.00 0.01 0.89 0.07 0.13 0.68 0.17 0.61 
cis-p-
mentha




ol 0.00 0.00 0.29 0.00 0.26 0.00 0.48 0.00 0.32 0.01 
Cycloh
exanol, 




4-5 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
Camph
ene 0.00 0.00 0.01 0.00 0.00 0.09 0.01 0.00 0.00 0.00 
Camph
or 0.00 0.00 0.04 0.00 0.01 0.12 0.00 0.00 0.00 0.00 
Pinene 0.00 0.00 0.41 0.15 0.56 0.22 0.48 0.01 0.47 0.36 
Ocimen
e 0.00 0.00 0.71 0.27 0.89 0.35 0.24 0.02 0.58 0.55 
Terpine
ol NA 0.00 0.00 0.00 0.00 0.00 0.17 0.69 0.05 0.00 
Isoaro
maden
drene e 0.00 NA 0.01 0.00 0.00 0.00 0.81 0.75 0.09 0.00 
Isoaro
maden
drene e 0.00 0.01 NA 0.00 0.00 0.00 0.12 0.34 0.00 0.00 
Cholest
an-3-ol, 
2- 0.00 0.00 0.00 NA 0.00 0.00 0.44 0.25 0.00 0.00 
Cubeno
l 0.00 0.00 0.00 0.00 NA 0.00 0.57 0.57 0.00 0.00 
Aroma
dendre





misini 0.17 0.81 0.12 0.44 0.57 0.17 NA 0.00 0.02 0.00 
Artemi




y- 0.05 0.09 0.00 0.00 0.00 0.01 0.02 0.00 NA 0.00 
beta-
Guaien




hept 0.46 0.89 0.00 0.00 0.28 0.89 0.00 0.00 0.00 0.00 
Chiapin 
B 0.03 0.05 0.01 0.00 0.16 0.07 0.00 0.00 0.00 0.00 
beta-
copaen
e 0.02 0.10 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
Deoxya
rtemisi
nin 0.26 0.48 0.00 0.00 0.10 0.04 0.01 0.00 0.00 0.00 
Olean-
12-en-
3-one 0.03 0.00 0.44 0.09 0.12 0.05 0.96 0.00 0.12 0.29 
Caryop
hyllene 0.60 0.29 0.31 0.93 0.40 0.32 0.02 0.07 0.32 0.82 
Cycloh
exane, 
1-eth 0.50 0.17 0.56 0.08 0.32 0.43 0.21 0.10 0.25 0.60 
Germa
crene D 0.60 0.18 0.13 0.00 0.21 0.36 0.02 0.48 0.11 0.01 
ylange
ne 0.53 0.14 0.03 0.00 0.10 0.21 0.01 0.54 0.05 0.01 
copaen
e 0.51 0.16 0.04 0.00 0.13 0.27 0.01 0.45 0.07 0.01 
compo
und 1 0.00 0.00 0.57 0.46 0.21 0.08 0.60 0.13 0.16 0.60 
Eucalyp
tol 0.00 0.00 0.35 0.37 0.40 0.03 0.01 0.00 0.00 0.09 
Artemi
sinic 





Bisabo 0.56 0.20 0.04 0.16 0.00 0.42 0.84 0.56 0.01 0.01 
Isoaro
maden
drene e 0.01 0.16 1.00 0.65 0.01 0.01 0.00 0.17 0.30 0.83 
Heptac
osane 0.04 0.31 0.43 0.07 0.17 0.04 0.20 0.69 0.05 0.14 
Unkow
n 
alkane 0.00 0.05 0.63 0.25 0.22 0.01 0.08 0.31 0.01 0.03 
endo-
Borneo
l 0.00 0.13 0.55 0.01 0.72 0.06 0.28 0.79 0.12 0.46 
Caryop
hylene 
oxide 0.00 0.00 0.46 0.02 0.12 0.03 0.44 0.66 0.24 0.19 
Isoaro
maden
drene e 0.10 0.26 0.81 0.14 0.98 0.19 0.54 0.20 0.43 0.24 
Aroma
dendre








ol 0.28 0.02 0.08 0.40 0.66 0.92 0.05 0.63 0.60 0.19 


































ene 0.15 0.00 0.03 0.13 0.63 0.00 0.02 0.00 0.00 0.00 
Cedren
-13-ol, 
8- 0.03 0.02 0.00 0.01 0.00 0.55 0.06 0.09 0.11 0.14 
Cymen
e 0.51 0.23 0.77 0.75 0.73 0.00 0.49 0.64 0.48 0.63 
Terpine





2-m 0.96 0.38 0.94 0.33 0.42 0.87 0.21 0.25 0.20 0.22 
Neoint
ermede
ol 0.00 0.00 0.00 0.00 0.36 0.59 0.33 0.01 0.00 0.00 
Isoaro
maden




e, 0.61 0.99 0.45 0.18 0.64 0.49 0.01 0.01 0.00 0.01 
Elemen 0.77 0.52 0.33 0.65 0.06 0.68 0.00 0.00 0.00 0.00 
Epiglob
ulol 0.23 0.81 0.07 0.13 0.79 0.16 0.13 0.16 0.06 0.09 
Corym




2,6,6-t 0.12 0.51 0.01 0.01 0.49 0.30 0.24 0.17 0.05 0.08 
cis-p-
mentha




ol 0.00 0.00 0.00 0.00 0.66 0.09 0.83 0.31 0.36 0.30 
Cycloh
exanol, 




4-5 0.00 0.00 0.00 0.00 0.61 0.15 0.81 0.22 0.20 0.18 
Camph
ene 0.04 0.00 0.00 0.01 0.96 0.16 0.40 0.60 0.51 0.44 
Camph
or 0.00 0.00 0.00 0.00 0.12 0.17 0.17 0.46 0.49 0.41 
Pinene 0.39 0.00 0.06 0.29 0.60 0.01 0.97 0.79 0.96 0.81 
Ocimen
e 0.73 0.02 0.18 0.64 0.51 0.03 0.70 0.86 0.86 0.77 
Terpine





drene e 0.89 0.05 0.10 0.48 0.00 0.29 0.17 0.18 0.14 0.16 
Isoaro
maden
drene e 0.00 0.01 0.00 0.00 0.44 0.31 0.56 0.13 0.03 0.04 
Cholest
an-3-ol, 
2- 0.00 0.00 0.00 0.00 0.09 0.93 0.08 0.00 0.00 0.00 
Cubeno
l 0.28 0.16 0.00 0.10 0.12 0.40 0.32 0.21 0.10 0.13 
Aroma
dendre
ne oxid 0.89 0.07 0.00 0.04 0.05 0.32 0.43 0.36 0.21 0.27 
Dihydr
oartes
misini 0.00 0.00 0.00 0.01 0.96 0.02 0.21 0.02 0.01 0.01 
Artemi




y- 0.00 0.00 0.00 0.00 0.12 0.32 0.25 0.11 0.05 0.07 
beta-
Guaien




hept NA 0.00 0.00 0.00 0.02 0.55 0.08 0.40 0.21 0.23 
Chiapin 
B 0.00 NA 0.00 0.00 0.01 0.73 0.06 0.26 0.23 0.22 
beta-
copaen
e 0.00 0.00 NA 0.00 0.00 0.52 0.05 0.33 0.18 0.20 
Deoxya
rtemisi
nin 0.00 0.00 0.00 NA 0.00 0.83 0.03 0.37 0.30 0.32 
Olean-
12-en-
3-one 0.02 0.01 0.00 0.00 NA 0.03 0.00 0.00 0.00 0.00 
Caryop
hyllene 0.55 0.73 0.52 0.83 0.03 NA 0.00 0.00 0.00 0.00 
Cycloh
exane, 




crene D 0.40 0.26 0.33 0.37 0.00 0.00 0.00 NA 0.00 0.00 
ylange
ne 0.21 0.23 0.18 0.30 0.00 0.00 0.00 0.00 NA 0.00 
Copaen
e 0.23 0.22 0.20 0.32 0.00 0.00 0.00 0.00 0.00 NA 
compo
und 1 0.00 0.01 0.00 0.00 0.01 0.08 0.11 0.74 0.72 0.82 
Eucalyp
tol 0.00 0.00 0.00 0.00 0.00 0.11 0.06 0.69 0.53 0.60 
Artemi
sinic 
acid 0.00 0.00 0.00 0.00 0.00 0.08 0.02 0.68 0.53 0.57 
cis-Z-
alpha-
Bisabo 0.25 0.58 0.59 0.68 0.30 0.87 0.85 0.23 0.19 0.19 
Isoaro
maden
drene e 0.00 0.29 0.83 0.90 0.07 0.27 0.04 0.01 0.00 0.00 
Heptac
osane 0.00 0.24 0.25 0.11 0.19 0.21 0.23 0.14 0.11 0.12 
Unkow
n 
alkane 0.24 0.88 0.87 0.84 0.23 0.32 0.32 0.73 0.66 0.65 
endo-
Borneo
l 0.05 0.05 0.05 0.01 0.23 0.71 0.90 0.27 0.21 0.21 
Caryop
hylene 
oxide 0.25 0.05 0.12 0.06 0.00 0.28 0.70 0.48 0.51 0.49 
Isoaro
maden
drene e 0.26 0.21 0.19 0.20 0.34 0.33 0.65 0.46 0.50 0.48 
Aroma
dendre








ol 0.00 0.18 0.64 0.98 0.13 0.68 0.29 0.11 0.04 0.05 






































ene 0.00 0.01 0.05 0.52 0.68 0.11 0.00 0.06 0.01 0.09 
Cedren
-13-ol, 
8- 0.01 0.33 0.30 0.05 0.03 0.06 0.00 0.46 0.84 0.12 
Cymen
e 0.00 0.00 0.00 0.00 0.49 0.47 0.36 0.14 0.51 0.07 
Terpine
n 0.03 0.05 0.01 0.00 0.35 0.97 0.54 0.02 0.35 0.16 
Butanoi
c acid, 
2-m 0.03 0.81 0.05 0.43 0.94 0.00 0.00 0.00 0.00 0.86 
Neoint
ermede
ol 0.00 0.00 0.00 0.47 0.07 0.67 0.47 0.08 0.62 0.43 
Isoaro
maden




e, 0.00 0.00 0.03 0.45 0.19 0.29 0.83 0.82 0.06 0.46 
Elemen 0.02 0.00 0.00 0.42 0.01 0.87 0.28 0.58 0.15 0.28 
Epiglob
ulol 0.06 0.01 0.02 0.46 0.23 0.04 0.13 0.67 0.08 0.97 
Corym




2,6,6-t 0.00 0.00 0.00 0.25 0.12 0.25 0.78 0.44 0.13 0.48 
cis-p-
mentha




ol 0.18 0.02 0.64 0.71 0.33 0.00 0.00 0.00 0.00 0.02 
Cycloh
exanol, 






4-5 0.02 0.06 0.27 0.53 0.88 0.13 0.03 0.03 0.00 0.18 
Camph
ene 0.01 0.05 0.59 0.19 0.42 0.86 0.44 0.06 0.00 0.56 
Camph
or 0.39 0.80 0.43 0.43 0.30 0.66 0.98 0.51 0.09 0.07 
Pinene 0.01 0.00 0.03 0.05 0.20 0.06 0.01 0.07 0.00 0.07 
Ocimen
e 0.01 0.00 0.02 0.12 0.49 0.34 0.05 0.16 0.00 0.63 
Terpine
ol 0.00 0.00 0.01 0.56 0.01 0.04 0.00 0.00 0.00 0.10 
Isoaro
maden
drene e 0.00 0.00 0.00 0.20 0.16 0.31 0.05 0.13 0.00 0.26 
Isoaro
maden
drene e 0.57 0.35 0.10 0.04 1.00 0.43 0.63 0.55 0.46 0.81 
Cholest
an-3-ol, 
2- 0.46 0.37 0.02 0.16 0.65 0.07 0.25 0.01 0.02 0.14 
Cubeno
l 0.21 0.40 0.65 0.00 0.01 0.17 0.22 0.72 0.12 0.98 
Aroma
dendre
ne oxid 0.08 0.03 0.19 0.42 0.01 0.04 0.01 0.06 0.03 0.19 
Dihydr
oartes
misini 0.60 0.01 0.34 0.84 0.00 0.20 0.08 0.28 0.44 0.54 
Artemi




y- 0.16 0.00 0.00 0.01 0.30 0.05 0.01 0.12 0.24 0.43 
beta-
Guaien




hept 0.00 0.00 0.00 0.25 0.00 0.00 0.24 0.05 0.25 0.26 
Chiapin 





e 0.00 0.00 0.00 0.59 0.83 0.25 0.87 0.05 0.12 0.19 
Deoxya
rtemisi
nin 0.00 0.00 0.00 0.68 0.90 0.11 0.84 0.01 0.06 0.20 
Olean-
12-en-
3-one 0.01 0.00 0.00 0.30 0.07 0.19 0.23 0.23 0.00 0.34 
Caryop
hyllene 0.08 0.11 0.08 0.87 0.27 0.21 0.32 0.71 0.28 0.33 
Cycloh
exane, 
1-eth 0.11 0.06 0.02 0.85 0.04 0.23 0.32 0.90 0.70 0.65 
Germa
crene D 0.74 0.69 0.68 0.23 0.01 0.14 0.73 0.27 0.48 0.46 
ylange
ne 0.72 0.53 0.53 0.19 0.00 0.11 0.66 0.21 0.51 0.50 
copaen
e 0.82 0.60 0.57 0.19 0.00 0.12 0.65 0.21 0.49 0.48 
compo
und 1 NA 0.00 0.00 0.54 0.12 0.59 0.00 0.26 0.33 0.20 
Eucalyp
tol 0.00 NA 0.00 0.16 0.01 0.14 0.00 0.48 0.00 0.26 
Artemi
sinic 
acid 0.00 0.00 NA 0.07 0.25 0.86 0.01 0.19 0.26 0.47 
cis-Z-
alpha-
Bisabo 0.54 0.16 0.07 NA 0.28 0.16 0.05 0.30 0.23 0.06 
Isoaro
maden
drene e 0.12 0.01 0.25 0.28 NA 0.01 0.58 0.21 0.43 0.11 
Heptac
osane 0.59 0.14 0.86 0.16 0.01 NA 0.00 0.00 0.00 0.26 
Unkow
n 
alkane 0.00 0.00 0.01 0.05 0.58 0.00 NA 0.00 0.00 0.19 
endo-
Borneo
l 0.26 0.48 0.19 0.30 0.21 0.00 0.00 NA 0.00 0.91 
Caryop
hylene 
oxide 0.33 0.00 0.26 0.23 0.43 0.00 0.00 0.00 NA 0.90 
Isoaro
maden













ol 0.17 0.61 0.63 0.08 0.00 0.00 0.07 0.35 0.11 0.92 

















ene 0.01 0.07 0.22        
Cedren
-13-ol, 
8- 0.03 0.10 0.47        
Cymen
e 0.02 0.65 0.31        
Terpine
n 0.26 0.88 0.97        
Butanoi
c acid, 
2-m 0.18 0.45 0.22        
Neoint
ermede
ol 0.99 0.04 0.55        
Isoaro
maden




e, 0.07 0.70 0.26        
Elemen 0.15 0.27 0.76        
Epiglob
ulol 0.73 0.61 0.49        
Corym
bolone 0.18 0.75 0.09        
2-











ol 0.00 0.01 0.18        
Cycloh
exanol, 




4-5 0.00 0.00 0.02        
Camph
ene 0.00 0.01 0.07        
Camph
or 0.00 0.00 0.15        
Pinene 0.01 0.17 0.57        
Ocimen
e 0.04 0.35 0.32        
Terpine
ol 0.00 0.20 0.28        
Isoaro
maden
drene e 0.00 0.44 0.02        
Isoaro
maden
drene e 0.00 0.01 0.08        
Cholest
an-3-ol, 
2- 0.00 0.02 0.40        
Cubeno
l 0.13 0.93 0.66        
Aroma
dendre
ne oxid 0.02 0.56 0.92        
Dihydr
oartes
misini 0.02 0.00 0.05        
Artemi
sinin 0.02 0.02 0.63        
Phenol, 











hept 0.00 0.00 0.00        
Chiapin 
B 0.00 0.01 0.18        
beta-
copaen
e 0.00 0.01 0.64        
Deoxya
rtemisi
nin 0.01 0.09 0.98        
Olean-
12-en-
3-one 0.50 0.28 0.13        
Caryop
hyllene 0.67 0.36 0.68        
Cycloh
exane, 
1-eth 0.99 0.28 0.29        
Germa
crene D 0.27 0.04 0.11        
ylange
ne 0.14 0.01 0.04        
copaen
e 0.14 0.01 0.05        
compo
und 1 0.02 0.83 0.17        
Eucalyp
tol 0.32 0.34 0.61        
Artemi
sinic 
acid 0.56 0.39 0.63        
cis-Z-
alpha-
Bisabo 0.44 0.36 0.08        
Isoaro
maden
drene e 0.00 0.00 0.00        
Heptac





alkane 0.00 0.02 0.07        
endo-
Borneo
l 0.19 0.23 0.35        
Caryop
hylene 
oxide 0.02 0.53 0.11        
Isoaro
maden
drene e 0.07 0.82 0.92        
Aroma
dendre















Metabolite yield  
Genotype  ART SD SE AA SD SE DHAA SD SE 
A 0.011408 0.001871 0.000764 0.000232 0.000277 0.000113 0.015210 0.001708 0.000697 
B 0.008801 0.000550 0.000246 0.000244 0.000241 0.000108 0.014743 0.001116 0.000499 
C 0.014655 0.001793 0.000732 0.000784 0.000259 0.000106 0.014268 0.000408 0.000167 
D 0.008683 0.000786 0.000321 0.000804 0.000122 4.97E-05 0.020835 0.002108 0.000861 
E 0.008449 0.001922 0.000784 0.000796 0.000438 0.000179 0.027917 0.005543 0.002263 
F 0.004125 0.000595 0.000266 0.000306 0.000311 0.000139 0.011540 0.000528 0.000236 
G 0.019329 0.001774 0.000724 0.001413 0.000274 0.000112 0.035164 0.008954 0.003655 
H 0.004274 0.000337 0.000138 0.005298 0.001204 0.000491 0.007711 0.001886 0.000770 
I 0.016653 0.001138 0.000465 0.000228 0.000190 7.75E-05 0.026225 0.003721 0.001519 
J 0.024241 0.002094 0.000855 0.000829 0.000488 0.000199 0.070899 0.020968 0.008560 
118 
 
K 0.011603 0.001346 0.000550 0.000272 0.000147 6.00E-05 0.016682 0.001176 0.000480 
L 0.011526 0.001012 0.000413 0.000270 0.000109 4.46E-05 0.010091 0.000650 0.000265 
 
Genotype Camphor SD SE 
endo 
borneol SD SE 
A 1.478932 0.125588 0.051271 1.608464 0.268925 0.109788 
B 0.718140 0.032026 0.014323 0.009653 0.000928 0.000415 
C 2.109206 0.119811 0.048913 0.064204 0.007464 0.003047 
D 0.000107 0.000261 0.000107 0 0.000000 0.000000 
E 0.000807 0.001189 0.000485 8.13E-05 0.000199 0.000081 
F 0.000753 0.001226 0.000548 0 0.000000 0.000000 
G 1.018489 0.094753 0.038683 0.006622 0.000815 0.000333 
H 1.087971 0.121629 0.049655 0.024581 0.003990 0.001629 
I 1.834355 0.189417 0.077329 0.028382 0.004165 0.001700 
J 3.048455 0.350242 0.142986 0.033854 0.005285 0.002158 
K 2.887858 0.239312 0.097699 0.02048 0.003225 0.001317 
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mRNA abundance graphs 
 
 
Figure 1: Relative mRNA abundance of HMGR gene within the 12 A. annua genotypes of the WVU 
germplasm collection. mRNA abundance was measured and averaged (n=3) with young, unexpanded leaf 
materials collect from plants grown for 45 days.  Error bars indicate standard error and statistical analysis 





























Figure 2: Relative mRNA abundance of DXS1 gene within the 12 A. annua genotypes of the WVU 
germplasm collection. mRNA abundance was measured and averaged (n=3) with young, unexpanded leaf 
materials collect from plants grown for 45 days.  Error bars indicate standard error and statistical analysis 
indicated none of the genotypes are significantly different (Tukey’s test, α=0.05). 
 
 
Figure 3: Relative mRNA abundance of DXR1 gene within the 12 A. annua genotypes of the WVU 
germplasm collection. mRNA abundance was measured and averaged (n=3) with young, unexpanded leaf 
materials collect from plants grown for 45 days.  Error bars indicate standard error and statistical analysis 


















































Figure 4: Relative mRNA abundance of ADS gene within the 12 A. annua genotypes of the WVU germplasm 
collection. mRNA abundance was measured and averaged (n=3) with young, unexpanded leaf materials 
collect from plants grown for 45 days.  Error bars indicate standard error and statistical analysis indicated 
none of the genotypes are significantly different (Tukey’s test, α=0.05).  
 
 
Figure 5: Relative mRNA abundance of CYP7AV1 gene within the 12 A. annua genotypes of the WVU 
germplasm collection. mRNA abundance was measured and averaged (n=3) with young, unexpanded leaf 
materials collect from plants grown for 45 days.  Error bars indicate standard error and statistical analysis 













































Figure 6: Relative mRNA abundance of ADH1 gene within the 12 A. annua genotypes of the WVU 
germplasm collection. mRNA abundance was measured and averaged (n=3) with young, unexpanded leaf 
materials collect from plants grown for 45 days.  Error bars indicate standard error and statistical analysis 
indicated none of the genotypes are significantly different (Tukey’s test, α=0.05). 
 
 
Figure 7: Relative mRNA abundance of ALDH1 gene within the 12 A. annua genotypes of the WVU 
germplasm collection. mRNA abundance was measured and averaged (n=3) with young, unexpanded leaf 
materials collect from plants grown for 45 days.  Error bars indicate standard error and statistical analysis 

















































Figure 8: Relative mRNA abundance of ERF1 gene within the 12 A. annua genotypes of the WVU 
germplasm collection. mRNA abundance was measured and averaged (n=3) with young, unexpanded leaf 
materials collect from plants grown for 45 days.  Error bars indicate standard error and statistical analysis 
indicated none of the genotypes are significantly different (Tukey’s test, α=0.05). 
 
 
Figure 9: Relative mRNA abundance of ORA gene within the 12 A. annua genotypes of the WVU germplasm 
collection. mRNA abundance was measured and averaged (n=3) with young, unexpanded leaf materials 
collect from plants grown for 45 days.  Error bars indicate standard error and statistical analysis indicated 



















































Figure 10: Relative mRNA abundance of MYC2 gene within the 12 A. annua genotypes of the WVU 
germplasm collection. mRNA abundance was measured and averaged (n=3) with young, unexpanded leaf 
materials collect from plants grown for 45 days.  Error bars indicate standard error and statistical analysis 
indicated none of the genotypes are significantly different (Tukey’s test, α=0.05).  
 
 
Figure 11: Relative mRNA abundance of WARKY1 gene within the 12 A. annua genotypes of the WVU 
germplasm collection. mRNA abundance was measured and averaged (n=3) with young, unexpanded leaf 
materials collect from plants grown for 45 days.  Error bars indicate standard error and statistical analysis 


















































Figure 12: Relative mRNA abundance of PYL9 gene within the 12 A. annua genotypes of the WVU 
germplasm collection. mRNA abundance was measured and averaged (n=3) with young, unexpanded leaf 
materials collect from plants grown for 45 days.  Error bars indicate standard error and statistical analysis 
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